Search by PubMed Identification
PMID | Data | Article Title | Citation | Organization | Data Download |
---|---|---|---|---|---|
24999828 | 2 | In vitro evaluation of potential bitterness-masking terpenoids from the Canada goldenrod (Solidago canadensis). | J Nat Prod 77: 1739-43 (2014) | The Ohio State University | 2D 3D TSV |
24999749 | 1 | A potent HDAC inhibitor, 1-alaninechlamydocin, from a Tolypocladium sp. induces G2/M cell cycle arrest and apoptosis in MIA PaCa-2 cells. | J Nat Prod 77: 1753-7 (2014) | University of Oklahoma | 2D 3D TSV |
24999562 | 10 | Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2. | J Med Chem 57: 6583-93 (2014) | Tokyo University of Pharmacy and Life Sciences | 2D 3D TSV |
24998602 | 17 | Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors. | Eur J Med Chem 83: 617-29 (2014) | Universit£ de Lyon | 2D 3D TSV |
24998378 | 62 | Discovery of triazines as selective PDE4B versus PDE4D inhibitors. | Bioorg Med Chem Lett 24: 4031-4 (2014) | Northern Illinois University | 2D 3D TSV |
24997687 | 3 | Inhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity. | Bioorg Med Chem Lett 24: 4019-22 (2014) | University of Utah | 2D 3D TSV |
24997686 | 9 | Synthesis and biological evaluation of 2,3'-diindolylmethanes as agonists of aryl hydrocarbon receptor. | Bioorg Med Chem Lett 24: 4023-5 (2014) | University of Wisconsin | 2D 3D TSV |
24997685 | 39 | The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1). | Bioorg Med Chem Lett 24: 3974-8 (2014) | The Scripps Research Institute | 2D 3D TSV |
24997578 | 41 | Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors. | Bioorg Med Chem 22: 3850-5 (2014) | University of Rajshahi | 2D 3D TSV |
24997577 | 17 | Structure-based optimization and biological evaluation of trisubstituted pyrazole as a core structure of potent ROS1 kinase inhibitors. | Bioorg Med Chem 22: 3871-8 (2014) | Yonsei University | 2D 3D TSV |
24997293 | 16 | Pyridopyrimidinone inhibitors of HIV-1 RNase H. | Eur J Med Chem 83: 609-16 (2014) | GlaxoSmithKline | 2D 3D TSV |
24996144 | 20 | Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents. | Eur J Med Chem 83: 581-93 (2014) | Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University) | 2D 3D TSV |
24996140 | 26 | Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands. | Eur J Med Chem 83: 534-46 (2014) | Jagiellonian University Medical College | 2D 3D TSV |
24996139 | 26 | Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane baseds1 receptor ligands. | Eur J Med Chem 83: 526-33 (2014) | University of Trieste | 2D 3D TSV |
24992874 | 58 | Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kß/d inhibitors for the treatment of PTEN-deficient tumours. | Bioorg Med Chem Lett 24: 3928-35 (2014) | AstraZeneca | 2D 3D TSV |
24992702 | 2 | Spongiapyridine and related spongians isolated from an Indonesian Spongia sp. | J Nat Prod 77: 1644-9 (2014) | University of Hawaii at Manoa | 2D 3D TSV |
24992374 | 33 | Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor. | J Med Chem 57: 5965-74 (2014) | University of Naples"Federico II" | 2D 3D TSV |
24992074 | 35 | Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors. | Eur J Med Chem 83: 466-73 (2014) | Wuhan University School of Pharmaceutical Sciences | 2D 3D TSV |
24992073 | 2 | A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo. | Eur J Med Chem 83: 455-65 (2014) | Universit£ Grenoble Alpes | 2D 3D TSV |
24992072 | 10 | Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties. | Eur J Med Chem 83: 448-54 (2014) | Universiti Sains Malaysia | 2D 3D TSV |
24992070 | 51 | High affinity ligands and potent antagonists for thea1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives. | Eur J Med Chem 83: 419-32 (2014) | Universit£ di Catania | 2D 3D TSV |
24988361 | 28 | Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipasea anda/ß-hydrolase domain 6. | J Med Chem 57: 6610-22 (2014) | Leiden University | 2D 3D TSV |
24986657 | 56 | Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies. | Bioorg Med Chem Lett 24: 3278-84 (2014) | Ministry of Health of Turkey | 2D 3D TSV |
24984937 | 22 | Benzoquinones as inhibitors of botulinum neurotoxin serotype A. | Bioorg Med Chem 22: 3971-81 (2014) | The Scripps Research Institute | 2D 3D TSV |
24984936 | 28 | Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix. | Bioorg Med Chem 22: 3989-93 (2014) | Tufts University | 2D 3D TSV |
24984935 | 24 | Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB2R selective benzimidazoles reveal unexpected intrinsic properties. | Bioorg Med Chem 22: 3938-46 (2014) | Julius-Maximilians-Universit£t W£rzburg | 2D 3D TSV |
24984230 | 22 | Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis. | J Med Chem 57: 5893-903 (2014) | Leo Pharma A/S | 2D 3D TSV |
24983663 | 8 | Development of first lead structures for phosphoinositide 3-kinase-C2¿ inhibitors. | J Med Chem 58: 212-21 (2015) | Eberhard Karls University Tuebingen | 2D 3D TSV |
24983538 | 16 | Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies. | Eur J Med Chem 83: 398-408 (2014) | Minia University | 2D 3D TSV |
24983484 | 11 | Toward fluorescent probes for G-protein-coupled receptors (GPCRs). | J Med Chem 57: 8187-203 (2014) | Shandong University | 2D 3D TSV |
24980703 | 296 | Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors. | Bioorg Med Chem 22: 4135-50 (2014) | Nerviano Medical Sciences | 2D 3D TSV |
24980117 | 62 | Synthesis ofa,ß-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloidß-induced cytotoxicity. | Eur J Med Chem 83: 355-65 (2014) | Universiti Kebangsaan Malaysia | 2D 3D TSV |
24980116 | 3 | Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers. | Eur J Med Chem 83: 344-54 (2014) | CSIR-Indian Institute of Chemical Technology | 2D 3D TSV |
24980056 | 44 | Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites. | Bioorg Med Chem Lett 24: 3255-9 (2014) | Universit£ di Camerino | 2D 3D TSV |
24980053 | 153 | Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonists. | Bioorg Med Chem Lett 24: 3268-73 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24980052 | 37 | Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: part II. | Bioorg Med Chem Lett 24: 3238-42 (2014) | Glenmark Pharmaceuticals Ltd | 2D 3D TSV |
24977643 | 9 | Broad-spectrum allosteric inhibition of herpesvirus proteases. | Biochemistry 53: 4648-60 (2014) | University of California San Francisco | 2D 3D TSV |
24976941 | 2 | Design of symmetrical and nonsymmetrical | Medchemcomm 2013: 693-696 (2013) | Imperial College | 2D 3D TSV |
24974351 | 36 | Novel, potent and selective 17ß-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities. | Eur J Med Chem 83: 317-37 (2014) | Saarland University | 2D 3D TSV |
24974349 | 20 | Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking. | Eur J Med Chem 83: 294-306 (2014) | The Second People's Hospital of Fujian Provinc | 2D 3D TSV |
24974342 | 33 | The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists. | Bioorg Med Chem Lett 24: 3285-90 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24974340 | 90 | Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors. | Bioorg Med Chem Lett 24: 3234-7 (2014) | Korea University | 2D 3D TSV |
24973818 | 70 | Pyrrolo- and pyridomorphinans: non-selective opioid antagonists and delta opioid agonists/mu opioid partial agonists. | Bioorg Med Chem 22: 4067-72 (2014) | University of Bath | 2D 3D TSV |
24973662 | 8 | Targeting integrinsavß3 anda5ß1 with newß-lactam derivatives. | Eur J Med Chem 83: 284-93 (2014) | University of Bologna | 2D 3D TSV |
24973661 | 10 | 9- and 11-substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma. | Eur J Med Chem 83: 274-83 (2014) | Technische Universit£t Braunschweig | 2D 3D TSV |
24973660 | 150 | Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides. | Eur J Med Chem 83: 256-73 (2014) | Jagiellonian University Medical College | 2D 3D TSV |
24973029 | 57 | Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists. | Bioorg Med Chem Lett 24: 3516-20 (2014) | Lund University | 2D 3D TSV |
24973028 | 29 | Synthesis and biological evaluation ofa-1-C-4'-arylbutyl-L-arabinoiminofuranoses, a new class ofa-glucosidase inhibitors. | Bioorg Med Chem Lett 24: 3298-301 (2014) | Tohoku Pharmaceutical University | 2D 3D TSV |
24972725 | 6 | Effect of p-aminophenols on tyrosinase activity. | Bioorg Med Chem 22: 3994-4000 (2014) | Hoshi University | 2D 3D TSV |
24972724 | 16 | Influence of azide incorporation on binding affinity by small papain inhibitors. | Bioorg Med Chem 22: 5593-603 (2014) | Radboud University Nijmegen | 2D 3D TSV |
24972328 | 26 | Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii. | J Nat Prod 77: 1663-9 (2014) | University of Szeged | 2D 3D TSV |
24972256 | 2 | 2-Hexylthio-ß,¿-CH2-ATP is an effective and selective NTPDase2 inhibitor. | J Med Chem 57: 5919-34 (2014) | Bar-Ilan University | 2D 3D TSV |
24972108 | 256 | Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study. | J Med Chem 57: 6210-25 (2014) | Universit£ di Trieste | 2D 3D TSV |
24972008 | 36 | 1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. | J Med Chem 57: 6259-65 (2014) | Sapienza University of Rome | 2D 3D TSV |
24971742 | 4 | KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor. | J Med Chem 57: 5975-85 (2014) | National Tsing Hua University | 2D 3D TSV |
24969016 | 16 | Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor. | Bioorg Med Chem Lett 24: 3302-6 (2014) | National Institute of Diabetes and Digestive and Kidney Diseases | 2D 3D TSV |
24969015 | 118 | Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety. | Bioorg Med Chem Lett 24: 3307-14 (2014) | Vanderbilt University Medical Center | 2D 3D TSV |
24967731 | 2 | Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system. | J Med Chem 57: 6572-82 (2014) | AstraZeneca | 2D 3D TSV |
24967667 | 45 | Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists. | J Med Chem 57: 6128-40 (2014) | AstraZeneca | 2D 3D TSV |
24962584 | 2 | Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells. | J Biol Chem 289: 22078-89 (2014) | National Taiwan University | 2D 3D TSV |
24961874 | 5 | Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening. | Bioorg Med Chem 22: 4042-8 (2014) | Universit£ Paris 13 | 2D 3D TSV |
24961642 | 82 | Discovery and SAR of a novel series of metabotropic glutamate receptor 5 positive allosteric modulators with high ligand efficiency. | Bioorg Med Chem Lett 24: 3641-6 (2014) | Vanderbilt University Medical Center | 2D 3D TSV |
24960438 | 24 | Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17ß-hydroxysteroid dehydrogenase 2 inhibitors. | J Med Chem 57: 5995-6007 (2014) | University of Innsbruck | 2D 3D TSV |
24960305 | 11 | Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine. | J Med Chem 57: 7838-58 (2014) | Merck Research Laboratories | 2D 3D TSV |
24960234 | 6 | Lower homologues of ahpatinin, aspartic protease inhibitors, from a marine Streptomyces sp. | J Nat Prod 77: 1749-52 (2014) | The University of Tokyo | 2D 3D TSV |
24959987 | 2 | Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene. | J Nat Prod 77: 1670-7 (2014) | Aichi Gakuin University | 2D 3D TSV |
24959892 | 152 | Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099). | J Med Chem 57: 6060-82 (2014) | AstraZeneca | 2D 3D TSV |
24959717 | 30 | Discovery of inter-domain stabilizers-a novel assay system for allosteric akt inhibitors. | ACS Chem Biol 10: 279-88 (2015) | Technische Universit??t Dortmund | 2D 3D TSV |
24957878 | 1 | i-Motif DNA: structure, stability and targeting with ligands. | Bioorg Med Chem 22: 4407-18 (2014) | University of East Anglia | 2D 3D TSV |
24955889 | 16 | Bioactive diterpenoids and flavonoids from the aerial parts of Scoparia dulcis. | J Nat Prod 77: 1594-600 (2014) | Institute of Chinese Materia Medica | 2D 3D TSV |
24955776 | 166 | Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency. | J Med Chem 57: 6679-703 (2014) | University of Bonn | 2D 3D TSV |
24954515 | 21 | Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. | Bioorg Med Chem 22: 4099-108 (2014) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
24954438 | 13 | Synthesis and evaluation of salicylanilide derivatives as potential epidermal growth factor receptor inhibitors. | Chem Biol Drug Des 85: 280-9 (2015) | Anhui University of Chinese Medicine | 2D 3D TSV |
24953950 | 30 | Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF). | Bioorg Med Chem 22: 4124-34 (2014) | Freie Universit£t Berlin | 2D 3D TSV |
24953948 | 33 | Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. | Bioorg Med Chem 22: 4223-32 (2014) | Birla Institute of Technology & Science-Pilani | 2D 3D TSV |
24953821 | 4 | Synthesis and biological evaluation of 4-aza-2,3-dihydropyridophenanthrolines as tubulin polymerization inhibitors. | Bioorg Med Chem Lett 24: 3356-60 (2014) | CSIR-Indian Institute of Chemical Technology | 2D 3D TSV |
24953819 | 49 | Development of novel azabenzofuran TRPA1 antagonists as in vivo tools. | Bioorg Med Chem Lett 24: 3464-8 (2014) | Amgen Inc | 2D 3D TSV |
24953602 | 12 | Synthesis of bi-/tricyclic azasugars fused thiazinan-4-one and their HIV-RT inhibitory activity. | Bioorg Med Chem Lett 24: 3426-9 (2014) | Hebei University | 2D 3D TSV |
24953600 | 35 | Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B. | Bioorg Med Chem Lett 24: 3337-40 (2014) | Chonnam National University | 2D 3D TSV |
24953599 | 26 | Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines. | Bioorg Med Chem Lett 24: 3469-74 (2014) | The Institute of Cancer Research | 2D 3D TSV |
24952377 | 10 | A novel 2-oxoindolinylidene inhibitor of bacterial MurD ligase: Enzyme kinetics, protein-inhibitor binding by NMR and a molecular dynamics study. | Eur J Med Chem 83: 92-101 (2014) | Slovenia National Institute of Chemistry | 2D 3D TSV |
24952376 | 2 | 4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells. | Eur J Med Chem 83: 74-83 (2014) | Ocean University of China | 2D 3D TSV |
24951334 | 34 | Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors. | Bioorg Med Chem Lett 24: 3351-5 (2014) | Central China Normal University | 2D 3D TSV |
24951332 | 3 | Conformational analysis of an anti-androgenic, (E,E)-8-hydroxygermacrene B, using NOESY and dynamic NMR spectroscopy. | Bioorg Med Chem Lett 24: 3526-9 (2014) | Naresuan University | 2D 3D TSV |
24951331 | 5 | Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3ß of substituted quinolines. | Bioorg Med Chem Lett 24: 3392-7 (2014) | Kansas State University | 2D 3D TSV |
24951330 | 25 | Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties. | Bioorg Med Chem Lett 24: 3341-5 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24950374 | 9 | 2',6'-Dihalostyrylanilines, pyridines, and pyrimidines for the inhibition of the catalytic subunit of methionine S-adenosyltransferase-2. | J Med Chem 57: 6083-91 (2014) | University of Kentucky | 2D 3D TSV |
24949913 | 13 | Vascular L-type Ca²¿ channel blocking activity of sulfur-containing indole alkaloids from Glycosmis petelotii. | J Nat Prod 77: 1586-93 (2014) | Vietnam Academy of Science and Technology | 2D 3D TSV |
24949551 | 22 | Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides. | J Med Chem 57: 5829-34 (2014) | Philipps-Universit£t Marburg | 2D 3D TSV |
24948568 | 41 | 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists. | Bioorg Med Chem Lett 24: 4039-43 (2014) | Seoul National University | 2D 3D TSV |
24948567 | 3 | Base-dependent formation of cis and trans olefins and their application in the synthesis of 5-oxo-ETE receptor antagonists. | Bioorg Med Chem Lett 24: 3385-8 (2014) | Florida Institute of Technology | 2D 3D TSV |
24948566 | 11 | Structural revision of kynapcin-12 by total synthesis, and inhibitory activities against prolyl oligopeptidase and cancer cells. | Bioorg Med Chem Lett 24: 3373-6 (2014) | RIKEN | 2D 3D TSV |
24948565 | 20 | Design and optimization of highly-selective fungal CYP51 inhibitors. | Bioorg Med Chem Lett 24: 3455-8 (2014) | Viamet Pharmaceuticals Inc | 2D 3D TSV |
24948564 | 5 | Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors. | Bioorg Med Chem Lett 24: 3447-51 (2014) | Jamia Hamdard | 2D 3D TSV |
24948563 | 44 | Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors. | Bioorg Med Chem Lett 24: 3422-5 (2014) | University of Perugia | 2D 3D TSV |
24946214 | 24 | Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors. | Eur J Med Chem 83: 1-14 (2014) | Universit£ degli Studi di Messina | 2D 3D TSV |
24944750 | 24 | Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain. | ACS Med Chem Lett 5: 717-21 (2014) | Merck Research Laboratories | 2D 3D TSV |
24944749 | 21 | Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV. | ACS Med Chem Lett 5: 711-6 (2014) | Boehringer Ingelheim (Canada) | 2D 3D TSV |
24944747 | 18 | Discovery of Novel Imidazo[4,5-b]pyridines as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A). | ACS Med Chem Lett 5: 700-5 (2014) | Amgen Inc | 2D 3D TSV |
24944746 | 13 | Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram. | ACS Med Chem Lett 5: 696-9 (2014) | National Institute on Drug Abuse-Intramural Research Program | 2D 3D TSV |
24944745 | 75 | Diamine Derivatives as Novel Small-Molecule, Potent, and Subtype-Selective Somatostatin SST3 Receptor Agonists. | ACS Med Chem Lett 5: 690-5 (2014) | Merck Research Laboratories | 2D 3D TSV |
24944744 | 3 | Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand. | ACS Med Chem Lett 5: 685-9 (2014) | Universit£ degli Studi di Bari"A. Moro" | 2D 3D TSV |
24944743 | 3 | Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents. | ACS Med Chem Lett 5: 679-84 (2014) | Biota Scientific Management Pty Ltd | 2D 3D TSV |
24944742 | 63 | Discovery of Anilinopyrimidines as Dual Inhibitors of c-Met and VEGFR-2: Synthesis, SAR, and Cellular Activity. | ACS Med Chem Lett 5: 673-8 (2014) | Shanghai Institute of Materia Medica | 2D 3D TSV |
24944740 | 37 | Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL. | ACS Med Chem Lett 5: 662-7 (2014) | Genentech | 2D 3D TSV |
24944737 | 20 | Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66. | ACS Med Chem Lett 5: 647-51 (2014) | National Institute on Drug Abuse-Intramural Research Program | 2D 3D TSV |
24944733 | 101 | Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors. | ACS Med Chem Lett 5: 628-33 (2014) | Chinese National Center for Drug Screening | 2D 3D TSV |
24944732 | 37 | Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics. | ACS Med Chem Lett 5: 623-7 (2014) | RTI International | 2D 3D TSV |
24944730 | 20 | Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer's Disease. | ACS Med Chem Lett 5: 619-20 (2014) | Temple University School of Pharmacy | 2D 3D TSV |
24943831 | 8 | Structure-based design of new KSP-Eg5 inhibitors assisted by a targeted multicomponent reaction. | Chembiochem 15: 1471-80 (2014) | University of Santiago de Compostela | 2D 3D TSV |
24942641 | 7 | Molecular basis of the selective binding of MDMA enantiomers to the alpha4beta2 nicotinic receptor subtype: synthesis, pharmacological evaluation and mechanistic studies. | Eur J Med Chem 81: 35-46 (2014) | University of Barcelona | 2D 3D TSV |
24941437 | 11 | Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus. | J Med Chem 57: 5738-47 (2014) | Universitat de Barcelona | 2D 3D TSV |
24941128 | 41 | Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives. | Eur J Med Chem 82: 536-44 (2014) | Tehran University of Medical Sciences | 2D 3D TSV |
24939758 | 72 | Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors. | Bioorg Med Chem Lett 24: 3403-6 (2014) | National Health Research Institutes | 2D 3D TSV |
24939756 | 28 | Strategies for the modulation of phase II metabolism in a series of PKCe inhibitors. | Bioorg Med Chem Lett 24: 3398-402 (2014) | Vertex Pharmaceuticals Inc | 2D 3D TSV |
24938644 | 9 | 2-(Hetero(aryl)methylene)hydrazine-1-carbothioamides as potent urease inhibitors. | Chem Biol Drug Des 85: 225-30 (2015) | Quaid-i-Azam University | 2D 3D TSV |
24938496 | 32 | Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isoxazole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug concept. | Bioorg Med Chem 22: 4162-76 (2014) | ASKA Pharmaceutical Co., Ltd | 2D 3D TSV |
24938495 | 75 | Pharmacological evaluation and docking studies ofa,ß-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and proinflammatory cytokines. | Bioorg Med Chem 22: 4151-61 (2014) | Universiti Kebangsaan Malaysia | 2D 3D TSV |
24937185 | 1 | Development of second generation EP2 antagonists with high selectivity. | Eur J Med Chem 82: 521-35 (2014) | Emory University | 2D 3D TSV |
24937104 | 30 | GPR103 antagonists demonstrating anorexigenic activity in vivo: design and development of pyrrolo[2,3-c]pyridines that mimic the C-terminal Arg-Phe motif of QRFP26. | J Med Chem 57: 5935-48 (2014) | AstraZeneca | 2D 3D TSV |
24936678 | 49 | Radioiodinated benzyloxybenzene derivatives: a class of flexible ligands target to ?-amyloid plaques in Alzheimer's brains. | J Med Chem 57: 6030-42 (2014) | Beijing Normal University | 2D 3D TSV |
24936240 | 39 | Discovery of tetrahydroisoquinoline-based CXCR4 antagonists. | ACS Med Chem Lett 4: 1025-30 (2013) | Emory University | 2D 3D TSV |
24936238 | 1 | Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor. | ACS Med Chem Lett 3: 620-625 (2012) | TBA | 2D 3D TSV |
24936237 | 4 | The ?-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing. | ACS Med Chem Lett 3: 265-7 (2012) | University of Pennsylvania | 2D 3D TSV |
24936234 | 42 | Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist. | ACS Med Chem Lett 3: 985-990 (2012) | TBA | 2D 3D TSV |
24936233 | 8 | Discovery of Novel a4ß2 Neuronal Nicotinic Receptor Modulators through Structure-Based Virtual Screening. | ACS Med Chem Lett 2: 855-860 (2011) | TBA | 2D 3D TSV |
24936232 | 16 | Discovery of Potent Dual PPARa Agonists/CB1 Ligands. | ACS Med Chem Lett 2: 793-797 (2011) | TBA | 2D 3D TSV |
24936059 | 26 | The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability. | J Biol Chem 289: 21651-62 (2014) | AstraZeneca R&D Boston | 2D 3D TSV |
24934993 | 6 | Coumarin hybrids as novel therapeutic agents. | Bioorg Med Chem 22: 3806-14 (2014) | Punjabi University | 2D 3D TSV |
24934992 | 50 | Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma. | Bioorg Med Chem 22: 4109-18 (2014) | Second Affiliated Hospital of Southeast University | 2D 3D TSV |
24934571 | 14 | Diphenylpyrroles: Novel p53 activators. | Eur J Med Chem 82: 472-9 (2014) | Cairo University | 2D 3D TSV |
24933607 | 5 | Tyrosinase inhibitory activity of a glucosylated hydroxystilbene in mouse melan-a melanocytes. | J Nat Prod 77: 1270-4 (2014) | The Chinese University of Hong Kong | 2D 3D TSV |
24933507 | 15 | Synthesis and evaluation of three structurally related¹8F-labeled orvinols of different intrinsic activities: 6-O-[¹8F]fluoroethyl-diprenorphine ([¹8F]FDPN), 6-O-[¹8F]fluoroethyl-buprenorphine ([¹8F]FBPN), and 6-O-[¹8F]fluoroethyl-phenethyl-orvinol ([¹8F]FPEO). | J Med Chem 57: 5464-9 (2014) | University of Oslo | 2D 3D TSV |
24931384 | 66 | Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents. | J Med Chem 57: 6150-64 (2014) | Bristol-Myers Squibb Research | 2D 3D TSV |
24931275 | 6 | Synthesis and evaluation of N6-substituted apioadenosines as potential adenosine A3 receptor modulators. | Bioorg Med Chem 22: 4257-68 (2014) | Ghent University | 2D 3D TSV |
24930969 | 6 | Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor. | Chem Biol 21: 782-91 (2014) | University of California San Diego | 2D 3D TSV |
24930835 | 18 | Synthesis of new melatoninergic hexahydroindenopyridines. | Bioorg Med Chem Lett 24: 3534-6 (2014) | Universidad de Valencia | 2D 3D TSV |
24930833 | 136 | Synthesis and structure-activity relationships of 4-fluorophenyl-imidazole p38a MAPK, CK1d and JAK2 kinase inhibitors. | Bioorg Med Chem Lett 24: 3412-8 (2014) | Syncom B.V. | 2D 3D TSV |
24929292 | 2 | Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. | Eur J Med Chem 82: 418-25 (2014) | Universidade de S£o Paulo (USP) | 2D 3D TSV |
24929290 | 19 | Inhibition of 17ß-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker. | Eur J Med Chem 82: 394-406 (2014) | Saarland University | 2D 3D TSV |
24929289 | 10 | Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents. | Eur J Med Chem 82: 385-93 (2014) | Nirma University | 2D 3D TSV |
24928400 | 33 | Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein. | Bioorg Med Chem Lett 24: 3480-5 (2014) | The University of Tokyo | 2D 3D TSV |
24927250 | 18 | New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment. | J Med Chem 57: 5748-63 (2014) | Pharmaleads , Paris BioPark, 11 Rue Watt, 75013 Paris, France. | 2D 3D TSV |
24926891 | 8 | Polyketides from the cultured lichen mycobiont of a Vietnamese Pyrenula sp. | J Nat Prod 77: 1404-12 (2014) | Kobe Pharmaceutical University | 2D 3D TSV |
24925519 | 14 | Synthesis and evaluation of a new series of 3,5-bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and their cyclized products 'pyrimidinylthio pyrimidotriazolothiadiazines' as 15- lipo-oxygenase inhibitors. | Chem Biol Drug Des 85: 216-24 (2015) | Ferdowsi University of Mashhad | 2D 3D TSV |
24924423 | 21 | Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes. | Bioorg Med Chem 22: 4293-7 (2014) | University of California | 2D 3D TSV |
24922587 | 45 | Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2H)-one-7-carboxamide derivatives as poly(ADP-ribose)polymerase-1 inhibitors. | J Med Chem 57: 5579-601 (2014) | St. John's University | 2D 3D TSV |
24922543 | 24 | Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands. | Eur J Med Chem 82: 281-92 (2014) | Universit£ di Sassari | 2D 3D TSV |
24922538 | 5 | Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold. | Bioorg Chem 16-26 (2014) | Ain Shams University | 2D 3D TSV |
24921156 | 6 | Dose-dependent inhibition of BACE-1 by the monoterpenoid 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer's disease. | J Nat Prod 77: 1275-9 (2014) | University of Coimbra | 2D 3D TSV |
24920381 | 77 | SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase. | J Med Chem 57: 5638-48 (2014) | University Jena | 2D 3D TSV |
24918870 | 74 | Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors. | J Med Chem 57: 5714-27 (2014) | Genentech Inc | 2D 3D TSV |
24918716 | 22 | Dual protonophore-chitinase inhibitors dramatically affect O. volvulus molting. | J Med Chem 57: 5792-9 (2014) | The Scripps Research Institute | 2D 3D TSV |
24918545 | 81 | Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity. | J Med Chem 57: 6105-15 (2014) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24917667 | 36 | Digoxin derivatives with enhanced selectivity for the a2 isoform of Na,K-ATPase: effects on intraocular pressure in rabbits. | J Biol Chem 289: 21153-62 (2014) | Weizmann Institute of Science | 2D 3D TSV |
24916029 | 42 | Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists. Part 2. | Bioorg Med Chem 22: 4323-37 (2014) | Astellas Pharma Inc | 2D 3D TSV |
24916028 | 21 | Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors. | Bioorg Med Chem 22: 4285-92 (2014) | Nanjing University | 2D 3D TSV |
24915291 | 73 | Discovery of a series of 2,5-diaminopyrimidine covalent irreversible inhibitors of Bruton's tyrosine kinase with in vivo antitumor activity. | J Med Chem 57: 5112-28 (2014) | Peking University | 2D 3D TSV |
24915003 | 34 | Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors. | Eur J Med Chem 82: 274-80 (2014) | E£tv£s Lor£nd University (ELTE) | 2D 3D TSV |
24914738 | 43 | Aminoazabenzimidazoles, a novel class of orally active antimalarial agents. | J Med Chem 57: 5702-13 (2014) | AstraZeneca | 2D 3D TSV |
24914612 | 36 | Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). | J Med Chem 57: 5620-37 (2014) | Vanderbilt University Medical Center | 2D 3D TSV |
24914455 | 38 | Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain. | J Med Chem 57: 5800-16 (2014) | Merck Research Laboratories | 2D 3D TSV |
24914408 | 6 | Development of CBAP-BPyne, a probe for ?-secretase and presenilinase. | Medchemcomm 5: 338-341 (2014) | Memorial Sloan-Kettering Cancer Center | 2D 3D TSV |
24913985 | 73 | SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H. | Bioorg Med Chem 22: 4233-45 (2014) | Kurukshetra University | 2D 3D TSV |
24913984 | 20 | Pyridine analogues of spirocyclics1 receptor ligands. | Bioorg Med Chem 22: 4277-84 (2014) | Institut f£r Pharmazeutische und Medizinische Chemie der Westf£lischen Wilhelms-Universit£t M£nster | 2D 3D TSV |
24913714 | 53 | Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteres. | Bioorg Med Chem Lett 24: 3609-13 (2014) | Merck Research Laboratories | 2D 3D TSV |
24913411 | 13 | Elements and modulation of functional dynamics. | J Med Chem 57: 7819-37 (2014) | Janssen Research and Development LLC | 2D 3D TSV |
24911880 | 10 | Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry. | J Nat Prod 77: 1351-8 (2014) | University of North Carolina at Greensboro | 2D 3D TSV |
24911527 | 30 | Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases. | J Med Chem 57: 5764-76 (2014) | McGill University | 2D 3D TSV |
24909680 | 18 | Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P1 agonists. | Bioorg Med Chem 22: 4246-56 (2014) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
24909678 | 24 | Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents. | Bioorg Med Chem 22: 4312-22 (2014) | Nanjing University | 2D 3D TSV |
24909677 | 19 | Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists. | Bioorg Med Chem 22: 4298-311 (2014) | GlaxoSmithKline | 2D 3D TSV |
24909083 | 5 | Rational design of the first difluorostatone-based PfSUB1 inhibitors. | Bioorg Med Chem Lett 24: 3582-6 (2014) | University of Siena | 2D 3D TSV |
24909082 | 9 | Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase. | Bioorg Med Chem Lett 24: 3618-21 (2014) | N.D. Zelinsky Institute of Organic Chemistry | 2D 3D TSV |
24908653 | 34 | Guanidine-baseda2-adrenoceptor ligands: Towards selective antagonist activity. | Eur J Med Chem 82: 242-54 (2014) | Trinity College | 2D 3D TSV |
24908608 | 37 | Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups. | Bioorg Med Chem Lett 24: 3104-7 (2014) | GlaxoSmithKline | 2D 3D TSV |
24906513 | 21 | 4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B. | Bioorg Med Chem 22: 3670-83 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24905252 | 17 | Efficient modulation of ?-aminobutyric acid type A receptors by piperine derivatives. | J Med Chem 57: 5602-19 (2014) | University of Vienna | 2D 3D TSV |
24904968 | 7 | Design ofa7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivative. | Eur J Med Chem 82: 214-24 (2014) | Universit£ d'Orl£ans | 2D 3D TSV |
24904963 | 18 | New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies. | Eur J Med Chem 82: 164-71 (2014) | Sapienza University of Rome | 2D 3D TSV |
24904961 | 27 | Synthesis and in vivo SAR study of indolin-2-one-based multi-targeted inhibitors as potential anticancer agents. | Eur J Med Chem 82: 139-51 (2014) | Qilu Pharmaceutical Co., Ltd | 2D 3D TSV |
24903887 | 4 | Structural basis for low-affinity binding of non-R2 carboxylate-substituted tricyclic quinoline analogs to CK2a: comparative molecular dynamics simulation studies. | Chem Biol Drug Des 85: 189-200 (2015) | Beijing University of Technology | 2D 3D TSV |
24903735 | 3 | Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors. | Chem Biol Drug Des 85: 181-8 (2015) | Shandong University | 2D 3D TSV |
24901800 | 12 | Endiandric acid analogues from Beilschmiedia ferruginea as dual inhibitors of Bcl-xL/Bak and Mcl-1/Bid interactions. | J Nat Prod 77: 1430-7 (2014) | Institut de Chimie des Substances Naturelles (ICSN) | 2D 3D TSV |
24901667 | 50 | 4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1. | J Med Chem 57: 5190-202 (2014) | National Institutes of Health | 2D 3D TSV |
24901260 | 12 | Recent developments in novel antidepressants targetinga4ß2-nicotinic acetylcholine receptors. | J Med Chem 57: 8204-23 (2014) | University of Illinois at Chicago | 2D 3D TSV |
24900889 | 2 | Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents. | ACS Med Chem Lett 5: 609-14 (2014) | Merck Research Laboratories | 2D 3D TSV |
24900886 | 66 | Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors. | ACS Med Chem Lett 5: 592-7 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24900884 | 14 | Late-Stage C-H Coupling Enables Rapid Identification of HDAC Inhibitors: Synthesis and Evaluation of NCH-31 Analogues. | ACS Med Chem Lett 5: 582-6 (2014) | Nagoya University | 2D 3D TSV |
24900883 | 8 | Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT. | ACS Med Chem Lett 5: 576-81 (2014) | Australian National University | 2D 3D TSV |
24900882 | 30 | Pivotal Role of an Aliphatic Side Chain in the Development of an HDM2 Inhibitor. | ACS Med Chem Lett 5: 572-5 (2014) | Merck Research Laboratories | 2D 3D TSV |
24900880 | 12 | Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar. | ACS Med Chem Lett 5: 561-5 (2014) | Merck Research Laboratories | 2D 3D TSV |
24900878 | 40 | Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists. | ACS Med Chem Lett 5: 550-5 (2014) | Universit£ de Montr£al | 2D 3D TSV |
24900877 | 107 | Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors. | ACS Med Chem Lett 5: 544-9 (2014) | Merck Research Laboratories | 2D 3D TSV |
24900876 | 56 | Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein Interaction. | ACS Med Chem Lett 5: 538-43 (2014) | AstraZeneca | 2D 3D TSV |
24900874 | 52 | New Hits as Antagonists of GPR103 Identified by HTS. | ACS Med Chem Lett 5: 527-32 (2014) | AstraZeneca | 2D 3D TSV |
24900872 | 19 | Optimization of GPR40 Agonists for Type 2 Diabetes. | ACS Med Chem Lett 5: 517-21 (2014) | Amgen Inc | 2D 3D TSV |
24900871 | 8 | 2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological Evaluation. | ACS Med Chem Lett 5: 512-6 (2014) | National Institute of Pharmaceutical Education and Research (NIPER) | 2D 3D TSV |
24900870 | 4 | Novel carboline derivatives as potent antifungal lead compounds: design, synthesis, and biological evaluation. | ACS Med Chem Lett 5: 506-11 (2014) | Second Military Medical University | 2D 3D TSV |
24900867 | 2 | Biarylmethoxy Nicotinamides As Novel and Specific Inhibitors of Mycobacterium tuberculosis. | ACS Med Chem Lett 5: 491-5 (2014) | Alkem Laboratories Ltd | 2D 3D TSV |
24900865 | 7 | Discovery of antitubulin agents with antiangiogenic activity as single entities with multitarget chemotherapy potential. | ACS Med Chem Lett 5: 480-4 (2014) | Duquesne University | 2D 3D TSV |
24900864 | 21 | Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate. | ACS Med Chem Lett 5: 474-9 (2014) | Pfizer Inc | 2D 3D TSV |
24900862 | 14 | Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation. | ACS Med Chem Lett 5: 462-7 (2014) | Virginia Commonwealth University | 2D 3D TSV |
24900861 | 8 | Fused Thiazin-3-ones as KCa3.1 Inhibitors. | ACS Med Chem Lett 5: 460-1 (2014) | Temple University School of Pharmacy | 2D 3D TSV |
24900859 | 4 | Treatment of Immunological or Inflammatory Disorders with ITK Kinase Inhibitors. | ACS Med Chem Lett 5: 456-7 (2014) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900853 | 42 | 3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 Inhibitors. | ACS Med Chem Lett 5: 428-33 (2014) | F. Hoffmann-La Roche Inc | 2D 3D TSV |
24900852 | 22 | Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1. | ACS Med Chem Lett 5: 422-7 (2014) | Boehringer Ingelheim (Canada) Ltd | 2D 3D TSV |
24900851 | 6 | Discovery of AZD3199, An Inhaled Ultralong Acting?2 Receptor Agonist with Rapid Onset of Action. | ACS Med Chem Lett 5: 416-21 (2014) | AstraZeneca | 2D 3D TSV |
24900849 | 17 | Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome. | ACS Med Chem Lett 5: 405-10 (2014) | Weill Cornell Medical College | 2D 3D TSV |
24900848 | 11 | C-ring cannabinoid lactones: a novel cannabinergic chemotype. | ACS Med Chem Lett 5: 400-4 (2014) | Northeastern University | 2D 3D TSV |
24900845 | 30 | Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists. | ACS Med Chem Lett 5: 384-9 (2014) | Amgen Inc | 2D 3D TSV |
24900844 | 50 | Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2. | ACS Med Chem Lett 5: 378-83 (2014) | Constellation Pharmaceuticals | 2D 3D TSV |
24900843 | 60 | Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit. | ACS Med Chem Lett 5: 373-7 (2014) | Latvian Institute of Organic Synthesis | 2D 3D TSV |
24900842 | 71 | Novel delta opioid receptor agonists with oxazatricyclodecane structure. | ACS Med Chem Lett 5: 368-72 (2014) | Kitasato University | 2D 3D TSV |
24900841 | 33 | Structure-Activity Relationship of Semicarbazone EGA Furnishes Photoaffinity Inhibitors of Anthrax Toxin Cellular Entry. | ACS Med Chem Lett 5: 363-7 (2014) | University of California | 2D 3D TSV |
24900840 | 35 | Enhancing a CH-? Interaction to Increase the Affinity for 5-HT1A Receptors. | ACS Med Chem Lett 5: 358-62 (2014) | University of Li£ge | 2D 3D TSV |
24900839 | 24 | Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes. | ACS Med Chem Lett 5: 346-51 (2014) | Vanderbilt University Department of Chemistry | 2D 3D TSV |
24900838 | 30 | Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor. | ACS Med Chem Lett 5: 340-5 (2014) | Merck Research Laboratories | 2D 3D TSV |
24900835 | 6 | Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17. | ACS Med Chem Lett 5: 326-30 (2014) | University of Bonn | 2D 3D TSV |
24900832 | 29 | Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning. | ACS Med Chem Lett 5: 309-14 (2014) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
24900831 | 62 | Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities. | ACS Med Chem Lett 5: 304-8 (2014) | State Key Laboratory of Drug Research | 2D 3D TSV |
24900830 | 46 | Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors. | ACS Med Chem Lett 5: 298-303 (2014) | Vichem Chemie Research Ltd. | 2D 3D TSV |
24900829 | 11 | Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2. | ACS Med Chem Lett 5: 293-7 (2014) | University of Copenhagen | 2D 3D TSV |
24900827 | 8 | Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications. | ACS Med Chem Lett 5: 286-7 (2014) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900826 | 22 | Selective 5-HT Receptor Modulators May Deliver Focused Targeting with Fewer Adverse Effects. | ACS Med Chem Lett 5: 284-5 (2014) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900825 | 8 | Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2. | ACS Med Chem Lett 5: 282-3 (2014) | Dart Neuroscience LLC | 2D 3D TSV |
24900824 | 6 | Novel cycloalkenepyrazoles as inhibitors of bub1 kinase. | ACS Med Chem Lett 5: 280-1 (2014) | Dart Neuroscience LLC | 2D 3D TSV |
24900823 | 6 | Phenyl carboxamide analogues as spleen tyrosine kinase (syk) inhibitors. | ACS Med Chem Lett 5: 278-9 (2014) | Dart Neuroscience LLC | 2D 3D TSV |
24900822 | 4 | Thiazolocarboxamide Analogues as NAMPT Inhibitors. | ACS Med Chem Lett 5: (2014) | Dart Neuroscience LLC | 2D 3D TSV |
24900821 | 5 | Quinoline Derivatives as 5-HT6 Receptor PET Ligands. | ACS Med Chem Lett 5: 275-6 (2014) | Dart Neuroscience LLC | 2D 3D TSV |
24900818 | 100 | Novel Quinoline-Based P2-P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease Inhibitors. | ACS Med Chem Lett 5: 264-9 (2014) | Merck Research Laboratories | 2D 3D TSV |
24900814 | 2 | Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core. | ACS Med Chem Lett 5: 255-8 (2014) | Seoul National University | 2D 3D TSV |
24900813 | 6 | Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' Region. | ACS Med Chem Lett 5: 249-54 (2014) | Uppsala University | 2D 3D TSV |
24900801 | 18 | Discovery and development of potent and selective inhibitors of histone methyltransferase g9a. | ACS Med Chem Lett 5: 205-9 (2014) | AbbVie Inc | 2D 3D TSV |
24900800 | 46 | Small Macrocycles As Highly Active Integrin?2?1 Antagonists. | ACS Med Chem Lett 5: 193-8 (2014) | Sanofi R & D | 2D 3D TSV |
24900799 | 3 | Inhibitors of factor d may provide a treatment for age-related macular degeneration. | ACS Med Chem Lett 5: 106-7 (2014) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900798 | 1 | Selective EP4 Antagonist May Be Useful in Treating Arthritis and Arthritic Pain. | ACS Med Chem Lett 5: 104-5 (2014) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900796 | 42 | Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors. | ACS Med Chem Lett 5: 188-92 (2014) | Bristol-Myers Squibb R & D | 2D 3D TSV |
24900795 | 22 | Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar. | ACS Med Chem Lett 5: 183-7 (2014) | Merck Research Laboratories | 2D 3D TSV |
24900793 | 2 | Functionally Optimized Neuritogenic Farinosone C Analogs: SAR-Study and Investigations on Their Mode of Action. | ACS Med Chem Lett 5: 172-7 (2014) | University of Basel | 2D 3D TSV |
24900792 | 9 | FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures. | ACS Med Chem Lett 5: 166-71 (2014) | AstraZeneca | 2D 3D TSV |
24900790 | 8 | Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone. | ACS Med Chem Lett 5: 158-61 (2014) | Universit£ d'Orl£ans | 2D 3D TSV |
24900789 | 6 | Neutral ?-Lactams Inactivate High Molecular Mass Penicillin-Binding Proteins of Class B1, Including PBP2a of MRSA. | ACS Med Chem Lett 5: 154-7 (2014) | Wesleyan University | 2D 3D TSV |
24900786 | 9 | Crystal Structures of PI3K? Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design. | ACS Med Chem Lett 5: 138-42 (2014) | Shanghai Jiao Tong University | 2D 3D TSV |
24900785 | 64 | Isomannide-based peptidomimetics as inhibitors for human tissue kallikreins 5 and 7. | ACS Med Chem Lett 5: 128-32 (2014) | Universidade Federal do ABC | 2D 3D TSV |
24900784 | 20 | Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development. | ACS Med Chem Lett 5: 124-7 (2014) | Roche Pharma Research | 2D 3D TSV |
24900783 | 2 | Qualification of LSP1-2111 as a Brain Penetrant Group III Metabotropic Glutamate Receptor Orthosteric Agonist. | ACS Med Chem Lett 5: 119-23 (2014) | Lundbeck Research USA, Inc. | 2D 3D TSV |
24900779 | 3 | (S)-N-Methyldihydroquinazolinones are the Active Enantiomers of Retro-2 Derived Compounds against Toxins. | ACS Med Chem Lett 5: 94-7 (2014) | CEA | 2D 3D TSV |
24900778 | 1 | Evaluation of aminohydantoins as a novel class of antimalarial agents. | ACS Med Chem Lett 5: 89-93 (2014) | Saint Louis University | 2D 3D TSV |
24900776 | 75 | Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability. | ACS Med Chem Lett 5: 78-83 (2014) | Array BioPharma | 2D 3D TSV |
24900774 | 40 | Discovery of Tertiary Amine and Indole Derivatives as Potent ROR?t Inverse Agonists. | ACS Med Chem Lett 5: 65-8 (2014) | GlaxoSmithKline | 2D 3D TSV |
24900773 | 14 | Novel Indole-N-glucoside, TA-1887 As a Sodium Glucose Cotransporter 2 Inhibitor for Treatment of Type 2 Diabetes. | ACS Med Chem Lett 5: 51-5 (2014) | Mitsubishi Tanabe Pharma Corporation | 2D 3D TSV |
24900770 | 5 | Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors. | ACS Med Chem Lett 5: 18-22 (2014) | University of Oulu | 2D 3D TSV |
24900769 | 88 | Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase. | ACS Med Chem Lett 5: 12-7 (2014) | National Center for Advancing Translational Sciences | 2D 3D TSV |
24900768 | 10 | Tankyrase inhibitors: potential treatment of hyperproliferative diseases. | ACS Med Chem Lett 5: 10-1 (2014) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900767 | 3 | Inhibitors of Tropomyosin-Receptor Kinases (Trk's): Potential Pain Therapy and More. | ACS Med Chem Lett 5: 8-9 (2014) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900763 | 107 | Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity. | ACS Med Chem Lett 4: 875-9 (2013) | University of Camerino | 2D 3D TSV |
24900761 | 17 | [(11)C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide Receptor. | ACS Med Chem Lett 4: 863-8 (2013) | Merck Research Labortories | 2D 3D TSV |
24900758 | 44 | Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors. | ACS Med Chem Lett 4: 835-40 (2013) | Constellation Pharmaceuticals | 2D 3D TSV |
24900757 | 32 | Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy Studies. | ACS Med Chem Lett 4: 829-34 (2013) | Amgen Inc | 2D 3D TSV |
24900755 | 3 | Gamma secretase modulators. | ACS Med Chem Lett 4: (2013) | Montclair State University | 2D 3D TSV |
24900754 | 2 | Substituted Benzylspiroindolin-2-one Analogues as Positive Allosteric Modulators of the Muscarinic Acetylcholine Receptor M1. | ACS Med Chem Lett 4: (2013) | Montclair State University | 2D 3D TSV |
24900753 | 25 | Trisubstituted imidazoles as positive modulators of metabotropic glutamate receptor subtype 5. | ACS Med Chem Lett 4: 819-21 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900751 | 6 | Inhibitors of PI3K? as Potential Treatment for Cancer. | ACS Med Chem Lett 4: 815-6 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900750 | 14 | Aminopyridyl/Pyrazinyl Spiro[indoline-3,4'-piperidine]-2-ones As Highly Selective and Efficacious c-Met/ALK Inhibitors. | ACS Med Chem Lett 4: 806-10 (2013) | Southern Medical University | 2D 3D TSV |
24900749 | 6 | Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo. | ACS Med Chem Lett 4: 800-5 (2013) | AstraZeneca | 2D 3D TSV |
24900748 | 16 | Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics. | ACS Med Chem Lett 4: 795-9 (2013) | Universit£ degli Studi di Milano | 2D 3D TSV |
24900747 | 25 | Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes. | ACS Med Chem Lett 4: 790-4 (2013) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
24900745 | 63 | Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety. | ACS Med Chem Lett 4: 773-8 (2013) | Merck Research Laboratories | 2D 3D TSV |
24900744 | 39 | Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery. | ACS Med Chem Lett 4: 768-72 (2013) | Sanofi-Aventis | 2D 3D TSV |
24900743 | 86 | Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors. | ACS Med Chem Lett 4: 757-61 (2013) | University of Connecticut | 2D 3D TSV |
24900741 | 4 | Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors. | ACS Med Chem Lett 4: 742-6 (2013) | AstraZeneca | 2D 3D TSV |
24900739 | 16 | Contribution of Cage-Shaped Structure of Physalins to Their Mode of Action in Inhibition of NF-kB Activation | ACS Med Chem Lett 4: 730-5 (2013) | RIKEN | 2D 3D TSV |
24900736 | 1 | Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X7-Evoked Glutamate Release. | ACS Med Chem Lett 4: 704-9 (2013) | University of Cambridge | 2D 3D TSV |
24900734 | 9 | Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington's Disease. | ACS Med Chem Lett 4: 692-3 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900732 | 2 | Inhibitors of ATR Kinase for Treatment of Cancer. | ACS Med Chem Lett 4: 688-9 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900728 | 7 | Synthesis of 2?-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo. | ACS Med Chem Lett 4: 671-4 (2013) | Teikyo University | 2D 3D TSV |
24900721 | 24 | Discovery of novel insulin-like growth factor-1 receptor inhibitors with unique time-dependent binding kinetics. | ACS Med Chem Lett 4: 627-31 (2013) | OSI Pharmaceuticals LLC | 2D 3D TSV |
24900720 | 2 | Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors. | ACS Med Chem Lett 4: 622-6 (2013) | Universit£ degli Studi di Siena | 2D 3D TSV |
24900719 | 12 | C-Glucopyranosyl-1,2,4-triazoles As New Potent Inhibitors of Glycogen Phosphorylase. | ACS Med Chem Lett 4: 612-5 (2013) | University of Debrecen | 2D 3D TSV |
24900718 | 52 | 4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors. | ACS Med Chem Lett 4: 606-11 (2013) | Universit£ Lille Nord de France | 2D 3D TSV |
24900717 | 14 | Structure-Activity Relationships and in Vivo Evaluation of Quinoxaline Derivatives for PET Imaging of ?-Amyloid Plaques. | ACS Med Chem Lett 4: 596-600 (2013) | Kyoto University | 2D 3D TSV |
24900715 | 3 | Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections. | ACS Med Chem Lett 4: 585-9 (2013) | BioFocus | 2D 3D TSV |
24900714 | 8 | ?-Secretase Inhibitors for the Treatment of Alzheimer's Disease and Down's Syndrome. | ACS Med Chem Lett 4: 578-9 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900713 | 3 | ERK2 Inhibitors May Provide Treatment for Cancer. | ACS Med Chem Lett 4: 576-7 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900712 | 3 | FPRL-1 Receptor Modulators May Provide Treatment for Inflammation. | ACS Med Chem Lett 4: 574-5 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900710 | 25 | Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold. | ACS Med Chem Lett 4: 565-9 (2013) | University of Florence | 2D 3D TSV |
24900709 | 3 | Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor. | ACS Med Chem Lett 4: 560-4 (2013) | Eli Lilly and Company | 2D 3D TSV |
24900707 | 23 | Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles. | ACS Med Chem Lett 4: 551-5 (2013) | Amgen Inc | 2D 3D TSV |
24900705 | 49 | Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4. | ACS Med Chem Lett 4: 532-7 (2013) | University of Alberta | 2D 3D TSV |
24900704 | 24 | Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human ?-N-Acetyl-d-hexosaminidase. | ACS Med Chem Lett 4: 527-31 (2013) | East China University of Science and Technology | 2D 3D TSV |
24900702 | 8 | Metabolically Stable tert-Butyl Replacement. | ACS Med Chem Lett 4: 514-6 (2013) | Novartis Institutes for Biomedical Research | 2D 3D TSV |
24900701 | 36 | Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase. | ACS Med Chem Lett 4: 509-13 (2013) | Merck Research Laboratories | 2D 3D TSV |
24900700 | 21 | Identification of New Nonsteroidal ROR? Ligands; Related Structure-Activity Relationships and Docking Studies. | ACS Med Chem Lett 4: 504-8 (2013) | Genfit SA | 2D 3D TSV |
24900699 | 54 | Tricyclic Pyrimidines As Inhibitors of DYRK1A/DYRK1B As Potential Treatment for Down's Syndrome or Alzheimer's Disease. | ACS Med Chem Lett 4: 502-3 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900698 | 4 | Negative allosteric modulators of metabotropic glutamate receptor subtype. | ACS Med Chem Lett 4: 500-1 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900697 | 6 | Imidazopyrazine Derivatives As Inhibitors of mTOR. | ACS Med Chem Lett 4: 498-9 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900696 | 72 | Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold. | ACS Med Chem Lett 4: 491-6 (2013) | University of Antwerp (UA) | 2D 3D TSV |
24900695 | 19 | Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators. | ACS Med Chem Lett 4: 475-80 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
24900694 | 14 | Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development. | ACS Med Chem Lett 4: 466-9 (2013) | Roche Research Center | 2D 3D TSV |
24900691 | 4 | Novel thiazolobenzodiazepines as inhibitors of histamine h3 receptor. | ACS Med Chem Lett 4: (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900690 | 24 | Dihydrooxazines As Inhibitors of BACE-1 or BACE-2. | ACS Med Chem Lett 4: 433-4 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900689 | 16 | PAK1: A Therapeutic Target for Cancer Treatment. | ACS Med Chem Lett 4: 431-2 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900687 | 3 | Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists. | ACS Med Chem Lett 4: 419-22 (2013) | Janssen Research and Development LLC | 2D 3D TSV |
24900686 | 1 | Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes. | ACS Med Chem Lett 4: 414-8 (2013) | Hoffmann-La Roche Inc | 2D 3D TSV |
24900685 | 8 | Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway. | ACS Med Chem Lett 4: 408-13 (2013) | Soochow University | 2D 3D TSV |
24900684 | 12 | Design, Synthesis, and Pharmacological Evaluation of Fluorescent and Biotinylated Antagonists of?1 GABAC Receptors. | ACS Med Chem Lett 4: 402-7 (2013) | The University of Sydney | 2D 3D TSV |
24900683 | 26 | Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators. | ACS Med Chem Lett 4: 393-6 (2013) | University of Regensburg | 2D 3D TSV |
24900681 | 13 | Cyclopropyl-Fused 1,3-Thiazepines as BACE1 and BACE2 Inhibitors. | ACS Med Chem Lett 4: 379-80 (2013) | Temple University | 2D 3D TSV |
24900680 | 18 | Selective Cyp11B1 Inhibitors for the Treatment of Cortisol Dependent Diseases. | ACS Med Chem Lett 4: 377-8 (2013) | Temple University | 2D 3D TSV |
24900679 | 16 | Aldosterone synthase inhibitors. | ACS Med Chem Lett 4: 375-6 (2013) | Temple University | 2D 3D TSV |
24900677 | 8 | Targeting CCR2 Receptor To Treat Inflammation Diseases and Disorders. | ACS Med Chem Lett 4: 371-2 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900673 | 1 | Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors. | ACS Med Chem Lett 4: 358-62 (2013) | GlaxoSmithKline | 2D 3D TSV |
24900672 | 41 | Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction. | ACS Med Chem Lett 4: 353-7 (2013) | EntreMed Inc. | 2D 3D TSV |
24900670 | 47 | Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator. | ACS Med Chem Lett 4: 333-7 (2013) | Genomics Institute of the Novartis Research Foundation | 2D 3D TSV |
24900667 | 3 | Inhibition of mTOR Kinase and Cancer Treatment. | ACS Med Chem Lett 4: 321-2 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900666 | 6 | Positive allosteric modulators of nicotinic acetylcholine receptor. | ACS Med Chem Lett 4: 319-20 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900664 | 14 | High-Throughput Selectivity Assays for Small-Molecule Inhibitors of ?-Catenin/T-Cell Factor Protein-Protein Interactions. | ACS Med Chem Lett 4: 306-11 (2013) | University of Utah | 2D 3D TSV |
24900662 | 16 | Discovery of Indenopyrazoles as a New Class of Hypoxia Inducible Factor (HIF)-1 Inhibitors. | ACS Med Chem Lett 4: 297-301 (2013) | Gakushuin University | 2D 3D TSV |
24900661 | 17 | Optimization of a Novel Series of TRPV4 Antagonists with In Vivo Activity in a Model of Pulmonary Edema. | ACS Med Chem Lett 4: 293-6 (2013) | GlaxoSmithKline | 2D 3D TSV |
24900658 | 10 | Discovery of a highly potent, orally active mitosis/angiogenesis inhibitor r1530 for the treatment of solid tumors. | ACS Med Chem Lett 4: 259-63 (2013) | Hoffmann-La Roche Inc | 2D 3D TSV |
24900657 | 1 | Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes. | ACS Med Chem Lett 4: 249-53 (2013) | University Health Network | 2D 3D TSV |
24900656 | 9 | Discovery of novel N-substituted oxindoles as selective m1 and m4 muscarinic acetylcholine receptors partial agonists. | ACS Med Chem Lett 4: 244-8 (2013) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
24900655 | 165 | [3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase ? Inhibitors. | ACS Med Chem Lett 4: 230-4 (2013) | GlaxoSmithKline | 2D 3D TSV |
24900653 | 14 | Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195. | ACS Med Chem Lett 4: 211-5 (2013) | Abbott Laboratories | 2D 3D TSV |
24900652 | 30 | The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein-protein interactions. | ACS Med Chem Lett 4: 186-90 (2013) | Novartis Institutes for BioMedical Research Inc | 2D 3D TSV |
24900651 | 50 | Irreversible inhibitors of cysteine proteases. | ACS Med Chem Lett 4: 163-4 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900650 | 3 | PDE10 Inhibitors as Potential Treatment for Schizophrenia. | ACS Med Chem Lett 4: 161-2 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900649 | 3 | TRPV4 Antagonists: Potential Treatment for Congestive Heart Failure, Bladder Dysfunctions, and Pain. | ACS Med Chem Lett 4: 159-60 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900648 | 2 | Aldosterone synthase inhibitors: targeting chronic kidney disease and diabetic nephropathy. | ACS Med Chem Lett 4: 157-8 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900647 | 8 | Bodilisant-a novel fluorescent, highly affine histamine h3 receptor ligand. | ACS Med Chem Lett 4: 269-73 (2013) | Goethe University | 2D 3D TSV |
24900646 | 2 | Synthesis and antimycobacterial activity of 2,1'-dihydropyridomycins. | ACS Med Chem Lett 4: 264-8 (2013) | Swiss Federal Institute of Technology (ETH) Zurich | 2D 3D TSV |
24900643 | 4 | Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors. | ACS Med Chem Lett 4: 201-5 (2013) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24900640 | 3 | Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes. | ACS Med Chem Lett 4: 165-9 (2013) | Division of Medicinal & Process Chemistry, Division of Parasitology, Division of Pharmacokinetics and Metabolism, and Sophisticated Analytical Instrument Facility, Central Drug Research Institute | 2D 3D TSV |
24900635 | 104 | Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis. | ACS Med Chem Lett 4: 1238-43 (2013) | GlaxoSmithKline | 2D 3D TSV |
24900634 | 36 | Design and Synthesis of Peptide YY Analogues with C-terminal Backbone Amide-to-Ester Modifications. | ACS Med Chem Lett 4: 1228-32 (2013) | University of Copenhagen | 2D 3D TSV |
24900633 | 11 | Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors. | ACS Med Chem Lett 4: 1218-23 (2013) | Amgen Inc | 2D 3D TSV |
24900632 | 13 | Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase. | ACS Med Chem Lett 4: 1208-12 (2013) | Astex Pharmaceuticals Inc | 2D 3D TSV |
24900631 | 50 | Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors. | ACS Med Chem Lett 4: 1203-7 (2013) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24900630 | 16 | Synthesis and in vitro and in vivo pharmacological evaluation of new 4-aminoquinoline-based compounds. | ACS Med Chem Lett 4: 1198-202 (2013) | University of Cape Town | 2D 3D TSV |
24900629 | 102 | Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors. | ACS Med Chem Lett 4: 1193-7 (2013) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24900627 | 2 | Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase. | ACS Med Chem Lett 4: 1183-8 (2013) | Yale University | 2D 3D TSV |
24900626 | 15 | Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation. | ACS Med Chem Lett 4: 1178-82 (2013) | University of Siena | 2D 3D TSV |
24900625 | 52 | Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases. | ACS Med Chem Lett 4: 1173-7 (2013) | University of Bath | 2D 3D TSV |
24900624 | 18 | Exploring the chemical space of multitarget ligands using aligned self-organizing maps. | ACS Med Chem Lett 4: 1169-72 (2013) | Goethe University | 2D 3D TSV |
24900623 | 16 | Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin Secretion. | ACS Med Chem Lett 4: 1163-8 (2013) | AstraZeneca | 2D 3D TSV |
24900622 | 6 | Probing the Binding Site of Bile Acids in TGR5. | ACS Med Chem Lett 4: 1158-62 (2013) | Universit£ degli Studi di Perugia | 2D 3D TSV |
24900621 | 48 | Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors. | ACS Med Chem Lett 4: 1152-7 (2013) | Aurigene Discovery Technologies Limited | 2D 3D TSV |
24900619 | 42 | Diphenylpropane Derivatives as Agonist of PPAR Nuclear Receptors. | ACS Med Chem Lett 4: 1135-6 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900617 | 2 | Inhibition of CK2: An Attractive Therapeutic Target for Cancer Treatment. | ACS Med Chem Lett 4: 1131-2 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900612 | 5 | Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma. | ACS Med Chem Lett 4: 1102-7 (2013) | University of Toronto at Mississauga | 2D 3D TSV |
24900610 | 5 | Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility. | ACS Med Chem Lett 4: 1091-6 (2013) | New York Structural Biology Center | 2D 3D TSV |
24900608 | 9 | Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example. | ACS Med Chem Lett 4: 1079-84 (2013) | Pfizer Inc | 2D 3D TSV |
24900607 | 15 | Potent oxazolidinone antibacterials with heteroaromatic C-ring substructure. | ACS Med Chem Lett 4: 1074-8 (2013) | Research Foundation Itsuu Laboratory | 2D 3D TSV |
24900606 | 12 | Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide. | ACS Med Chem Lett 4: 1064-8 (2013) | Merck Research Laboratories | 2D 3D TSV |
24900605 | 43 | Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties. | ACS Med Chem Lett 4: 1059-63 (2013) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
24900604 | 40 | Discovery of Octahydroindenes as PAR1 Antagonists. | ACS Med Chem Lett 4: 1054-8 (2013) | Korea Research Institute of Technology | 2D 3D TSV |
24900603 | 3 | Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties. | ACS Med Chem Lett 4: 1037-41 (2013) | Merck Serono | 2D 3D TSV |
24900602 | 32 | Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists. | ACS Med Chem Lett 4: 1031-6 (2013) | University of Santiago de Compostela | 2D 3D TSV |
24900601 | 18 | N-[4-(1H-Pyrazolo[3,4-B]pyrazin-6yl)-phenyl]-sulonamides and Their Use As Pharmaceuticals. | ACS Med Chem Lett 4: 1022-4 (2013) | Temple University School of Pharmacy | 2D 3D TSV |
24900598 | 8 | Endothelial lipase inhibitors for the treatment of atherosclerosis and cardiovascular disorders. | ACS Med Chem Lett 4: 1016-7 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900597 | 3 | Sphingosine-1-phosphate (S1P) Receptor Modulators Provide Potential for Diverse Treatments. | ACS Med Chem Lett 4: 1014-5 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900594 | 6 | Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR. | ACS Med Chem Lett 4: 974-8 (2013) | Zhejiang University | 2D 3D TSV |
24900593 | 45 | Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development. | ACS Med Chem Lett 4: 964-8 (2013) | GlaxoSmithKline | 2D 3D TSV |
24900590 | 55 | Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy. | ACS Med Chem Lett 4: 948-52 (2013) | GlaxoSmithKline | 2D 3D TSV |
24900589 | 13 | Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. | ACS Med Chem Lett 4: 942-7 (2013) | Praecis Pharmaceuticals Inc | 2D 3D TSV |
24900588 | 25 | Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists. | ACS Med Chem Lett 4: 937-41 (2013) | Tokyo Medical and Dental University | 2D 3D TSV |
24900587 | 9 | Discovery of DF-461, a Potent Squalene Synthase Inhibitor. | ACS Med Chem Lett 4: 932-6 (2013) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
24900582 | 8 | Anabaseine analogues as modulators of nicotinic acetylcholine receptor. | ACS Med Chem Lett 4: 902-3 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900580 | 8 | Fighting Obesity and Metabolic Disorders with MGAT-2 Inhibitors. | ACS Med Chem Lett 4: 898-9 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900576 | 11 | Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-?/SPD304 Study. | ACS Med Chem Lett 4: 137-41 (2013) | The Centre for Research and Technology of Thessaly (CE.RE.TE.TH.) , 3rd km Karditsa-Mitropolis, Karditsa 43100, Greece. | 2D 3D TSV |
24900575 | 31 | Biological evaluation of new largazole analogues: alteration of macrocyclic scaffold with click chemistry. | ACS Med Chem Lett 4: 132-6 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
24900572 | 54 | Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes. | ACS Med Chem Lett 4: 118-23 (2013) | Pfizer Inc | 2D 3D TSV |
24900571 | 44 | Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation. | ACS Med Chem Lett 4: 113-7 (2013) | 3-V Biosciences, Inc. | 2D 3D TSV |
24900569 | 25 | Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349. | ACS Med Chem Lett 4: 103-7 (2013) | Genentech | 2D 3D TSV |
24900568 | 27 | Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. | ACS Med Chem Lett 4: 91-7 (2013) | Pfizer Inc | 2D 3D TSV |
24900567 | 21 | Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor. | ACS Med Chem Lett 4: 85-90 (2013) | Genentech | 2D 3D TSV |
24900564 | 46 | Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 Agonists. | ACS Med Chem Lett 4: 63-8 (2013) | Pfizer Inc | 2D 3D TSV |
24900562 | 126 | Azepines and piperidines with dual norepinephrine dopamine uptake inhibition and antidepressant activity. | ACS Med Chem Lett 4: 46-51 (2013) | AstraZeneca | 2D 3D TSV |
24900561 | 25 | Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55. | ACS Med Chem Lett 4: 41-5 (2013) | University of Bonn | 2D 3D TSV |
24900560 | 16 | Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions. | ACS Med Chem Lett 4: 37-40 (2013) | Pfizer Inc | 2D 3D TSV |
24900557 | 6 | Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent Highlight. | ACS Med Chem Lett 4: 18-9 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900556 | 8 | Treatment of Obesity and Related Disorders with Acetyl-CoA Carboxylase Inhibitors. | ACS Med Chem Lett 4: 16-7 (2013) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900551 | 14 | Modulators of the GPR119 Receptor for the Treatment of Metabolic Syndrome. | ACS Med Chem Lett 4: 8-9 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900549 | 6 | Metabolites of the pyrimidine amine preladenant as adenosine a2a receptor antagonists. | ACS Med Chem Lett 4: 5-6 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24900547 | 23 | Fluorescent Human EP3 Receptor Antagonists. | ACS Med Chem Lett 3: 774-779 (2012) | TBA | 2D 3D TSV |
24900546 | 29 | Symmetric kv1.5 blockers discovered by focused screening. | ACS Med Chem Lett 3: 769-773 (2012) | TBA | 2D 3D TSV |
24900545 | 21 | Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor. | ACS Med Chem Lett 3: 764-768 (2012) | TBA | 2D 3D TSV |
24900544 | 8 | Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor. | ACS Med Chem Lett 3: 754-758 (2012) | TBA | 2D 3D TSV |
24900543 | 27 | Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases. | ACS Med Chem Lett 3: 749-753 (2012) | TBA | 2D 3D TSV |
24900540 | 47 | Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease. | ACS Med Chem Lett 3: 731-735 (2012) | TBA | 2D 3D TSV |
24900539 | 27 | Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist. | ACS Med Chem Lett 3: 726-730 (2012) | TBA | 2D 3D TSV |
24900538 | 27 | Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors. | ACS Med Chem Lett 3: 705-709 (2012) | TBA | 2D 3D TSV |
24900537 | 9 | Prostaglandin e2 synthase-1 inhibitors as potential treatment for osteoarthritis: patent highlight. | ACS Med Chem Lett 3: 703-704 (2012) | TBA | 2D 3D TSV |
24900536 | 3 | Inhibitors of LRRK2 as Treatment for Parkinson's Disease: Patent Highlight. | ACS Med Chem Lett 3: 701-702 (2012) | TBA | 2D 3D TSV |
24900534 | 6 | Cyclopropyl-spiro-piperidines Useful as Sodium Channel Blockers: Patent Highlight. | ACS Med Chem Lett 3: 697-698 (2012) | TBA | 2D 3D TSV |
24900533 | 22 | Substituted pyridines as sodium channel blockers: patent highlight. | ACS Med Chem Lett 3: 695-696 (2012) | TBA | 2D 3D TSV |
24900532 | 1 | Bromodomains: are readers right for epigenetic therapy? | ACS Med Chem Lett 3: 691-694 (2012) | TBA | 2D 3D TSV |
24900529 | 6 | Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. | ACS Med Chem Lett 3: 678-682 (2012) | TBA | 2D 3D TSV |
24900526 | 3 | Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12. | ACS Med Chem Lett 3: 653-657 (2012) | TBA | 2D 3D TSV |
24900524 | 39 | Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic Effects. | ACS Med Chem Lett 3: 637-639 (2012) | TBA | 2D 3D TSV |
24900520 | 14 | Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators: patent highlight. | ACS Med Chem Lett 3: 614-615 (2012) | TBA | 2D 3D TSV |
24900519 | 3 | Fatty Acid synthase inhibitors as possible treatment for cancer: patent highlight. | ACS Med Chem Lett 3: 612-613 (2012) | TBA | 2D 3D TSV |
24900517 | 3 | Potassium channel modulators as possible treatment for pain: patent highlight. | ACS Med Chem Lett 3: 608-9 (2012) | Therachem Research Medilab (India) Pvt. Ltd. | 2D 3D TSV |
24900514 | 14 | Lipophilic Isosteres of a ?-? Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction. | ACS Med Chem Lett 3: 579-83 (2012) | Novartis Institutes for BioMedical Research Inc. | 2D 3D TSV |
24900510 | 16 | Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-Peptide conformation. | ACS Med Chem Lett 3: 560-564 (2012) | TBA | 2D 3D TSV |
24900508 | 40 | Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid Analogues. | ACS Med Chem Lett 3: 550-554 (2012) | TBA | 2D 3D TSV |
24900507 | 17 | Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design. | ACS Med Chem Lett 3: 540-543 (2012) | TBA | 2D 3D TSV |
24900506 | 39 | Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like Effect. | ACS Med Chem Lett 3: 535-539 (2012) | TBA | 2D 3D TSV |
24900505 | 11 | Design and synthesis of potent, selective inhibitors of matriptase. | ACS Med Chem Lett 3: 530-534 (2012) | TBA | 2D 3D TSV |
24900504 | 107 | Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta Inhibitors. | ACS Med Chem Lett 3: 524-529 (2012) | TBA | 2D 3D TSV |
24900501 | 9 | Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligase. | ACS Med Chem Lett 3: 509-514 (2012) | TBA | 2D 3D TSV |
24900500 | 21 | Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group. | ACS Med Chem Lett 3: 505-508 (2012) | TBA | 2D 3D TSV |
24900499 | 67 | The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes. | ACS Med Chem Lett 3: 484-489 (2012) | TBA | 2D 3D TSV |
24900494 | 72 | Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L. | ACS Med Chem Lett 3: 450-453 (2012) | TBA | 2D 3D TSV |
24900493 | 12 | Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors. | ACS Med Chem Lett 3: 445-449 (2012) | TBA | 2D 3D TSV |
24900488 | 1 | RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists. | ACS Med Chem Lett 3: 427-432 (2012) | TBA | 2D 3D TSV |
24900487 | 2 | ß-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine. | ACS Med Chem Lett 3: 422-426 (2012) | TBA | 2D 3D TSV |
24900486 | 18 | Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973). | ACS Med Chem Lett 3: 416-421 (2012) | TBA | 2D 3D TSV |
24900485 | 13 | Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides. | ACS Med Chem Lett 3: 411-415 (2012) | TBA | 2D 3D TSV |
24900484 | 64 | Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents. | ACS Med Chem Lett 3: 397-401 (2012) | TBA | 2D 3D TSV |
24900483 | 7 | Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A. | ACS Med Chem Lett 3: 387-391 (2012) | TBA | 2D 3D TSV |
24900482 | 32 | Targeted kinase selectivity from kinase profiling data. | ACS Med Chem Lett 3: 383-386 (2012) | TBA | 2D 3D TSV |
24900481 | 17 | A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial Scaffold. | ACS Med Chem Lett 3: 373-377 (2012) | TBA | 2D 3D TSV |
24900480 | 75 | Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics. | ACS Med Chem Lett 3: 367-372 (2012) | TBA | 2D 3D TSV |
24900478 | 4 | The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity. | ACS Med Chem Lett 3: 352-356 (2012) | TBA | 2D 3D TSV |
24900475 | 7 | A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases. | ACS Med Chem Lett 3: 342-346 (2012) | TBA | 2D 3D TSV |
24900474 | 5 | Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine. | ACS Med Chem Lett 3: 337-341 (2012) | TBA | 2D 3D TSV |
24900473 | 21 | Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. | ACS Med Chem Lett 3: 332-6 (2012) | Merck Research Laboratories | 2D 3D TSV |
24900466 | 55 | Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 Antagonist. | ACS Med Chem Lett 3: 289-293 (2012) | TBA | 2D 3D TSV |
24900464 | 66 | Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization. | ACS Med Chem Lett 3: 278-283 (2012) | TBA | 2D 3D TSV |
24900463 | 15 | Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators. | ACS Med Chem Lett 3: 273-277 (2012) | TBA | 2D 3D TSV |
24900461 | 49 | Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity. | ACS Med Chem Lett 3: 252-256 (2012) | TBA | 2D 3D TSV |
24900459 | 53 | NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with µ-Opioid Agonist Activity. | ACS Med Chem Lett 3: 227-231 (2012) | TBA | 2D 3D TSV |
24900458 | 12 | Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists. | ACS Med Chem Lett 3: 222-226 (2012) | TBA | 2D 3D TSV |
24900457 | 30 | Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication. | ACS Med Chem Lett 3: 216-221 (2012) | TBA | 2D 3D TSV |
24900456 | 46 | Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye. | ACS Med Chem Lett 3: 203-206 (2012) | TBA | 2D 3D TSV |
24900455 | 45 | Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia. | ACS Med Chem Lett 3: 187-192 (2012) | TBA | 2D 3D TSV |
24900454 | 43 | The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease? | ACS Med Chem Lett 3: 182-186 (2012) | TBA | 2D 3D TSV |
24900450 | 44 | Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetes. | ACS Med Chem Lett 3: 198-202 (2012) | TBA | 2D 3D TSV |
24900449 | 10 | BACE1 Inhibitor Peptides: Can an Infinitely Small k cat Value Turn the Substrate of an Enzyme into Its Inhibitor? | ACS Med Chem Lett 3: 193-197 (2012) | TBA | 2D 3D TSV |
24900447 | 45 | Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists. | ACS Med Chem Lett 3: 165-169 (2012) | TBA | 2D 3D TSV |
24900446 | 6 | Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group. | ACS Med Chem Lett 3: 159-164 (2012) | TBA | 2D 3D TSV |
24900445 | 10 | Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering. | ACS Med Chem Lett 3: 155-158 (2012) | TBA | 2D 3D TSV |
24900443 | 158 | Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models. | ACS Med Chem Lett 3: 140-145 (2012) | TBA | 2D 3D TSV |
24900442 | 51 | Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode. | ACS Med Chem Lett 3: 123-128 (2012) | TBA | 2D 3D TSV |
24900440 | 11 | Application of MM-GB/SA and WaterMap to SRC Kinase Inhibitor Potency Prediction. | ACS Med Chem Lett 3: 94-99 (2012) | TBA | 2D 3D TSV |
24900439 | 34 | Synthesis and biological evaluation of cyclic sulfamide derivatives as 11ß-hydroxysteroid dehydrogenase 1 inhibitors. | ACS Med Chem Lett 3: 88-93 (2012) | TBA | 2D 3D TSV |
24900437 | 32 | Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor. | ACS Med Chem Lett 3: 135-139 (2012) | TBA | 2D 3D TSV |
24900436 | 18 | Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened. | ACS Med Chem Lett 3: 106-111 (2012) | TBA | 2D 3D TSV |
24900435 | 50 | Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) Inhibitors. | ACS Med Chem Lett 3: 100-105 (2012) | TBA | 2D 3D TSV |
24900432 | 51 | Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. | ACS Med Chem Lett 3: 1091-1096 (2012) | TBA | 2D 3D TSV |
24900430 | 6 | Identification of amides as carboxylic Acid surrogates for quinolizidinone-based m1 positive allosteric modulators. | ACS Med Chem Lett 3: 1070-1074 (2012) | TBA | 2D 3D TSV |
24900428 | 67 | Structure-Based Design of Potent and Selective CK1¿ Inhibitors. | ACS Med Chem Lett 3: 1059-1064 (2012) | TBA | 2D 3D TSV |
24900427 | 68 | Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5. | ACS Med Chem Lett 3: 1050-1053 (2012) | TBA | 2D 3D TSV |
24900426 | 4 | A new approach to explore the binding space of polysaccharide-based ligands: selectin antagonists. | ACS Med Chem Lett 3: 1045-1049 (2012) | TBA | 2D 3D TSV |
24900425 | 72 | Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate. | ACS Med Chem Lett 3: 1039-1044 (2012) | TBA | 2D 3D TSV |
24900424 | 60 | SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease. | ACS Med Chem Lett 3: 1024-1028 (2012) | TBA | 2D 3D TSV |
24900421 | 87 | Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases. | ACS Med Chem Lett 3: 997-1002 (2012) | TBA | 2D 3D TSV |
24900419 | 3 | Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors. | ACS Med Chem Lett 3: 969-974 (2012) | TBA | 2D 3D TSV |
24900417 | 59 | Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis. | ACS Med Chem Lett 3: 959-964 (2012) | TBA | 2D 3D TSV |
24900416 | 25 | GPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight. | ACS Med Chem Lett 3: 955-958 (2012) | TBA | 2D 3D TSV |
24900410 | 2 | Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles. | ACS Med Chem Lett 3: 936-941 (2012) | TBA | 2D 3D TSV |
24900409 | 43 | Synthesis and SAR Studies of Fused Oxadiazines as ?-Secretase Modulators for Treatment of Alzheimer's Disease. | ACS Med Chem Lett 3: 931-5 (2012) | Merck Research Laboratory | 2D 3D TSV |
24900408 | 4 | Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases. | ACS Med Chem Lett 3: 920-924 (2012) | TBA | 2D 3D TSV |
24900407 | 63 | Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer. | ACS Med Chem Lett 3: 914-919 (2012) | TBA | 2D 3D TSV |
24900406 | 2 | Initial Optimization of a New Series of ?-Secretase Modulators Derived from a Triterpene Glycoside. | ACS Med Chem Lett 3: 908-13 (2012) | Satori Pharmaceuticals, Inc. | 2D 3D TSV |
24900404 | 27 | Discovery of SCH 900229, a Potent Presenilin 1 Selective ¿-Secretase Inhibitor for the Treatment of Alzheimer's Disease. | ACS Med Chem Lett 3: 892-896 (2012) | TBA | 2D 3D TSV |
24900403 | 42 | A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of ß-Secretase. | ACS Med Chem Lett 3: 886-891 (2012) | TBA | 2D 3D TSV |
24900400 | 18 | Benzenesulfonyl and Benzenesulfonamide as Modulators of the 5-HT6 Receptor: Patent Highlight. | ACS Med Chem Lett 3: 881-2 (2012) | Dart Neuroscience LLC | 2D 3D TSV |
24900399 | 10 | Novel and selective inhibitors of histone deacetylase: patent highlight. | ACS Med Chem Lett 3: 879-80 (2012) | Dart Neuroscience LLC | 2D 3D TSV |
24900397 | 18 | Compounds and Their Use as BACE Inhibitors: Patent Highlight. | ACS Med Chem Lett 3: 875-876 (2012) | TBA | 2D 3D TSV |
24900396 | 8 | 5-Amino-oxazepine and 5-Amino-thiazepine Compounds as ß-Secretase Antagonists and Methods of Use: Patent Highlight. | ACS Med Chem Lett 3: 873-874 (2012) | TBA | 2D 3D TSV |
24900395 | 3 | BACE-Inhibitors: Potential Treatment of Alzheimer Disease, Dementia, and Related Neurodegenerative Diseases. C. Spiro-Heterocyclic Derivatives: Patent Highlight. | ACS Med Chem Lett 3: 871-872 (2012) | TBA | 2D 3D TSV |
24900394 | 8 | BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (B): 3-Amino-4-fluoro-1H-isoindol Derivatives: Patent Highlight. | ACS Med Chem Lett 3: 869-870 (2012) | TBA | 2D 3D TSV |
24900393 | 4 | BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (A): 5,6-Dihydroimidazo[1,2-a]pyrazin-8-yl-amine Derivatives: Patent Highlight. | ACS Med Chem Lett 3: 867-868 (2012) | TBA | 2D 3D TSV |
24900389 | 8 | Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo. | ACS Med Chem Lett 3: 850-855 (2012) | TBA | 2D 3D TSV |
24900387 | 11 | Discovery of a novel chemotype of tyrosine kinase inhibitors by fragment-based docking and molecular dynamics. | ACS Med Chem Lett 3: 834-838 (2012) | TBA | 2D 3D TSV |
24900385 | 51 | Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate. | ACS Med Chem Lett 3: 823-827 (2012) | TBA | 2D 3D TSV |
24900382 | 41 | Discovery of 2-Alkyl-1-arylsulfonylprolinamides as 11ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitors. | ACS Med Chem Lett 3: 793-798 (2012) | TBA | 2D 3D TSV |
24900381 | 27 | Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47. | ACS Med Chem Lett 3: 789-792 (2012) | TBA | 2D 3D TSV |
24900380 | 3 | Novel compounds for the treatment of neurodegenerative diseases: patent highlight. | ACS Med Chem Lett 3: 788-788 (2012) | TBA | 2D 3D TSV |
24900376 | 5 | Combatting Drug-Resistant Bacteria with Gyrase and Topoisomerase IV Inhibitors: Patent Highlight. | ACS Med Chem Lett 3: 783-784 (2012) | TBA | 2D 3D TSV |
24900375 | 4 | Factor D Inhibitors for the Treatment of AMD: Patent Highlight. | ACS Med Chem Lett 3: 781-782 (2012) | TBA | 2D 3D TSV |
24900374 | 34 | Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. | ACS Med Chem Lett 3: 74-78 (2012) | TBA | 2D 3D TSV |
24900372 | 60 | Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia. | ACS Med Chem Lett 3: 63-68 (2012) | TBA | 2D 3D TSV |
24900371 | 4 | (18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains. | ACS Med Chem Lett 3: 58-62 (2012) | TBA | 2D 3D TSV |
24900367 | 16 | Proposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor. | ACS Med Chem Lett 3: 20-24 (2012) | TBA | 2D 3D TSV |
24900366 | 1 | Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo. | ACS Med Chem Lett 3: 10-14 (2012) | TBA | 2D 3D TSV |
24900364 | 32 | Optimization of Potent Inhibitors of P. falciparum Dihydroorotate Dehydrogenase for the Treatment of Malaria. | ACS Med Chem Lett 2: 708-713 (2011) | TBA | 2D 3D TSV |
24900362 | 5 | A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of ?-Amyloid Plaques. | ACS Med Chem Lett 2: 673-7 (2011) | Technische Universit£t M£nchen | 2D 3D TSV |
24900361 | 27 | Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets. | ACS Med Chem Lett 2: 662-666 (2011) | TBA | 2D 3D TSV |
24900360 | 24 | Synthesis and Cardiac Imaging of (18)F-Ligands Selective for ß1-Adrenoreceptors. | ACS Med Chem Lett 2: 650-655 (2011) | TBA | 2D 3D TSV |
24900359 | 31 | Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists. | ACS Med Chem Lett 2: 644-649 (2011) | TBA | 2D 3D TSV |
24900358 | 69 | Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors. | ACS Med Chem Lett 2: 632-637 (2011) | TBA | 2D 3D TSV |
24900357 | 16 | The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease. | ACS Med Chem Lett 2: 614-619 (2011) | TBA | 2D 3D TSV |
24900353 | 6 | Combination of a Beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity. | ACS Med Chem Lett 2: 583-586 (2011) | TBA | 2D 3D TSV |
24900351 | 19 | Bivalent Ligands for the Serotonin 5-HT3 Receptor. | ACS Med Chem Lett 2: 571-576 (2011) | TBA | 2D 3D TSV |
24900349 | 90 | Optimization of the First Selective Steroid-11ß-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases. | ACS Med Chem Lett 2: 559-564 (2011) | TBA | 2D 3D TSV |
24900346 | 90 | Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. | ACS Med Chem Lett 2: 538-543 (2011) | TBA | 2D 3D TSV |
24900345 | 28 | Structure-Activity Relationship Studies of HIV-1 Integrase Oligonucleotide Inhibitors. | ACS Med Chem Lett 2: 532-7 (2011) | Lomonosov Moscow State University | 2D 3D TSV |
24900342 | 106 | Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors. | ACS Med Chem Lett 2: 519-522 (2011) | TBA | 2D 3D TSV |
24900341 | 30 | Benzodiazepinone Derivatives as CRTH2 Antagonists. | ACS Med Chem Lett 2: 515-518 (2011) | TBA | 2D 3D TSV |
24900340 | 40 | N-Methylated sst2 Selective Somatostatin Cyclic Peptide Analogue as a Potent Candidate for Treating Neurogenic Inflammation. | ACS Med Chem Lett 2: 509-514 (2011) | TBA | 2D 3D TSV |
24900338 | 19 | Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as ?-Amyloid PET Ligands and Identification of MK-3328. | ACS Med Chem Lett 2: 498-502 (2011) | Merck Research Laboratories | 2D 3D TSV |
24900335 | 6 | Ranking high affinity ligands of low solubility by NMR spectroscopy. | ACS Med Chem Lett 2: 485-487 (2011) | TBA | 2D 3D TSV |
24900334 | 89 | N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy. | ACS Med Chem Lett 2: 481-484 (2011) | TBA | 2D 3D TSV |
24900333 | 9 | Potent CXCR4 antagonists containing amidine type Peptide bond isosteres. | ACS Med Chem Lett 2: 477-480 (2011) | TBA | 2D 3D TSV |
24900331 | 5 | Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors. | ACS Med Chem Lett 2: 461-5 (2011) | University of Southampton | 2D 3D TSV |
24900330 | 47 | The impact of ionization States of matrix metalloproteinase inhibitors on docking-based inhibitor design. | ACS Med Chem Lett 2: 455-460 (2011) | TBA | 2D 3D TSV |
24900329 | 49 | Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. | ACS Med Chem Lett 2: 450-454 (2011) | TBA | 2D 3D TSV |
24900325 | 10 | Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinases. | ACS Med Chem Lett 2: 428-432 (2011) | TBA | 2D 3D TSV |
24900324 | 8 | Discovery of substituted biphenyl oxazolidinone inhibitors of cholesteryl ester transfer protein. | ACS Med Chem Lett 2: 424-427 (2011) | TBA | 2D 3D TSV |
24900321 | 10 | Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1. | ACS Med Chem Lett 2: 407-412 (2011) | TBA | 2D 3D TSV |
24900320 | 1 | Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases. | ACS Med Chem Lett 2: 402-406 (2011) | TBA | 2D 3D TSV |
24900318 | 8 | Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist. | ACS Med Chem Lett 2: 368-372 (2011) | TBA | 2D 3D TSV |
24900317 | 11 | Indomethacin Analogues that Enhance Doxorubicin Cytotoxicity in Multidrug Resistant Cells without Cox Inhibitory Activity. | ACS Med Chem Lett 2: 353-357 (2011) | TBA | 2D 3D TSV |
24900315 | 42 | Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors. | ACS Med Chem Lett 2: 342-7 (2011) | Array BioPharma | 2D 3D TSV |
24900313 | 97 | Discovery of AMG 853, a CRTH2 and DP Dual Antagonist. | ACS Med Chem Lett 2: 326-330 (2011) | TBA | 2D 3D TSV |
24900305 | 14 | Structure Guided Development of Potent Reversibly Binding Penicillin Binding Protein Inhibitors | ACS Med Chem Lett 2: 219-223 (2011) | TBA | 2D 3D TSV |
24900302 | 27 | Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity | ACS Med Chem Lett 2: 243-247 (2011) | TBA | 2D 3D TSV |
24900301 | 24 | Discovery of a Potent and Short−Acting Oral Calcilytic with a Pulsatile Secretion of Parathyroid Hormone | ACS Med Chem Lett 2: 238-242 (2011) | TBA | 2D 3D TSV |
24900298 | 100 | Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist | ACS Med Chem Lett 2: 213-218 (2011) | TBA | 2D 3D TSV |
24900297 | 47 | Synthesis and SAR of Thiazolylmethylphenyl Glucoside as Novel C-Aryl Glucoside SGLT2 Inhibitors | ACS Med Chem Lett 2: 182-187 (2011) | TBA | 2D 3D TSV |
24900296 | 38 | Sulfonate-Containing Thiiranes as Selective Gelatinase Inhibitors | ACS Med Chem Lett 2: 177-181 (2011) | TBA | 2D 3D TSV |
24900295 | 61 | Discovery of a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia | ACS Med Chem Lett 2: 171-176 (2011) | TBA | 2D 3D TSV |
24900294 | 72 | Novel 3-Aryl Indoles as Progesterone Receptor Antagonists for Uterine Fibroids | ACS Med Chem Lett 2: 148-153 (2011) | TBA | 2D 3D TSV |
24900293 | 78 | Discovery of novel cyanamide-based inhibitors of cathepsin C. | ACS Med Chem Lett 2: 142-147 (2011) | TBA | 2D 3D TSV |
24900292 | 9 | TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT. | ACS Med Chem Lett 2: 136-141 (2011) | TBA | 2D 3D TSV |
24900290 | 7 | Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140 | ACS Med Chem Lett 2: 124-129 (2011) | TBA | 2D 3D TSV |
24900289 | 155 | Identification of Potent and Selective Glucosylceramide Synthase Inhibitors from a Library of N-Alkylated Iminosugars | ACS Med Chem Lett 2: 119-123 (2011) | TBA | 2D 3D TSV |
24900288 | 32 | Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5 | ACS Med Chem Lett 2: 107-112 (2011) | TBA | 2D 3D TSV |
24900287 | 47 | Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1) | ACS Med Chem Lett 2: 102-106 (2011) | TBA | 2D 3D TSV |
24900286 | 65 | Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS | ACS Med Chem Lett 2: 97-101 (2011) | TBA | 2D 3D TSV |
24900284 | 129 | Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids. | ACS Med Chem Lett 2: 938-942 (2011) | TBA | 2D 3D TSV |
24900283 | 80 | Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality. | ACS Med Chem Lett 2: 933-937 (2011) | TBA | 2D 3D TSV |
24900281 | 15 | Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats. | ACS Med Chem Lett 2: 919-923 (2011) | TBA | 2D 3D TSV |
24900280 | 81 | Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist. | ACS Med Chem Lett 2: 913-918 (2011) | TBA | 2D 3D TSV |
24900278 | 3 | Discovery of a Potent Retinoid X Receptor Antagonist Structurally Closely Related to RXR Agonist NEt-3IB. | ACS Med Chem Lett 2: 896-900 (2011) | TBA | 2D 3D TSV |
24900277 | 36 | Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists. | ACS Med Chem Lett 2: 890-895 (2011) | TBA | 2D 3D TSV |
24900275 | 1 | Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum. | ACS Med Chem Lett 2: 866-869 (2011) | TBA | 2D 3D TSV |
24900272 | 14 | Homology Model and Docking-Based Virtual Screening for Ligands of the s1 Receptor. | ACS Med Chem Lett 2: 834-839 (2011) | TBA | 2D 3D TSV |
24900270 | 22 | Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 Diabetes. | ACS Med Chem Lett 2: 824-827 (2011) | TBA | 2D 3D TSV |
24900269 | 18 | Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity. | ACS Med Chem Lett 2: 809-813 (2011) | TBA | 2D 3D TSV |
24900268 | 18 | Mannitol Bis-phosphate Based Inhibitors of Fructose 1,6-Bisphosphate Aldolases. | ACS Med Chem Lett 2: 804-808 (2011) | TBA | 2D 3D TSV |
24900267 | 9 | Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable ¿-Secretase Modulator. | ACS Med Chem Lett 2: 786-791 (2011) | TBA | 2D 3D TSV |
24900266 | 24 | Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer. | ACS Med Chem Lett 2: 774-779 (2011) | TBA | 2D 3D TSV |
24900264 | 106 | The Discovery of VX-745: A Novel and Selective p38a Kinase Inhibitor. | ACS Med Chem Lett 2: 758-763 (2011) | TBA | 2D 3D TSV |
24900263 | 18 | 4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1. | ACS Med Chem Lett 2: 752-757 (2011) | TBA | 2D 3D TSV |
24900262 | 31 | Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility. | ACS Med Chem Lett 2: 747-751 (2011) | TBA | 2D 3D TSV |
24900258 | 14 | 3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors. | ACS Med Chem Lett 2: 720-723 (2011) | TBA | 2D 3D TSV |
24900256 | 19 | Development of Selective LH Receptor Agonists by Heterodimerization with a FSH Receptor Antagonist | ACS Med Chem Lett 2: 85-89 (2011) | TBA | 2D 3D TSV |
24900255 | 19 | Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile | ACS Med Chem Lett 2: 58-62 (2011) | TBA | 2D 3D TSV |
24900254 | 14 | Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. | ACS Med Chem Lett 2: 53-57 (2011) | TBA | 2D 3D TSV |
24900253 | 28 | Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity | ACS Med Chem Lett 2: 43-47 (2011) | TBA | 2D 3D TSV |
24900252 | 33 | Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors | ACS Med Chem Lett 2: 34-38 (2011) | TBA | 2D 3D TSV |
24900250 | 81 | Kinase Inhibition by Deoxy Analogues of the Resorcylic Lactone L-783277 | ACS Med Chem Lett 2: 22-27 (2011) | TBA | 2D 3D TSV |
24900248 | 10 | Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology | ACS Med Chem Lett 2: 11-16 (2011) | TBA | 2D 3D TSV |
24900247 | 78 | First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases | ACS Med Chem Lett 2: 2-6 (2011) | TBA | 2D 3D TSV |
24900244 | 8 | Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands. | ACS Med Chem Lett 1: 536-539 (2010) | TBA | 2D 3D TSV |
24900243 | 44 | Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors. | ACS Med Chem Lett 1: 530-535 (2010) | TBA | 2D 3D TSV |
24900242 | 16 | Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues. | ACS Med Chem Lett 1: 526-529 (2010) | TBA | 2D 3D TSV |
24900241 | 15 | Modification at the Lipophilic Domain of RXR Agonists Differentially Influences Activation of RXR Heterodimers. | ACS Med Chem Lett 1: 521-525 (2010) | TBA | 2D 3D TSV |
24900240 | 19 | Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR. | ACS Med Chem Lett 1: 510-515 (2010) | TBA | 2D 3D TSV |
24900239 | 7 | Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents. | ACS Med Chem Lett 1: 504-509 (2010) | TBA | 2D 3D TSV |
24900237 | 41 | Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity. | ACS Med Chem Lett 1: 493-498 (2010) | TBA | 2D 3D TSV |
24900236 | 56 | Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy. | ACS Med Chem Lett 1: 488-492 (2010) | TBA | 2D 3D TSV |
24900235 | 25 | Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity. | ACS Med Chem Lett 1: 483-487 (2010) | TBA | 2D 3D TSV |
24900233 | 7 | Discovery of omecamtiv mecarbil the first, selective, small molecule activator of cardiac Myosin. | ACS Med Chem Lett 1: 472-477 (2010) | TBA | 2D 3D TSV |
24900231 | 22 | Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway. | ACS Med Chem Lett 1: 454-459 (2010) | TBA | 2D 3D TSV |
24900229 | 41 | Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery. | ACS Med Chem Lett 1: 439-442 (2010) | TBA | 2D 3D TSV |
24900227 | 8 | Exploring a7-Nicotinic Receptor Ligand Diversity by Scaffold Enumeration from the Chemical Universe Database GDB. | ACS Med Chem Lett 1: 422-426 (2010) | TBA | 2D 3D TSV |
24900226 | 3 | From taxuspine x to structurally simplified taxanes with remarkable p-glycoprotein inhibitory activity. | ACS Med Chem Lett 1: 416-421 (2010) | TBA | 2D 3D TSV |
24900225 | 26 | Antiproliferative and differentiating activities of a novel series of histone deacetylase inhibitors. | ACS Med Chem Lett 1: 411-5 (2010) | Menarini Ricerche S.p.A. | 2D 3D TSV |
24900220 | 9 | Identification of a New Series of STAT3 Inhibitors by Virtual Screening. | ACS Med Chem Lett 1: 371-375 (2010) | TBA | 2D 3D TSV |
24900218 | 20 | Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1. | ACS Med Chem Lett 1: 350-354 (2010) | TBA | 2D 3D TSV |
24900217 | 1 | Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469. | ACS Med Chem Lett 1: 345-349 (2010) | TBA | 2D 3D TSV |
24900216 | 33 | Novel and Potent 5-Piperazinyl Methyl-N 1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands. | ACS Med Chem Lett 1: 340-344 (2010) | TBA | 2D 3D TSV |
24900213 | 25 | Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists. | ACS Med Chem Lett 1: 316-320 (2010) | TBA | 2D 3D TSV |
24900210 | 29 | Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist. | ACS Med Chem Lett 1: 290-294 (2010) | TBA | 2D 3D TSV |
24900209 | 5 | Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase. | ACS Med Chem Lett 1: 286-289 (2010) | TBA | 2D 3D TSV |
24900206 | 3 | Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulators. | ACS Med Chem Lett 1: 263-267 (2010) | TBA | 2D 3D TSV |
24900205 | 5 | Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria. | ACS Med Chem Lett 1: 258-262 (2010) | TBA | 2D 3D TSV |
24900203 | 13 | Development of Fluorescent Ligands for the Human 5-HT1A Receptor. | ACS Med Chem Lett 1: 249-253 (2010) | TBA | 2D 3D TSV |
24900202 | 38 | Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists. | ACS Med Chem Lett 1: 244-248 (2010) | TBA | 2D 3D TSV |
24899257 | 71 | Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors. | J Med Chem 57: 5179-89 (2014) | Saarland University | 2D 3D TSV |
24894560 | 24 | Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation. | Bioorg Med Chem Lett 24: 3142-5 (2014) | Sungkyunkwan University | 2D 3D TSV |
24893124 | 4 | Development of synthetic lethality anticancer therapeutics. | J Med Chem 57: 7859-73 (2014) | The University of Texas M.D. Anderson Cancer Center | 2D 3D TSV |
24891505 | 6 | Two amino acid residues confer different binding affinities of Abelson family kinase SRC homology 2 domains for phosphorylated cortactin. | J Biol Chem 289: 19704-13 (2014) | Yale University | 2D 3D TSV |
24890653 | 19 | Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR). | Bioorg Med Chem 22: 3713-9 (2014) | University of Strasburg | 2D 3D TSV |
24890652 | 44 | The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents. | Bioorg Med Chem 22: 3753-72 (2014) | Duquesne University | 2D 3D TSV |
24890090 | 1 | Thiazolidine-2,4-diones derivatives as PPAR-¿ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-¿ gene expression. | Bioorg Med Chem Lett 24: 3034-42 (2014) | Jamia Hamdard (Hamdard University) | 2D 3D TSV |
24889744 | 4 | Identification of 1, 4-Dihydrothieno [3', 2':5, 6]thiopyrano[4, 3-c] pyrazole derivatives as human 5-Lipo-oxygenase inhibitors. | Chem Biol Drug Des 84: 642-7 (2014) | Peking University | 2D 3D TSV |
24884780 | 53 | Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEd prenyl binding site. | J Med Chem 57: 5435-48 (2014) | Max Planck Institute of Molecular Physiology | 2D 3D TSV |
24884675 | 70 | Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists. | J Med Chem 57: 5129-40 (2014) | Genomics Institute of the Novartis Research Foundation | 2D 3D TSV |
24884590 | 17 | Discovery of the first potent and orally available agonist of the orphan G-protein-coupled receptor 52. | J Med Chem 57: 5226-37 (2014) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24883177 | 10 | Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1. | ACS Med Chem Lett 5: 29-33 (2014) | Medical University of South Carolina | 2D 3D TSV |
24882676 | 6 | Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. | Bioorg Med Chem 22: 3620-8 (2014) | Jishou University | 2D 3D TSV |
24882675 | 12 | Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors. | Bioorg Med Chem 22: 3642-53 (2014) | Shenyang Pharmaceutical University | 2D 3D TSV |
24881567 | 73 | Towards the next generation of dual Bcl-2/Bcl-xL inhibitors. | Bioorg Med Chem Lett 24: 3026-33 (2014) | AstraZeneca | 2D 3D TSV |
24881566 | 140 | Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). | Bioorg Med Chem Lett 24: 3100-3 (2014) | GlaxoSmithKline | 2D 3D TSV |
24881565 | 15 | Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitors. | Bioorg Med Chem Lett 24: 3018-22 (2014) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
24880903 | 24 | Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonists. | Bioorg Med Chem Lett 24: 3204-6 (2014) | AstraZeneca | 2D 3D TSV |
24880902 | 50 | Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole. | Bioorg Med Chem Lett 24: 3050-6 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24880489 | 7 | Novel synthesis of dihydropyrimidines for a-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking. | Bioorg Chem 54: 96-104 (2014) | COMSATS Institute of Information Technology | 2D 3D TSV |
24880232 | 25 | Inhibition of Enterococcus faecalis biofilm formation by highly active lactones and lactams analogues of rubrolides. | Eur J Med Chem 82: 127-38 (2014) | Federal University of Vi£osa | 2D 3D TSV |
24878638 | 32 | Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties. | Eur J Med Chem 82: 96-105 (2014) | University of Namur (UNamur) | 2D 3D TSV |
24878360 | 76 | Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. | Bioorg Med Chem 22: 3684-95 (2014) | King Saud University | 2D 3D TSV |
24878269 | 50 | Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT6 and dopamine D2 receptor ligands. | J Med Chem 57: 5823-8 (2014) | University of Copenhagen | 2D 3D TSV |
24878222 | 50 | Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT2C) receptor agonists with exquisite functional selectivity over 5-HT2A and 5-HT2B receptors. | J Med Chem 57: 5258-69 (2014) | Pfizer Inc | 2D 3D TSV |
24878198 | 4 | Naturally occurring polyphenolic inhibitors of amyloid beta aggregation. | Bioorg Med Chem Lett 24: 3108-12 (2014) | CSIRO Manufacturing Flagship (Biomedical) | 2D 3D TSV |
24878193 | 8 | Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors. | Bioorg Med Chem Lett 24: 3600-4 (2014) | Hanyang University | 2D 3D TSV |
24874895 | 42 | Lead optimization of 1,4-azaindoles as antimycobacterial agents. | J Med Chem 57: 5728-37 (2014) | AstraZeneca | 2D 3D TSV |
24874785 | 333 | New, potent, and selective peptidic oxytocin receptor agonists. | J Med Chem 57: 5306-17 (2014) | Ferring Research Institute Inc. | 2D 3D TSV |
24874438 | 42 | Design, synthesis, and structure-activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents. | J Med Chem 57: 4772-95 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24872411 | 2 | Structure of REV-ERBß ligand-binding domain bound to a porphyrin antagonist. | J Biol Chem 289: 20054-66 (2014) | The Scripps Research Institute | 2D 3D TSV |
24871996 | 124 | Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. | Eur J Med Chem 82: 47-55 (2014) | Medical University of Gdansk | 2D 3D TSV |
24871995 | 18 | Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold. | Eur J Med Chem 82: 36-46 (2014) | Universit£ degli Studi di Siena | 2D 3D TSV |
24871899 | 31 | Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase. | Eur J Med Chem 81: 492-8 (2014) | University of Naples | 2D 3D TSV |
24871036 | 13 | 4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity. | J Med Chem 57: 5419-34 (2014) | AstraZeneca | 2D 3D TSV |
24870926 | 50 | Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent. | J Med Chem 57: 5293-305 (2014) | Institut Pasteur Korea | 2D 3D TSV |
24867403 | 156 | The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents. | J Med Chem 58: 130-46 (2015) | EntreMed Inc. | 2D 3D TSV |
24867309 | 1 | Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase. | J Med Chem 57: 5203-11 (2014) | Lanzhou University | 2D 3D TSV |
24864041 | 16 | Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists. | Bioorg Med Chem 22: 3654-69 (2014) | Latvian Institute of Organic Synthesis | 2D 3D TSV |
24864038 | 112 | Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors. | Bioorg Med Chem 22: 3720-31 (2014) | Nippon Pharmaceutical Chemicals Co., Ltd | 2D 3D TSV |
24863981 | 59 | 4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists. | Eur J Med Chem 82: 1-15 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24863744 | 15 | DDD-028: a potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain. | Bioorg Med Chem Lett 24: 3088-91 (2014) | University of Missouri | 2D 3D TSV |
24860094 | 14 | Structure of the Acinetobacter baumannii dithiol oxidase DsbA bound to elongation factor EF-Tu reveals a novel protein interaction site. | J Biol Chem 289: 19869-80 (2014) | University of Queensland | 2D 3D TSV |
24859762 | 10 | Aromatic diacylhydrazine derivatives as a new class of polo-like kinase 1 (PLK1) inhibitors. | Eur J Med Chem 81: 420-6 (2014) | Nanjing University | 2D 3D TSV |
24858546 | 46 | Guanidinium-based derivatives: searching for new kinase inhibitors. | Eur J Med Chem 81: 427-41 (2014) | Trinity College | 2D 3D TSV |
24858540 | 12 | Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases. | Eur J Med Chem 81: 350-8 (2014) | Instituto de Qu£mica M£dica | 2D 3D TSV |
24857777 | 13 | Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene(thio) barbiturates as novel tyrosinase inhibitors. | Bioorg Med Chem 22: 3279-84 (2014) | China National Analytical Center (Guangzhou) | 2D 3D TSV |
24856674 | 52 | Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound. | J Med Chem 57: 5318-32 (2014) | Research Triangle Institute | 2D 3D TSV |
24856614 | 6 | Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor. | J Med Chem 57: 5405-18 (2014) | Monash University (Parkville Campus) | 2D 3D TSV |
24856304 | 25 | New coumarin derivatives: design, synthesis and use as inhibitors of hMAO. | Bioorg Med Chem 22: 3732-8 (2014) | Anhui Medical University | 2D 3D TSV |
24856302 | 1 | Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors. | Bioorg Med Chem 22: 3781-90 (2014) | La Trobe University | 2D 3D TSV |
24856185 | 2 | Inhibition by active site directed covalent modification of human glyoxalase I. | Bioorg Med Chem 22: 3301-8 (2014) | University of Maryland | 2D 3D TSV |
24856184 | 24 | Oxidation of cyanobenzocycloheptatrienes: Synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives. | Bioorg Med Chem 22: 3537-43 (2014) | AgriIbrahim£e£en University | 2D 3D TSV |
24856183 | 4 | Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. | Bioorg Med Chem 22: 3245-51 (2014) | Corbus Pharmaceuticals, Inc. | 2D 3D TSV |
24856182 | 23 | Combination of cyclohexane and piperazine based¿-opioid receptor agonists: Synthesis and pharmacological evaluation of trans,trans-configured perhydroquinoxalines. | Bioorg Med Chem 22: 3316-24 (2014) | Institut f£r Pharmazeutische und Medizinische Chemie der Universit£t M£nster | 2D 3D TSV |
24856068 | 48 | Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity. | Bioorg Med Chem Lett 24: 3137-41 (2014) | Banasthali University | 2D 3D TSV |
24856064 | 9 | Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists. | Bioorg Med Chem Lett 24: 3189-93 (2014) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
24856061 | 13 | Targeting the homologous recombination pathway by small molecule modulators. | Bioorg Med Chem Lett 24: 3006-13 (2014) | Drexel University College of Medicine | 2D 3D TSV |
24856059 | 7 | trans-Caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-a. | Bioorg Med Chem Lett 24: 3168-74 (2014) | Korea University | 2D 3D TSV |
24856058 | 3 | Protein-ligand interactions: probing the energetics of a putative cation-? interaction. | Bioorg Med Chem Lett 24: 3164-7 (2014) | The University of Texas | 2D 3D TSV |
24853323 | 17 | Identification and characterization of a new reversible MAGL inhibitor. | Bioorg Med Chem 22: 3285-91 (2014) | University of Pisa | 2D 3D TSV |
24853320 | 62 | Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases. | Bioorg Med Chem 22: 3370-8 (2014) | Martin-Luther-Universit£t Halle-Wittenberg | 2D 3D TSV |
24852275 | 15 | Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction. | Eur J Med Chem 81: 277-88 (2014) | Chinese Academy of Medical Science and Peking Union Medical College | 2D 3D TSV |
24852118 | 7 | Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists. | Bioorg Med Chem Lett 24: 2909-12 (2014) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
24850589 | 71 | Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease. | J Med Chem 57: 7160-81 (2014) | Universidad Complutense de Madrid | 2D 3D TSV |
24848155 | 35 | Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D3 receptor antagonists. | J Med Chem 57: 4962-8 (2014) | University of Michigan | 2D 3D TSV |
24847974 | 13 | A fragment-based approach to identifying S-adenosyl-l-methionine -competitive inhibitors of catechol O-methyl transferase (COMT). | J Med Chem 57: 5459-63 (2014) | Takeda California Inc | 2D 3D TSV |
24847734 | 32 | Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors. | J Med Chem 57: 4950-61 (2014) | Johns Hopkins University School of Medicine | 2D 3D TSV |
24847082 | 6 | Opioid receptor function is regulated by post-endocytic peptide processing. | J Biol Chem 289: 19613-26 (2014) | Icahn School of Medicine at Mount Sinai | 2D 3D TSV |
24846781 | 14 | Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(a or¿)-thio-(a,ß- orß,¿)-methylenetriphosphate scaffold. | J Med Chem 57: 4677-91 (2014) | Bar-Ilan University | 2D 3D TSV |
24844758 | 6 | Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities. | Bioorg Med Chem 22: 3488-97 (2014) | Keio University | 2D 3D TSV |
24844756 | 26 | Synthesis andß-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones. | Bioorg Med Chem 22: 3449-54 (2014) | University of Karachi | 2D 3D TSV |
24844534 | 46 | Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1. | J Nat Prod 77: 1445-51 (2014) | University of Tuebingen | 2D 3D TSV |
24844195 | 21 | Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A. | Bioorg Med Chem Lett 24: 2954-6 (2014) | Georgetown University Medical Center | 2D 3D TSV |
24844139 | 4 | Tryptophan hydroxylase 1 (Tph-1)-targeted bone anabolic agents for osteoporosis. | J Med Chem 57: 4692-709 (2014) | Nanjing University | 2D 3D TSV |
24842618 | 56 | The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties. | Bioorg Med Chem 22: 3414-22 (2014) | AMRI | 2D 3D TSV |
24840014 | 25 | Ingol-type diterpenes from Euphorbia antiquorum with mouse 11ß-hydroxysteroid dehydrogenase type 1 inhibition activity. | J Nat Prod 77: 1452-8 (2014) | Lanzhou University | 2D 3D TSV |
24839540 | 26 | In Vitro Membrane Permeation Studies and in Vivo Antinociception of Glycosylated Dmt | ACS Med Chem Lett 5: 352-357 (2014) | Vrije Universiteit Brussel | 2D 3D TSV |
24837158 | 60 | Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists. | Bioorg Med Chem 22: 3478-87 (2014) | Astellas Pharma Inc | 2D 3D TSV |
24837157 | 2 | Novel estrogen receptor (ER) modulators containing various hydrophobic bent-core structures. | Bioorg Med Chem 22: 3508-14 (2014) | Tohoku Pharmaceutical University | 2D 3D TSV |
24837154 | 18 | Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability. | Bioorg Med Chem 22: 3515-26 (2014) | Yamanouchi Pharmaceutical Co., Ltd | 2D 3D TSV |
24836072 | 38 | Synthesis of novel 2-mercaptobenzoxazole based 1,2,3-triazoles as inhibitors of proinflammatory cytokines and suppressors of COX-2 gene expression. | Eur J Med Chem 81: 204-17 (2014) | Jamia Hamdard (Hamdard University) | 2D 3D TSV |
24836068 | 19 | Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations. | Eur J Med Chem 81: 158-75 (2014) | Ratka Resanovica1 | 2D 3D TSV |
24836064 | 7 | Tamiphosphor monoesters as effective anti-influenza agents. | Eur J Med Chem 81: 106-18 (2014) | National Taiwan University | 2D 3D TSV |
24835985 | 46 | Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists. | Bioorg Med Chem Lett 24: 2949-53 (2014) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
24835984 | 59 | Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4. | Bioorg Med Chem Lett 24: 2885-91 (2014) | Amgen Inc | 2D 3D TSV |
24835983 | 38 | Optimization of ketone-based P2Y(12) receptor antagonists as antithrombotic agents: pharmacodynamics and receptor kinetics considerations. | Bioorg Med Chem Lett 24: 2963-8 (2014) | AstraZeneca | 2D 3D TSV |
24835980 | 98 | Discovery of TD-4306, a long-actingß2-agonist for the treatment of asthma and COPD. | Bioorg Med Chem Lett 24: 2871-6 (2014) | Theravance, Inc. | 2D 3D TSV |
24835788 | 28 | Preparation, anticholinesterase activity and molecular docking of new lupane derivatives. | Bioorg Med Chem 22: 3341-50 (2014) | Universidad Nacional del Sur | 2D 3D TSV |
24835202 | 68 | Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonists. | Bioorg Med Chem Lett 24: 3199-203 (2014) | AstraZeneca | 2D 3D TSV |
24835200 | 18 | Design and synthesis of quinolinopropellane derivatives with selectived opioid receptor agonism. | Bioorg Med Chem Lett 24: 2851-4 (2014) | University of Tsukuba | 2D 3D TSV |
24835199 | 31 | Design and synthesis of phenylisoxazole derivatives as novel human acrosin inhibitors. | Bioorg Med Chem Lett 24: 2802-6 (2014) | Second Military Medical University | 2D 3D TSV |
24835197 | 13 | ß-Secretase (BACE1)-inhibiting C-methylrotenoids from Abronia nana suspension cultures. | Bioorg Med Chem Lett 24: 2945-8 (2014) | Kyungpook National University | 2D 3D TSV |
24831826 | 59 | Small molecule inhibitors targeting activator protein 1 (AP-1). | J Med Chem 57: 6930-48 (2014) | University of Texas Medical Branch | 2D 3D TSV |
24831693 | 116 | Functionally selective dopamine D2, D3 receptor partial agonists. | J Med Chem 57: 4861-75 (2014) | Friedrich-Alexander University | 2D 3D TSV |
24831536 | 2 | From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds. | J Med Chem 57: 7145-59 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24831513 | 35 | Functionalization of ß-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System. | ACS Chem Biol 9: 1499-507 (2014) | University of Bern , Bühlstrasse 28, CH-3012 Bern, Switzerland. | 2D 3D TSV |
24831010 | 11 | ORA1, a zebrafish olfactory receptor ancestral to all mammalian V1R genes, recognizes 4-hydroxyphenylacetic acid, a putative reproductive pheromone. | J Biol Chem 289: 19778-88 (2014) | German Institute of Human Nutrition Potsdam-Rehbruecke | 2D 3D TSV |
24828006 | 4 | Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists. | J Med Chem 57: 4819-33 (2014) | University of Ljubljana | 2D 3D TSV |
24827861 | 27 | Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interaction. | J Med Chem 57: 5094-111 (2014) | Harvard Medical School | 2D 3D TSV |
24827597 | 38 | Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D2 receptor. | J Med Chem 57: 4924-39 (2014) | Monash University | 2D 3D TSV |
24825301 | 34 | Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD(2) receptors CRTH2 and DP. | Bioorg Med Chem Lett 24: 2877-80 (2014) | Amgen Inc | 2D 3D TSV |
24824984 | 55 | Identification of Inhibitors of PvdQ, an Enzyme Involved in the Synthesis of the Siderophore Pyoverdine. | ACS Chem Biol 9: 1536-44 (2014) | The Broad Institute , Cambridge, Massachusetts 02142, United States | 2D 3D TSV |
24824658 | 8 | Structure-activity relationship studies of N-methylated and N-hydroxylated spider polyamine toxins as inhibitors of ionotropic glutamate receptors. | J Med Chem 57: 4940-9 (2014) | University of Copenhagen | 2D 3D TSV |
24824064 | 48 | Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I). | Eur J Med Chem 81: 89-94 (2014) | China Pharmaceutical University | 2D 3D TSV |
24821398 | 42 | Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues ass2 receptor ligands. | J Med Chem 57: 4239-51 (2014) | Washington University | 2D 3D TSV |
24821376 | 2 | Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds. | Bioorg Med Chem Lett 24: 2924-7 (2014) | Universit£ di Milano | 2D 3D TSV |
24821375 | 5 | The dipeptide H-Trp-Glu-OH (WE) shows agonistic activity to peroxisome proliferator-activated protein-a and reduces hepatic lipid accumulation in lipid-loaded H4IIE cells. | Bioorg Med Chem Lett 24: 2957-62 (2014) | Korea University | 2D 3D TSV |
24819955 | 36 | Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine. | Eur J Med Chem 81: 15-21 (2014) | University of W£rzburg | 2D 3D TSV |
24819954 | 16 | Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents. | Eur J Med Chem 81: 1-14 (2014) | University of Messina | 2D 3D TSV |
24819116 | 135 | Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain expo | J Med Chem 57: 4720-44 (2014) | Pfizer Inc | 2D 3D TSV |
24818857 | 3 | Structural insights into the molecular mechanism of vitamin D receptor activation by lithocholic acid involving a new mode of ligand recognition. | J Med Chem 57: 4710-9 (2014) | Institute of Genetics and Molecular and Cellular Biology (IGBMC) | 2D 3D TSV |
24816066 | 12 | Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors. | Bioorg Med Chem 22: 3096-104 (2014) | Gazi University | 2D 3D TSV |
24815510 | 8 | Synthesis of 2'-O,4'-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase. | Bioorg Med Chem Lett 24: 2699-702 (2014) | Idenix Pharmaceuticals | 2D 3D TSV |
24815509 | 51 | Discovery of camphor-derived pyrazolones as 11ß-hydroxysteroid dehydrogenase type 1 inhibitors. | Bioorg Med Chem Lett 24: 2707-11 (2014) | Hoffmann-La Roche Inc | 2D 3D TSV |
24815508 | 29 | Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. | Bioorg Med Chem Lett 24: 2669-73 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24815000 | 21 | 8-Substituted 2-alkynyl-N(9)-propargyladenines as A2A adenosine receptor antagonists. | Bioorg Med Chem 22: 3072-82 (2014) | Yamasa Corporation | 2D 3D TSV |
24814885 | 5 | Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketones. | Bioorg Med Chem 22: 3091-5 (2014) | Hokkaido University | 2D 3D TSV |
24814197 | 63 | Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines asa7 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disorders. | J Med Chem 57: 3966-83 (2014) | Critical Therapeutics, Inc. | 2D 3D TSV |
24813882 | 41 | Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease. | Eur J Med Chem 80: 543-61 (2014) | Okayama University | 2D 3D TSV |
24813742 | 98 | Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors. | Bioorg Med Chem Lett 24: 2617-20 (2014) | Universit£ degli Studi | 2D 3D TSV |
24813741 | 110 | Multivalent design of long-actingß(2)-adrenoceptor agonists incorporating biarylamines. | Bioorg Med Chem Lett 24: 2625-30 (2014) | Theravance, Inc. | 2D 3D TSV |
24813737 | 107 | Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2. | Bioorg Med Chem Lett 24: 2635-9 (2014) | Array BioPharma Inc | 2D 3D TSV |
24813735 | 17 | Discovery of 1-arylpyrrolidone derivatives as potent p53-MDM2 inhibitors based on molecule fusing strategy. | Bioorg Med Chem Lett 24: 2648-50 (2014) | Second Military Medical University | 2D 3D TSV |
24813734 | 44 | Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase. | Bioorg Med Chem Lett 24: 2737-40 (2014) | Merck Research Laboratories | 2D 3D TSV |
24813730 | 20 | Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKß inhibitors. | Bioorg Med Chem Lett 24: 2655-60 (2014) | Yonsei University | 2D 3D TSV |
24811300 | 20 | Biased and unbiased strategies to identify biologically active small molecules. | Bioorg Med Chem 22: 4474-89 (2014) | Institut de Chimie des Substances Naturelles | 2D 3D TSV |
24809953 | 28 | Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. | J Med Chem 57: 4889-905 (2014) | AstraZeneca | 2D 3D TSV |
24809814 | 25 | Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis. | J Med Chem 57: 5074-84 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24805946 | 25 | Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness. | J Med Chem 57: 4834-48 (2014) | Northeastern University | 2D 3D TSV |
24805199 | 10 | Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells. | J Med Chem 57: 4569-83 (2014) | Georgetown University | 2D 3D TSV |
24805037 | 380 | Novel arylsulfonamide derivatives with 5-HT6/5-HT7 receptor antagonism targeting behavioral and psychological symptoms of dementia. | J Med Chem 57: 4543-57 (2014) | Adamed Ltd. | 2D 3D TSV |
24803362 | 12 | Concise synthesis of C-1-cyano-iminosugars via a new Staudinger/aza Wittig/Strecker multicomponent reaction strategy. | Bioorg Med Chem Lett 24: 2777-80 (2014) | Technical University Graz | 2D 3D TSV |
24803299 | 10 | Arylazopyrazole AAP1742 inhibits CDKs and induces apoptosis in multiple myeloma cells via Mcl-1 downregulation. | Chem Biol Drug Des 84: 402-8 (2014) | Institute of Experimental Botany ASCR and Palacky University | 2D 3D TSV |
24801997 | 30 | Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors. | J Med Chem 57: 5381-94 (2014) | University of Texas at Dallas | 2D 3D TSV |
24801610 | 52 | Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors. | J Med Chem 57: 4598-605 (2014) | Universit£ degli Studi di Padova | 2D 3D TSV |
24801499 | 31 | Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity. | J Med Chem 57: 5370-80 (2014) | University of Alabama at Birmingham | 2D 3D TSV |
24800942 | 10 | Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors. | J Med Chem 57: 4324-36 (2014) | Purdue University | 2D 3D TSV |
24800940 | 146 | Identification of a new selective dopamine D4 receptor ligand. | Bioorg Med Chem 22: 3105-14 (2014) | Florida A&M University | 2D 3D TSV |
24799995 | 54 | Development of novel Vitamin D Receptor-Coactivator Inhibitors. | ACS Med Chem Lett 5: 199-204 (2014) | University of Wisconsin-Milwaukee | 2D 3D TSV |
24799086 | 74 | Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. | Hepatology 60: 1015-22 (2014) | Pfizer Inc | 2D 3D TSV |
24798337 | 5 | Human UTY(KDM6C) is a male-specific N¿-methyl lysyl demethylase. | J Biol Chem 289: 18302-13 (2014) | University of Oxford | 2D 3D TSV |
24798019 | 30 | Acridone alkaloids from Glycosmis chlorosperma as DYRK1A inhibitors. | J Nat Prod 77: 1117-22 (2014) | Institut de Chimie des Substances Naturelles | 2D 3D TSV |
24797717 | 40 | Synthesis and evaluation of novel marine bromopyrrole alkaloid-based derivatives as potential antidepressant agents. | Chem Biol Drug Des 84: 593-602 (2014) | University of KwaZulu-Natal | 2D 3D TSV |
24797455 | 5 | Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase. | Chembiochem 15: 1121-30 (2014) | Genentech Inc | 2D 3D TSV |
24794772 | 3 | Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1). | Eur J Med Chem 80: 407-15 (2014) | University of Salerno | 2D 3D TSV |
24794747 | 36 | Novel aromatic-polyamine conjugates as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. | Bioorg Med Chem 22: 3213-9 (2014) | Henan University | 2D 3D TSV |
24794746 | 168 | Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy. | Bioorg Med Chem 22: 3187-203 (2014) | Aurigene Discovery Technologies Limited | 2D 3D TSV |
24794745 | 20 | Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP. | Bioorg Med Chem 22: 3123-40 (2014) | National Institute of Industrial Technology | 2D 3D TSV |
24794744 | 54 | Optimization of diaryl amine derivatives as kinesin spindle protein inhibitors. | Bioorg Med Chem 22: 3171-9 (2014) | Kyoto University | 2D 3D TSV |
24794743 | 85 | Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75. | Bioorg Med Chem 22: 3146-58 (2014) | South China Normal University | 2D 3D TSV |
24794112 | 50 | Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs. | Bioorg Med Chem Lett 24: 2693-8 (2014) | Vanderbilt University Medical Center | 2D 3D TSV |
24794110 | 36 | a-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonists. | Bioorg Med Chem Lett 24: 2685-8 (2014) | Seoul National University | 2D 3D TSV |
24794108 | 15 | Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors. | Bioorg Med Chem Lett 24: 2712-6 (2014) | Hunan Agricultural University | 2D 3D TSV |
24794107 | 32 | Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1. | Bioorg Med Chem Lett 24: 2764-7 (2014) | Peking University | 2D 3D TSV |
24794105 | 38 | a-Tetralone derivatives as inhibitors of monoamine oxidase. | Bioorg Med Chem Lett 24: 2758-63 (2014) | North-West University | 2D 3D TSV |
24794104 | 6 | Serendipitous oxidation product of BIBN4096BS: a potent CGRP receptor antagonist. | Bioorg Med Chem Lett 24: 2744-8 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24794103 | 1 | Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors. | Bioorg Med Chem Lett 24: 2689-92 (2014) | Dainippon Sumitomo Pharma Co., Ltd. | 2D 3D TSV |
24793885 | 11 | Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors. | Eur J Med Chem 80: 383-92 (2014) | Beijing Institute of Technology | 2D 3D TSV |
24793884 | 151 | Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors. | Eur J Med Chem 80: 364-82 (2014) | Amgen Inc | 2D 3D TSV |
24793878 | 25 | New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO. | Eur J Med Chem 80: 278-84 (2014) | Anhui Medical University | 2D 3D TSV |
24793360 | 29 | Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors. | J Med Chem 57: 4640-60 (2014) | University of Lille | 2D 3D TSV |
24792813 | 80 | Sulfonamide inhibition studies of twoß-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. | Bioorg Med Chem 22: 2939-46 (2014) | Kochi Medical School | 2D 3D TSV |
24792812 | 2 | Anti-inflammatory drimane sesquiterpene lactones from an Aspergillus species. | Bioorg Med Chem 22: 2912-8 (2014) | Institute of Biotechnology and Drug Research (IBWF) | 2D 3D TSV |
24792811 | 19 | Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity. | Bioorg Med Chem 22: 2947-54 (2014) | Nanjing University | 2D 3D TSV |
24792774 | 24 | Discovery of novel type II c-Met inhibitors based on BMS-777607. | Eur J Med Chem 80: 254-66 (2014) | Fudan University | 2D 3D TSV |
24786728 | 1 | Griseorhodins D-F, neuroactive intermediates and end products of post-PKS tailoring modification in Griseorhodin biosynthesis. | J. Nat. Prod. 77: 1224-30 (2014) | University of Utah | 2D 3D TSV |
24786585 | 200 | Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-ß type I receptor kinase as cancer immunotherapeutic/antifibrotic agent. | J Med Chem 57: 4213-38 (2014) | Ewha Womans University | 2D 3D TSV |
24786387 | 58 | Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies. | J Med Chem 57: 4511-20 (2014) | Momenta Pharmaceuticals Inc. | 2D 3D TSV |
24785705 | 12 | Discovery of novel and selective SIRT6 inhibitors. | J Med Chem 57: 4796-804 (2014) | University of Bologna | 2D 3D TSV |
24785465 | 80 | Discovery of novel 2,4-diarylaminopyrimidine analogues (DAAPalogues) showing potent inhibitory activities against both wild-type and mutant ALK kinases. | J Med Chem 58: 197-211 (2015) | Chinese Academy of Sciences | 2D 3D TSV |
24785301 | 83 | Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD. | J Med Chem 57: 4661-76 (2014) | AstraZeneca | 2D 3D TSV |
24783948 | 14 | Molecular Basis of 1-Deoxygalactonojirimycin Arylthiourea Binding to Human a-Galactosidase A: Pharmacological Chaperoning Efficacy on Fabry Disease Mutants. | ACS Chem Biol 9: 1460-9 (2014) | Tottori University , Yonago 683-8503, Japan | 2D 3D TSV |
24782313 | 10 | In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth. | J Biol Chem 289: 17980-95 (2014) | Harvard School of Public Health | 2D 3D TSV |
24780600 | 53 | Dual inhibition of thea-glucosidase and butyrylcholinesterase studied by molecular field topology analysis. | Eur J Med Chem 80: 228-42 (2014) | University of Florida | 2D 3D TSV |
24780598 | 7 | Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea/thiourea derivatives as anti-hyperglycaemic agents and aldose reductase inhibitors. | Eur J Med Chem 80: 209-17 (2014) | Jamia Hamdard (Hamdard University) | 2D 3D TSV |
24780593 | 46 | Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity. | Eur J Med Chem 80: 167-74 (2014) | Shoolini University | 2D 3D TSV |
24780592 | 2 | Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK-VEGFR3 protein-protein interaction. | Eur J Med Chem 80: 154-66 (2014) | Roswell Park Cancer Institute | 2D 3D TSV |
24780121 | 19 | Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors. | Bioorg Med Chem Lett 24: 2477-80 (2014) | Genentech Inc | 2D 3D TSV |
24779610 | 33 | Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding? | J Med Chem 57: 4368-81 (2014) | McGill University | 2D 3D TSV |
24779514 | 128 | Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase. | J Med Chem 57: 3856-73 (2014) | Gilead Sciences Inc | 2D 3D TSV |
24775917 | 59 | Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor. | Bioorg Med Chem 22: 2919-38 (2014) | Beckman Research Institute | 2D 3D TSV |
24775307 | 42 | Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors. | Bioorg Med Chem Lett 24: 2444-7 (2014) | Viamet Pharmaceuticals Inc | 2D 3D TSV |
24775305 | 30 | P3 SAR exploration of biphenyl carbamate based Legumain inhibitors. | Bioorg Med Chem Lett 24: 2521-4 (2014) | Queen's University Belfast | 2D 3D TSV |
24775304 | 36 | Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives. | Bioorg Med Chem Lett 24: 2424-8 (2014) | Keimyung University | 2D 3D TSV |
24773565 | 24 | Combination of triple bond and adamantane ring on the vitamin D side chain produced partial agonists for vitamin D receptor. | J Med Chem 57: 4073-87 (2014) | Rikkyo University | 2D 3D TSV |
24773549 | 20 | Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic properties. | J Med Chem 57: 4098-110 (2014) | Development Center for Biotechnology | 2D 3D TSV |
24773054 | 11 | Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid. | J Med Chem 57: 4058-72 (2014) | St. John's University | 2D 3D TSV |
24769348 | 63 | New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors. | Eur J Med Chem 80: 101-11 (2014) | Sapienza University of Rome | 2D 3D TSV |
24767852 | 5 | Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor. | Bioorg Med Chem Lett 24: 2473-6 (2014) | University of Utah | 2D 3D TSV |
24767850 | 8 | Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors. | Bioorg Med Chem Lett 24: 2486-92 (2014) | Korea Research Institute of Chemical Technology | 2D 3D TSV |
24767849 | 2 | Design, synthesis and biological evaluation of Pontin ATPase inhibitors through a molecular docking approach. | Bioorg Med Chem Lett 24: 2512-6 (2014) | University of Bordeaux | 2D 3D TSV |
24767848 | 2 | Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor. | Bioorg Med Chem Lett 24: 2508-11 (2014) | University of Siena | 2D 3D TSV |
24767846 | 37 | Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands. | Bioorg Med Chem Lett 24: 2465-8 (2014) | Shandong University | 2D 3D TSV |
24767843 | 40 | 2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists. | Bioorg Med Chem Lett 24: 2481-5 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24767842 | 29 | Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors. | Bioorg Med Chem Lett 24: 2448-52 (2014) | Genentech Inc | 2D 3D TSV |
24767840 | 2 | Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking. | Bioorg Med Chem Lett 24: 2493-6 (2014) | University of Zurich | 2D 3D TSV |
24767818 | 13 | Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed fromß-amino acid as proteasome inhibitors. | Bioorg Med Chem 22: 2955-65 (2014) | Zhejiang University | 2D 3D TSV |
24766560 | 16 | Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells. | J Med Chem 57: 4009-22 (2014) | Taipei Medical University | 2D 3D TSV |
24763362 | 22 | Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors. | Eur J Med Chem 80: 47-56 (2014) | National Institute of Pharmaceutical Education and Research | 2D 3D TSV |
24763360 | 46 | Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties. | Eur J Med Chem 80: 8-35 (2014) | Universit£ degli Studi di Urbino | 2D 3D TSV |
24763264 | 7 | Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo. | Eur J Med Chem 79: 436-45 (2014) | University of Helsinki | 2D 3D TSV |
24763262 | 8 | 4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies. | Eur J Med Chem 79: 413-21 (2014) | Peking University Health Science Center | 2D 3D TSV |
24763261 | 35 | Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening. | Eur J Med Chem 79: 399-412 (2014) | China Pharmaceutical University | 2D 3D TSV |
24761755 | 76 | Selectively promiscuous opioid ligands: discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinity. | J Med Chem 57: 4049-57 (2014) | University of Bath | 2D 3D TSV |
24758871 | 61 | Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1. | Bioorg Med Chem 22: 3030-54 (2014) | University of Oxford | 2D 3D TSV |
24758746 | 36 | Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia. | J Med Chem 57: 4196-212 (2014) | Janssen Pharmaceutica NV | 2D 3D TSV |
24758147 | 31 | Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity. | J Med Chem 57: 4382-96 (2014) | Northwestern University | 2D 3D TSV |
24755525 | 33 | Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activity. | Bioorg Med Chem 22: 2992-7 (2014) | RTI International | 2D 3D TSV |
24755524 | 60 | Design, synthesis and preliminary evaluation ofa-sulfonyl¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors. | Bioorg Med Chem 22: 3055-64 (2014) | Shandong University | 2D 3D TSV |
24755431 | 59 | The discovery of diazepinone-based 5-HT3 receptor partial agonists. | Bioorg Med Chem Lett 24: 2578-81 (2014) | AMRI | 2D 3D TSV |
24755427 | 107 | The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation. | Bioorg Med Chem Lett 24: 2571-7 (2014) | AstraZeneca | 2D 3D TSV |
24755426 | 38 | Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitors. | Bioorg Med Chem Lett 24: 2555-9 (2014) | Shanghai Hengrui Pharmaceutical Co., Ltd | 2D 3D TSV |
24755425 | 22 | Synthesis and structure-activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists. | Bioorg Med Chem Lett 24: 2539-45 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24755374 | 95 | Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F. | Bioorg Chem 55: 2-15 (2014) | University of Ljubljana, A?kerceva 7, 1000 Ljubljana, Slovenia | 2D 3D TSV |
24755226 | 6 | Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration. | J Biol Chem 289: 16349-61 (2014) | University of Colorado School of Medicine | 2D 3D TSV |
24754677 | 76 | Identification of type II and III DDR2 inhibitors. | J Med Chem 57: 4252-62 (2014) | Technical University of Dortmund | 2D 3D TSV |
24754640 | 28 | New 5-unsubstituted dihydropyridines with improved CaV1.3 selectivity as potential neuroprotective agents against ischemic injury. | J Med Chem 57: 4313-23 (2014) | Universidad Complutense | 2D 3D TSV |
24754609 | 35 | Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase¿. | J Med Chem 58: 517-21 (2015) | Vertex Pharmaceuticals Inc | 2D 3D TSV |
24753254 | 2 | Functional rescue of Kallmann syndrome-associated prokineticin receptor 2 (PKR2) mutants deficient in trafficking. | J Biol Chem 289: 15518-26 (2014) | Central South University | 2D 3D TSV |
24752625 | 25 | Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors. | Org Biomol Chem 12: 3441-5 (2014) | Lanzhou University | 2D 3D TSV |
24751552 | 20 | Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents. | Bioorg Med Chem 22: 2855-66 (2014) | K.L.E.U's College of Pharmacy | 2D 3D TSV |
24751446 | 5 | Cell permeable vanX inhibitors as vancomycin re-sensitizing agents. | Bioorg Med Chem Lett 24: 2535-8 (2014) | University of Minnesota | 2D 3D TSV |
24751445 | 15 | Hot spot-based design of small-molecule inhibitors for protein-protein interactions. | Bioorg Med Chem Lett 24: 2546-54 (2014) | University of Utah | 2D 3D TSV |
24751443 | 52 | Discovery of structurally novel, potent and orally efficacious GPR119 agonists. | Bioorg Med Chem Lett 24: 2383-7 (2014) | Genomics Institute of the Novartis Research Foundation | 2D 3D TSV |
24751441 | 18 | Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization. | Bioorg Med Chem Lett 24: 2525-9 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24751440 | 1 | Optimization of pancreatic lipase inhibition by Cudrania tricuspidata fruits using response surface methodology. | Bioorg Med Chem Lett 24: 2329-33 (2014) | Chungbuk National University | 2D 3D TSV |
24751157 | 6 | Design, Synthesis and Biological Evaluation of Peptidyl Epoxyketone Proteasome Inhibitors Composed of ??????-amino Acids. | Chem Biol Drug Des 84: 497-504 (2014) | Zhejiang University | 2D 3D TSV |
24749893 | 123 | 3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation. | J Med Chem 57: 4111-33 (2014) | University of Michigan Medical School | 2D 3D TSV |
24749861 | 39 | Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. | J Med Chem 57: 4289-301 (2014) | H. Lee Moffitt Cancer Center and Research Institute | 2D 3D TSV |
24746465 | 90 | Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties. | Bioorg Med Chem 22: 2867-74 (2014) | ENSCM/UMII/UMR-CNRS 5635 | 2D 3D TSV |
24746464 | 29 | Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors. | Bioorg Med Chem 22: 2887-95 (2014) | Sapienza University of Rome | 2D 3D TSV |
24745969 | 36 | Identification of the first potent, selective and bioavailable PPARa antagonist. | Bioorg Med Chem Lett 24: 2267-72 (2014) | Inception Sciences | 2D 3D TSV |
24745967 | 19 | Benzylpiperidine variations on histamine H3 receptor ligands for improved drug-likeness. | Bioorg Med Chem Lett 24: 2236-9 (2014) | Johann Wolfgang Goethe University | 2D 3D TSV |
24745965 | 22 | Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors. | Bioorg Med Chem Lett 24: 2263-6 (2014) | Montclair State University | 2D 3D TSV |
24745964 | 20 | Design, synthesis, docking and anti-inflammatory evaluation of novel series of benzofuran based prodrugs. | Bioorg Med Chem Lett 24: 2251-5 (2014) | Banaras Hindu University | 2D 3D TSV |
24742681 | 4 | Oxysterol-binding protein (OSBP)-related protein 4 (ORP4) is essential for cell proliferation and survival. | J Biol Chem 289: 15705-17 (2014) | Dalhousie University | 2D 3D TSV |
24742680 | 14 | Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis. | J Biol Chem 289: 15527-35 (2014) | University of Michigan | 2D 3D TSV |
24742384 | 90 | Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors. | Eur J Med Chem 79: 251-9 (2014) | Universit£ di Milano | 2D 3D TSV |
24742203 | 47 | Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria. | J Med Chem 57: 4134-53 (2014) | University of Belgrade | 2D 3D TSV |
24742174 | 11 | A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group. | J Med Chem 57: 4351-67 (2014) | Showa Pharmaceutical University | 2D 3D TSV |
24742150 | 101 | Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors. | J Med Chem 57: 3939-65 (2014) | Vichem Chemie Ltd. | 2D 3D TSV |
24739388 | 14 | Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor. | J Biol Chem 289: 15987-6005 (2014) | University of Wuerzburg | 2D 3D TSV |
24738581 | 81 | Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist. | J Med Chem 57: 4273-88 (2014) | Pfizer Inc | 2D 3D TSV |
24738476 | 15 | New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease. | J Med Chem 57: 3773-85 (2014) | Instituto de Qu£mica M£dica | 2D 3D TSV |
24737316 | 18 | Structural basis of pharmacological chaperoning for human ß-galactosidase. | J Biol Chem 289: 14560-8 (2014) | The University of Tokyo | 2D 3D TSV |
24736117 | 2 | Elucidation of different inhibition mechanism of small chemicals on PtdInsP-binding domains using in silico docking experiments. | Bioorg Med Chem Lett 24: 2256-62 (2014) | Sookmyung Women's University | 2D 3D TSV |
24735647 | 34 | Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic. | Eur J Med Chem 79: 216-30 (2014) | Huazhong University of Science and Technology | 2D 3D TSV |
24735646 | 11 | Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors. | Eur J Med Chem 79: 203-15 (2014) | VIT University | 2D 3D TSV |
24735644 | 19 | Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-ß hydrolysis. | Eur J Med Chem 79: 184-93 (2014) | University of Lille | 2D 3D TSV |
24735492 | 98 | Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence. | J Med Chem 57: 4154-72 (2014) | Sanford-Burnham Medical Research Institute | 2D 3D TSV |
24731541 | 1 | The cannabinoid acids, analogs and endogenous counterparts. | Bioorg Med Chem 22: 2830-43 (2014) | The University of Massachusetts Medical School | 2D 3D TSV |
24731281 | 10 | Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents. | Bioorg Med Chem Lett 24: 2324-8 (2014) | Nanjing University | 2D 3D TSV |
24731278 | 22 | Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages. | Bioorg Med Chem Lett 24: 2283-7 (2014) | Bar-Ilan University | 2D 3D TSV |
24731277 | 2 | Small chemicals with inhibitory effects on PtdIns(3,4,5)P3 binding of Btk PH domain. | Bioorg Med Chem Lett 24: 2334-9 (2014) | Konkuk University | 2D 3D TSV |
24731275 | 21 | Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents. | Bioorg Med Chem Lett 24: 2319-23 (2014) | Virginia Commonwealth University | 2D 3D TSV |
24729834 | 79 | Trisubstituted Sulfonamides: a New Chemotype for Development of Potent and Selective CB | ACS Med Chem Lett 4: 387-392 (2013) | University of Pittsburgh | 2D 3D TSV |
24727489 | 8 | Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE). | Eur J Med Chem 79: 128-42 (2014) | Woosuk University | 2D 3D TSV |
24726809 | 72 | Design, synthesis and biological evaluation of benzylisoquinoline derivatives as multifunctional agents against Alzheimer's disease. | Bioorg Med Chem Lett 24: 2368-73 (2014) | China Pharmaceutical University | 2D 3D TSV |
24726807 | 30 | Scaffold hopping approach to a new series of smoothened antagonists. | Bioorg Med Chem Lett 24: 2300-4 (2014) | Soochow University | 2D 3D TSV |
24726806 | 108 | Syk inhibitors with high potency in presence of blood. | Bioorg Med Chem Lett 24: 2278-82 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24726306 | 11 | Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase. | Bioorg Med Chem 22: 2791-8 (2014) | University of Iowa | 2D 3D TSV |
24726305 | 3 | Preliminary investigations into triazole derived androgen receptor antagonists. | Bioorg Med Chem 22: 2692-706 (2014) | Deakin University | 2D 3D TSV |
24725435 | 15 | Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: Part I. | Bioorg Med Chem Lett 24: 2073-8 (2014) | Glenmark Pharmaceuticals Ltd | 2D 3D TSV |
24721831 | 2 | Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate. | Bioorg Med Chem 22: 2648-54 (2014) | Washington University | 2D 3D TSV |
24721830 | 33 | Synthesis and in vitro evaluation of bis-quaternary 2-(hydroxyimino)-N-(pyridin-3-yl)acetamide derivatives as reactivators against sarin and VX inhibited human acetylcholinesterase (hAChE). | Bioorg Med Chem 22: 2684-91 (2014) | Defence Research & Development Establishment (DRDE) | 2D 3D TSV |
24721313 | 21 | Synthesis and evaluation of several oleanolic acid glycoconjugates as protein tyrosine phosphatase 1B inhibitors. | Eur J Med Chem 79: 34-46 (2014) | North-West University | 2D 3D TSV |
24720475 | 26 | Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents. | Chem Biol Drug Des 84: 473-88 (2014) | Cairo University | 2D 3D TSV |
24719329 | 3 | Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation. | J Biol Chem 289: 16270-7 (2014) | McGill University | 2D 3D TSV |
24717153 | 46 | Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors. | Bioorg Med Chem Lett 24: 2118-22 (2014) | Gedeon Richter Plc | 2D 3D TSV |
24713308 | 48 | Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity. | Bioorg Med Chem 22: 2643-7 (2014) | Siedlce University of Natural Sciences and Humanities | 2D 3D TSV |
24712915 | 14 | Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays. | J Med Chem 57: 3737-45 (2014) | Zhejiang University | 2D 3D TSV |
24712832 | 66 | 4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors. | J Med Chem 57: 3874-83 (2014) | National Institute of Diabetes and Digestive and Kidney Diseases | 2D 3D TSV |
24712764 | 6 | Thienoquinolines as novel disruptors of the PKCe/RACK2 protein-protein interaction. | J Med Chem 57: 3235-46 (2014) | Innsbruck Medical University | 2D 3D TSV |
24712661 | 47 | Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptorß agonist in clinical trials for the treatment of dyslipidemia. | J Med Chem 57: 3912-23 (2014) | Madrigal Pharmaceuticals Inc | 2D 3D TSV |
24709560 | 1 | Discovery of two aminoglycoside antibiotics as inhibitors targeting the menin-mixed lineage leukaemia interface. | Bioorg Med Chem Lett 24: 2090-3 (2014) | Fuzhou University | 2D 3D TSV |
24708493 | 50 | Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor. | J Med Chem 57: 3532-45 (2014) | Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University) | 2D 3D TSV |
24707965 | 33 | A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1. | ACS Chem Biol 9: 1284-93 (2014) | Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, United States | 2D 3D TSV |
24707857 | 33 | Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway. | J Med Chem 57: 6897-918 (2014) | University of Ljubljana | 2D 3D TSV |
24707807 | 9 | Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growth. | BMC Biochem 15: 9 (2014) | International Centre for Genetic Engineering and Biotechnology | 2D 3D TSV |
24707347 | 57 | Truncated Orexin Peptides: Structure-Activity Relationship Studies. | ACS Med Chem Lett 4: 1224-1227 (2013) | Research Triangle Institute | 2D 3D TSV |
24704618 | 27 | Design, synthesis and biological evaluation of novel tetrahydroacridine pyridine- aldoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase. | Eur J Med Chem 78: 455-67 (2014) | University of Strasburg | 2D 3D TSV |
24704616 | 86 | Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new ROR¿ inhibitors using virtual screening, synthesis and biological evaluation. | Eur J Med Chem 78: 431-41 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24704612 | 23 | Design, synthesis, acetylcholinesterase inhibition and larvicidal activity of girgensohnine analogs on Aedes aegypti, vector of dengue fever. | Eur J Med Chem 78: 392-400 (2014) | Universidad Industrial de Santander | 2D 3D TSV |
24704197 | 32 | 4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-ß type I receptor kinase. | Bioorg Med Chem 22: 2724-32 (2014) | Ewha Womans University | 2D 3D TSV |
24704031 | 69 | The evolution of amidine-based brain penetrant BACE1 inhibitors. | Bioorg Med Chem Lett 24: 2033-45 (2014) | Janssen Pharmaceutica NV | 2D 3D TSV |
24704030 | 64 | Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis. | Bioorg Med Chem Lett 24: 2079-85 (2014) | Merck Research Laboratories | 2D 3D TSV |
24704029 | 14 | Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction. | Bioorg Med Chem Lett 24: 2110-4 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24704027 | 31 | Lactam and oxazolidinone derived potent 5-hydroxytryptamine 6 receptor antagonists. | Bioorg Med Chem Lett 24: 2094-7 (2014) | Cephalon Inc | 2D 3D TSV |
24703463 | 6 | Inhibitory effects of novel synthetic methimazole derivatives on mushroom tyrosinase and melanogenesis. | Bioorg Med Chem 22: 2809-15 (2014) | Hungkuang University | 2D 3D TSV |
24703233 | 63 | From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor. | Bioorg Med Chem Lett 24: 2212-21 (2014) | Argenta Discovery Ltd | 2D 3D TSV |
24702858 | 14 | RE12 derivatives displaying Vaccinia H1-related phosphatase (VHR) inhibition in the presence of detergent and their anti-proliferative activity against HeLa cells. | Bioorg Med Chem 22: 2771-82 (2014) | Japan Science and Technology Agency | 2D 3D TSV |
24702857 | 28 | Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives. | Bioorg Med Chem 22: 2707-13 (2014) | Xi'an Jiaotong University | 2D 3D TSV |
24702856 | 84 | Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (ROR¿)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand. | Bioorg Med Chem 22: 2799-808 (2014) | The University of Tokyo | 2D 3D TSV |
24702184 | 5 | Thermodynamic and structural characterization of halogen bonding in protein-ligand interactions: a case study of PDE5 and its inhibitors. | J Med Chem 57: 3588-93 (2014) | Chinese Academy of Sciences (CAS) | 2D 3D TSV |
24697360 | 2 | Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery. | J Med Chem 57: 6887-96 (2014) | Merck Research Laboratories | 2D 3D TSV |
24697311 | 5 | Novel derivatives of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with improved fluorescent ands receptors binding properties. | J Med Chem 57: 3314-23 (2014) | Universit£ degli Studi di Bari Aldo Moro | 2D 3D TSV |
24697290 | 6 | Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties. | J Med Chem 57: 3746-54 (2014) | University of Texas Southwestern Medical Center | 2D 3D TSV |
24697269 | 18 | Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors. | J Med Chem 57: 3283-94 (2014) | Fred Hutchinson Cancer Research Center | 2D 3D TSV |
24697244 | 23 | Indirubin core structure of glycogen synthase kinase-3 inhibitors as novel chemotype for intervention with 5-lipoxygenase. | J Med Chem 57: 3715-23 (2014) | Friedrich-Schiller-University | 2D 3D TSV |
24695735 | 6 | The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity. | J Biol Chem 289: 13042-53 (2014) | Harvard NeuroDiscovery Center | 2D 3D TSV |
24694215 | 8 | Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria. | J Med Chem 57: 3845-55 (2014) | Pfizer Inc | 2D 3D TSV |
24694071 | 11 | New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile. | J Med Chem 57: 4487-97 (2014) | MicuRx Pharmaceuticals Inc. | 2D 3D TSV |
24694055 | 35 | Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity. | J Med Chem 57: 3324-41 (2014) | Shandong University | 2D 3D TSV |
24692551 | 18 | Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor ß/d (FABP5-PPARß/d) signaling pathway. | J Biol Chem 289: 14941-54 (2014) | Emory University | 2D 3D TSV |
24691057 | 62 | SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives. | Eur J Med Chem 78: 324-39 (2014) | Jagiellonian University Medical College | 2D 3D TSV |
24690529 | 43 | a-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain. | Bioorg Med Chem 22: 2763-70 (2014) | The Scripps Research Institute | 2D 3D TSV |
24690494 | 92 | Antagonists of the kappa opioid receptor. | Bioorg Med Chem Lett 24: 2021-32 (2014) | The Scripps Research Institute | 2D 3D TSV |
24689821 | 6 | Exploring the water-binding pocket of the type II dehydroquinase enzyme in the structure-based design of inhibitors. | J Med Chem 57: 3494-510 (2014) | Universidad de Santiago de Compostela | 2D 3D TSV |
24689792 | 54 | Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes. | J Med Chem 57: 3522-31 (2014) | Griffith University | 2D 3D TSV |
24689770 | 4 | Optimization of an imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1). | J Med Chem 57: 3570-87 (2014) | MRC Technology | 2D 3D TSV |
24686016 | 22 | Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II. | Eur J Med Chem 78: 294-303 (2014) | National University of Singapore | 2D 3D TSV |
24685544 | 75 | Identification of tertiary sulfonamides as RORc inverse agonists. | Bioorg Med Chem Lett 24: 2182-7 (2014) | Genentech | 2D 3D TSV |
24685543 | 23 | Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulators. | Bioorg Med Chem Lett 24: 2168-72 (2014) | EMD-Serono Research Institute, Inc | 2D 3D TSV |
24685542 | 67 | Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases. | Bioorg Med Chem Lett 24: 2206-11 (2014) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
24685540 | 28 | Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors. | Bioorg Med Chem Lett 24: 2193-7 (2014) | Volzhsky Polytechnic Institute (branch) Volgograd State Technical University | 2D 3D TSV |
24685539 | 44 | The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2. | Bioorg Med Chem Lett 24: 2137-40 (2014) | Janssen Research and Development LLC | 2D 3D TSV |
24685113 | 44 | Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors. | Bioorg Med Chem 22: 2396-402 (2014) | Peking University | 2D 3D TSV |
24685112 | 13 | Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR). | Bioorg Med Chem 22: 2447-60 (2014) | Goethe-University Frankfurt | 2D 3D TSV |
24684845 | 35 | Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors. | Bioorg Med Chem Lett 24: 1889-94 (2014) | Jiangnan University | 2D 3D TSV |
24684843 | 24 | In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma. | Bioorg Med Chem Lett 24: 1875-9 (2014) | Alcon Laboratories Inc | 2D 3D TSV |
24684293 | 17 | Diacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C¿ and¿ from typical C1 domains. | J Med Chem 57: 3835-44 (2014) | National Cancer Institute-Bethesda | 2D 3D TSV |
24684270 | 34 | Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase. | J Med Chem 57: 3223-34 (2014) | Sapienza University of Rome | 2D 3D TSV |
24684213 | 56 | Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies. | J Med Chem 57: 4035-48 (2014) | Harvard Medical School | 2D 3D TSV |
24681986 | 42 | Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines. | Eur J Med Chem 78: 217-24 (2014) | Siedlce University of Natural Sciences and Humanities | 2D 3D TSV |
24681981 | 53 | Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. | Eur J Med Chem 78: 167-77 (2014) | Quaid-i-Azam University | 2D 3D TSV |
24681980 | 3 | Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease. | Eur J Med Chem 78: 157-66 (2014) | University of Bologna | 2D 3D TSV |
24681391 | 14 | New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies. | Eur J Med Chem 78: 140-50 (2014) | COMSATS Institute of Information Technology | 2D 3D TSV |
24681070 | 15 | Novel structural hybrids of pyrazolobenzothiazines with benzimidazoles as cholinesterase inhibitors. | Eur J Med Chem 78: 106-17 (2014) | Government College Women University | 2D 3D TSV |
24681066 | 35 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. | Eur J Med Chem 78: 65-71 (2014) | Sun Yat-sen University | 2D 3D TSV |
24680060 | 11 | Effect of prime-site sequence of retro-inverso-modified HTLV-1 protease inhibitor. | Bioorg Med Chem 22: 2482-8 (2014) | Kyoto Prefectural University of Medicine | 2D 3D TSV |
24680058 | 7 | Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors. | Bioorg Med Chem 22: 2535-41 (2014) | Fudan University | 2D 3D TSV |
24679441 | 16 | Anti-inflammatory components of Euphorbia humifusa Willd. | Bioorg Med Chem Lett 24: 1895-900 (2014) | Chungnam National University | 2D 3D TSV |
24678969 | 44 | Discovery of a novel series of orally active nociceptin/orphanin FQ (NOP) receptor antagonists based on a dihydrospiro(piperidine-4,7'-thieno[2,3-c]pyran) scaffold. | J Med Chem 57: 3418-29 (2014) | Eli Lilly and Company | 2D 3D TSV |
24678947 | 51 | Identification and characterization of small molecule modulators of the Epstein-Barr virus-induced gene 2 (EBI2) receptor. | J Med Chem 57: 3358-68 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24677340 | 20 | Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity. | Chembiochem 15: 701-712 (2014) | Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN, 46202 (USA) | 2D 3D TSV |
24675381 | 47 | Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinase. | Bioorg Med Chem Lett 24: 1923-7 (2014) | Array BioPharma, Inc. | 2D 3D TSV |
24675380 | 9 | Identification of novel SIRT2-selective inhibitors using a click chemistry approach. | Bioorg Med Chem Lett 24: 1871-4 (2014) | Nagoya City University | 2D 3D TSV |
24675378 | 33 | Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors. | Bioorg Med Chem Lett 24: 1918-22 (2014) | M.S. University of Baroda | 2D 3D TSV |
24675179 | 26 | Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases. | Eur J Med Chem 78: 43-53 (2014) | Quaid-i-Azam University | 2D 3D TSV |
24675176 | 74 | Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands. | Eur J Med Chem 78: 10-22 (2014) | Jagiellonian University Medical College | 2D 3D TSV |
24675175 | 5 | Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands. | Eur J Med Chem 78: 1-9 (2014) | South Dakota State University | 2D 3D TSV |
24675136 | 3 | Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitors. | Eur J Med Chem 77: 361-77 (2014) | Harvard Medical School | 2D 3D TSV |
24675135 | 4 | Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents. | Eur J Med Chem 77: 351-60 (2014) | Peking Union Medical College & Chinese Academy of Medical Sciences | 2D 3D TSV |
24674599 | 35 | Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation. | Chem Biol Drug Des 84: 364-77 (2014) | China Pharmaceutical University | 2D 3D TSV |
24673130 | 27 | Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization. | J Med Chem 57: 3484-93 (2014) | Genentech Inc | 2D 3D TSV |
24673104 | 185 | Identification of novel HSP90a/ß isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease. | J Med Chem 57: 3382-400 (2014) | Vertex Pharmaceuticals Inc | 2D 3D TSV |
24670009 | 65 | Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents. | J Med Chem 57: 3464-83 (2014) | Amgen Inc | 2D 3D TSV |
24669958 | 39 | Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines. | J Med Chem 57: 3213-22 (2014) | Leiden University | 2D 3D TSV |
24668804 | 7 | Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1. | J Biol Chem 289: 13717-25 (2014) | National Institutes of Health | 2D 3D TSV |
24666646 | 37 | Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms. | Bioorg Med Chem Lett 24: 1968-73 (2014) | Merck & Co. | 2D 3D TSV |
24666203 | 124 | Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacy. | J Med Chem 57: 3263-82 (2014) | Genomics Institute of the Novartis Research Foundation | 2D 3D TSV |
24666186 | 15 | Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors. | J Med Chem 57: 3559-69 (2014) | Virginia Commonwealth University | 2D 3D TSV |
24666157 | 30 | Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists. | J Med Chem 57: 3450-63 (2014) | National Center for Advancing Translational Sciences | 2D 3D TSV |
24661847 | 8 | Synthesis of thio-heterocyclic analogues from Baylis-Hillman bromides as potent cyclooxygenase-2 inhibitors. | Bioorg Med Chem Lett 24: 1952-7 (2014) | CSIR-Indian Institute of Chemical Technology | 2D 3D TSV |
24660890 | 12 | Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes. | J Med Chem 57: 3205-12 (2014) | Merck & Co. Inc | 2D 3D TSV |
24660812 | 4 | Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity. | J Med Chem 57: 3011-29 (2014) | University of Florida | 2D 3D TSV |
24660051 | 24 | An Accessible Chiral Linker to Enhance Potency and Selectivity of Neuronal Nitric Oxide Synthase Inhibitors. | ACS Med Chem Lett 5: 56-60 (2014) | Northwestern University | 2D 3D TSV |
24657567 | 4 | Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones. | Eur J Med Chem 77: 306-14 (2014) | Taipei Medical University | 2D 3D TSV |
24657054 | 66 | Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II. | Bioorg Med Chem 22: 2508-16 (2014) | Astraea Therapeutics, LLC. | 2D 3D TSV |
24657053 | 8 | Docking and SAR studies of calystegines: binding orientation and influence on pharmacological chaperone effects for Gaucher's disease. | Bioorg Med Chem 22: 2435-41 (2014) | University of Toyama | 2D 3D TSV |
24657052 | 42 | Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease. | Bioorg Med Chem 22: 2496-507 (2014) | Universit£ de Franche Comt£ | 2D 3D TSV |
24657049 | 5 | Polyfluorinated bis-styrylbenzenes as amyloid-ß plaque binding ligands. | Bioorg Med Chem 22: 2469-81 (2014) | Leiden University | 2D 3D TSV |
24656804 | 44 | 1,2-benzisothiazol-3-one derivatives as a novel class of small-molecule caspase-3 inhibitors. | Bioorg Med Chem 22: 2416-26 (2014) | Tianjin University of Science and Technology | 2D 3D TSV |
24656800 | 11 | Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography. | Bioorg Med Chem 22: 2427-34 (2014) | Astellas Pharma Inc | 2D 3D TSV |
24656662 | 33 | Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2,5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors. | Bioorg Med Chem Lett 24: 1958-62 (2014) | Kyung Hee University | 2D 3D TSV |
24656661 | 11 | Core modification of substituted piperidines as novel inhibitors of HDM2-p53 protein-protein interaction. | Bioorg Med Chem Lett 24: 1983-6 (2014) | Merck Research Laboratories | 2D 3D TSV |
24656565 | 73 | Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore. | Bioorg Med Chem Lett 24: 1934-40 (2014) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
24654918 | 19 | Pharmacophoric modifications lead to superpotentavß3 integrin ligands with suppresseda5ß1 activity. | J Med Chem 57: 3410-7 (2014) | Technische Universit£t M£nchen | 2D 3D TSV |
24654886 | 3 | New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors. | J Med Chem 57: 3247-62 (2014) | Universit£ degli Studi di Perugia | 2D 3D TSV |
24650714 | 21 | Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties. | Eur J Med Chem 77: 269-79 (2014) | United Arab Emirates University | 2D 3D TSV |
24650704 | 6 | Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors. | Bioorg Med Chem 22: 2253-60 (2014) | Rockefeller University | 2D 3D TSV |
24650702 | 16 | Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity. | Bioorg Med Chem 22: 2529-34 (2014) | Keio University | 2D 3D TSV |
24650641 | 110 | Arylamino bisphosphonates: potent and selective inhibitors of the tumor-associated carbonic anhydrase XII. | Bioorg Med Chem Lett 24: 1941-3 (2014) | Universit£ degli Studi 'Aldo Moro' di Bari | 2D 3D TSV |
24650640 | 43 | Discovery of 4-anilinoa-carbolines as novel Brk inhibitors. | Bioorg Med Chem Lett 24: 1948-51 (2014) | Martin-Luther-University Halle-Wittenberg | 2D 3D TSV |
24649848 | 47 | Discovery of a potent and selectivea3ß4 nicotinic acetylcholine receptor antagonist from ana-conotoxin synthetic combinatorial library. | J Med Chem 57: 3511-21 (2014) | Torrey Pines Institute for Molecular Studies | 2D 3D TSV |
24649802 | 18 | Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors. | J Med Chem 57: 3154-60 (2014) | Utrecht University | 2D 3D TSV |
24648867 | 58 | Chiral Effect of a Phe Residue in Position 3 of the Dmt | ACS Med Chem Lett 4: 656-659 (2013) | University of Arizona | 2D 3D TSV |
24648521 | 2 | Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance. | J Biol Chem 289: 13273-83 (2014) | St. Paul's Hospital's Centre of Heart and Lung Innovation | 2D 3D TSV |
24644281 | 3 | Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor ß/d (PPARß/d) in the brain. | J Biol Chem 289: 12748-58 (2014) | Case Western Reserve University School of Medicine | 2D 3D TSV |
24642566 | 17 | Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H. | Eur J Med Chem 77: 231-42 (2014) | Kurukshetra University | 2D 3D TSV |
24641677 | 65 | 1,3-disubstituted-4-aminopyrazolo [3, 4-d] pyrimidines, a new class of potent inhibitors for phospholipase D. | Chem Biol Drug Des 84: 270-81 (2014) | University of Massachusetts Boston | 2D 3D TSV |
24641190 | 16 | Development of a bioavailableµ opioid receptor (MOPr) agonist,d opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance. | J Med Chem 57: 3148-53 (2014) | University of Michigan | 2D 3D TSV |
24641103 | 104 | Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3. | J Med Chem 57: 3430-49 (2014) | Amgen Inc | 2D 3D TSV |
24641010 | 33 | Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP). | J Med Chem 57: 2773-88 (2014) | Imperial College | 2D 3D TSV |
24636945 | 37 | Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors. | Bioorg Med Chem Lett 24: 1657-60 (2014) | Merck Research Laboratories | 2D 3D TSV |
24636540 | 18 | Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study. | Chem Biol Drug Des 84: 409-19 (2014) | Y.B. Chavan College of Pharmacy | 2D 3D TSV |
24636345 | 25 | Discovery and Structure Optimization of a Series of Isatin Derivatives as Mycobacterium tuberculosis Chorismate Mutase Inhibitors. | Chem Biol Drug Des 83: 498-506 (2014) | Birla Institute of Technology | 2D 3D TSV |
24634223 | 8 | Trimethylation of histone H3 lysine 36 by human methyltransferase PRDM9 protein. | J Biol Chem 289: 12177-88 (2014) | University of Toronto | 2D 3D TSV |
24634219 | 2 | A novel small-molecule tumor necrosis factor a inhibitor attenuates inflammation in a hepatitis mouse model. | J Biol Chem 289: 12457-66 (2014) | Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | 2D 3D TSV |
24632506 | 23 | Synthesis and evaluation of c-Src kinase inhibitory activity of pyridin-2(1H)-one derivatives. | Bioorg Chem 53: 75-82 (2014) | University of Delhi, Delhi 110007, India | 2D 3D TSV |
24631898 | 17 | Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug. | Eur J Med Chem 77: 185-92 (2014) | Guru Nanak Dev University | 2D 3D TSV |
24631895 | 14 | 1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity. | Eur J Med Chem 77: 155-65 (2014) | Minia University | 2D 3D TSV |
24631727 | 4 | Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles. | Eur J Med Chem 77: 91-5 (2014) | Universitat Pompeu Fabra | 2D 3D TSV |
24631365 | 10 | Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents. | Bioorg Med Chem 22: 2080-9 (2014) | Cairo University | 2D 3D TSV |
24631361 | 3 | Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives. | Bioorg Med Chem 22: 2052-9 (2014) | Shandong University | 2D 3D TSV |
24631359 | 10 | N-Acyl-phosphoramidates as potential novel form of gemcitabine prodrugs. | Bioorg Med Chem 22: 2133-40 (2014) | Polish Academy of Sciences | 2D 3D TSV |
24631189 | 86 | Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors. | Bioorg Med Chem Lett 24: 1820-4 (2014) | AstraZeneca | 2D 3D TSV |
24631188 | 12 | Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum. | Bioorg Med Chem Lett 24: 1698-701 (2014) | Kyoto Pharmaceutical University | 2D 3D TSV |
24630695 | 11 | Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation. | Bioorg Med Chem 22: 2194-207 (2014) | Aristotle University of Thessaloniki | 2D 3D TSV |
24630694 | 11 | Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character. | Bioorg Med Chem 22: 2244-52 (2014) | The University of Tokyo | 2D 3D TSV |
24630693 | 8 | Some non-conventional biomolecular targets for diamidines. A short survey. | Bioorg Med Chem 22: 1983-92 (2014) | Xavier University of Louisiana | 2D 3D TSV |
24630562 | 58 | Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexant. | Bioorg Med Chem Lett 24: 1784-9 (2014) | Merck Research Laboratories | 2D 3D TSV |
24630560 | 2 | Inhibitory effect of Rhus verniciflua Stokes extract on human aromatase activity; butin is its major bioactive component. | Bioorg Med Chem Lett 24: 1730-3 (2014) | Hanyang University | 2D 3D TSV |
24630558 | 31 | Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase. | Bioorg Med Chem Lett 24: 1711-4 (2014) | Southwest Research Institute | 2D 3D TSV |
24630412 | 22 | Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors. | Bioorg Med Chem Lett 24: 1734-6 (2014) | Nanjing University | 2D 3D TSV |
24630411 | 38 | Mineralocorticoid receptor antagonists: identification of heterocyclic amide replacements in the oxazolidinedione series. | Bioorg Med Chem Lett 24: 1681-4 (2014) | Merck Research Laboratories | 2D 3D TSV |
24629449 | 2 | Computer-aided identification of novel 3,5-substituted rhodanine derivatives with activity against Staphylococcus aureus DNA gyrase. | Bioorg Med Chem 22: 2176-87 (2014) | University of the Sciences | 2D 3D TSV |
24629448 | 2 | Synthetic approaches to the 2012 new drugs. | Bioorg Med Chem 22: 2005-32 (2014) | PharmaPhase Co., Ltd | 2D 3D TSV |
24625069 | 28 | Structure-activity relationship studies toward the discovery of selective apelin receptor agonists. | J Med Chem 57: 2908-19 (2014) | University of Strasburg | 2D 3D TSV |
24625057 | 79 | Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7). | J Med Chem 57: 2874-83 (2014) | University of Victoria | 2D 3D TSV |
24618511 | 6 | A new potential approach to block HIV-1 replication via protein-protein interaction and strand-transfer inhibition. | Bioorg Med Chem 22: 2269-79 (2014) | Universit£ di Messina | 2D 3D TSV |
24618302 | 49 | Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors. | Bioorg Med Chem Lett 24: 1790-4 (2014) | Merck Research Laboratories | 2D 3D TSV |
24618300 | 28 | Synthesis and biological evaluation of a series of benzoxazole/benzothiazole-containing 2,3-dihydrobenzo[b][1,4]dioxine derivatives as potential antidepressants. | Bioorg Med Chem Lett 24: 1766-70 (2014) | Huazhong University of Science and Technology | 2D 3D TSV |
24617858 | 239 | Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). | J Med Chem 57: 3053-74 (2014) | University of Antwerp | 2D 3D TSV |
24617836 | 33 | Synthesis, pharmacological evaluation, ands1 receptor interaction analysis of hydroxyethyl substituted piperazines. | J Med Chem 57: 2884-94 (2014) | University of M£nster | 2D 3D TSV |
24613701 | 6 | Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression. | Bioorg Med Chem Lett 24: 1846-50 (2014) | Norwegian Medical Cyclotron Centre, PO Box 4950, Nydalen, N-0424 Oslo, Norway. | 2D 3D TSV |
24613627 | 5 | Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity. | Bioorg Med Chem 22: 2236-43 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24613626 | 21 | Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein. | Bioorg Med Chem 22: 2311-9 (2014) | Medical University Vienna | 2D 3D TSV |
24613625 | 24 | The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase. | Bioorg Med Chem 22: 2157-65 (2014) | St. Jude Children's Research Hospital | 2D 3D TSV |
24613457 | 64 | Endomorphin analogues with mixedµ-opioid (MOP) receptor agonism/d-opioid (DOP) receptor antagonism and lackingß-arrestin2 recruitment activity. | Bioorg Med Chem 22: 2208-19 (2014) | Nanjing Medical University | 2D 3D TSV |
24613378 | 33 | Alkylsulfone-containing trisubstituted cyclohexanes as potent and bioavailable chemokine receptor 2 (CCR2) antagonists. | Bioorg Med Chem Lett 24: 1843-5 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24613052 | 69 | Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin. | Bioorg Med Chem 22: 2339-52 (2014) | Hiroshima International University | 2D 3D TSV |
24612767 | 7 | Discovery of novel secretory phospholipase A2 inhibitors using virtual screen. | Chem Biol Drug Des 84: 216-22 (2014) | Peking University | 2D 3D TSV |
24611893 | 22 | Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones. | J Med Chem 57: 2930-41 (2014) | BMSSI UMR 5086 CNRS/Universit£ Lyon 1 | 2D 3D TSV |
24611879 | 79 | Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 3. Structure-activity relationships within the aryl carbinol region of the N-arylsulfonamido-N'-arylpiperazine series. | J Med Chem 57: 3094-116 (2014) | Amgen Inc | 2D 3D TSV |
24611085 | 101 | Discovery of ML314, a Brain Penetrant Non-Peptidic?-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor. | ACS Med Chem Lett 4: 846-851 (2013) | Sanford-Burnham Medical Research Institute | 2D 3D TSV |
24610996 | 16 | Thrombin inhibitory activity of some polyphenolic compounds. | Med Chem Res 23: 2324-2337 (2014) | University of Lodz | 2D 3D TSV |
24608000 | 27 | New synthesis of 3-(ß-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase. | Eur J Med Chem 76: 567-79 (2014) | University of Debrecen | 2D 3D TSV |
24607999 | 16 | SAR study on arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity. | Eur J Med Chem 76: 558-66 (2014) | Universit£ di Pisa | 2D 3D TSV |
24607998 | 13 | Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents. | Eur J Med Chem 76: 549-57 (2014) | Nanjing University | 2D 3D TSV |
24607877 | 20 | Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents. | Eur J Med Chem 76: 482-93 (2014) | Cairo University | 2D 3D TSV |
24607591 | 11 | Synthesis and evaluation of 2-anilinopyrimidines bearing 3-aminopropamides as potential epidermal growth factor receptor inhibitors. | Eur J Med Chem 77: 75-83 (2014) | China Pharmaceutical University | 2D 3D TSV |
24607578 | 11 | Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis. | Bioorg Chem 53: 67-74 (2014) | Swami Ramanand Teerth Marathwada University, Nanded (MS), India | 2D 3D TSV |
24606395 | 8 | Alkaloids from the roots of Stichoneuron caudatum and their acetylcholinesterase inhibitory activities. | J Nat Prod 77: 894-901 (2014) | University of Wollongong | 2D 3D TSV |
24606063 | 31 | Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors. | J Med Chem 57: 2714-25 (2014) | University of Minnesota | 2D 3D TSV |
24602903 | 11 | Evaluation of bisindole as potentß-glucuronidase inhibitors: synthesis and in silico based studies. | Bioorg Med Chem Lett 24: 1825-9 (2014) | University of Karachi | 2D 3D TSV |
24602795 | 4 | Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach. | Eur J Med Chem 76: 531-8 (2014) | Shandong University | 2D 3D TSV |
24602793 | 6 | Identification of human presequence protease (hPreP) agonists for the treatment of Alzheimer's disease. | Eur J Med Chem 76: 506-16 (2014) | University of Kansas | 2D 3D TSV |
24602792 | 6 | Benzimidazole: an emerging scaffold for analgesic and anti-inflammatory agents. | Eur J Med Chem 76: 494-505 (2014) | ASBASJSM College of Pharmacy | 2D 3D TSV |
24602787 | 27 | Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors. | Eur J Med Chem 76: 414-26 (2014) | Northwestern University | 2D 3D TSV |
24602401 | 40 | [Dmt(1)]DALDA analogues with enhancedµ opioid agonist potency and with a mixedµ/¿ opioid activity profile. | Bioorg Med Chem 22: 2333-8 (2014) | Nanjing Medical University | 2D 3D TSV |
24601669 | 5 | Potential anti-angiogenesis effects of p-terphenyl compounds from Polyozellus multiplex. | J Nat Prod 77: 963-8 (2014) | Meiji Pharmaceutical University | 2D 3D TSV |
24601644 | 113 | Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres. | J Med Chem 57: 2963-88 (2014) | Amgen Inc | 2D 3D TSV |
24601592 | 48 | Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis. | J Med Chem 57: 2942-52 (2014) | University College London | 2D 3D TSV |
24599514 | 23 | The SAMPL4 host-guest blind prediction challenge: an overview. | J Comput Aided Mol Des 28: 305-17 (2014) | University of California San Diego | 2D 3D TSV |
24597921 | 14 | Prenylated coumarins: natural phosphodiesterase-4 inhibitors from Toddalia asiatica. | J Nat Prod 77: 955-62 (2014) | Sun Yat-sen University | 2D 3D TSV |
24597733 | 57 | Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists. | J Med Chem 57: 2989-3004 (2014) | Amgen Inc | 2D 3D TSV |
24594525 | 25 | Design, synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents. | Eur J Med Chem 76: 376-86 (2014) | Southeast University | 2D 3D TSV |
24594354 | 46 | Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors. | Bioorg Med Chem Lett 24: 1815-9 (2014) | Universiti Sains Malaysia | 2D 3D TSV |
24593905 | 16 | Application of encoded library technology (ELT) to a protein-protein interaction target: discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists. | Bioorg Med Chem 22: 2353-65 (2014) | GlaxoSmithKline | 2D 3D TSV |
24593120 | 5 | Highly conjugated norditerpenoid and pyrroloquinoline alkaloids with potent PTP1B inhibitory activity from Nigella glandulifera. | J Nat Prod 77: 807-12 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24592914 | 6 | Targeting Staphylococcus aureus quorum sensing with nonpeptidic small molecule inhibitors. | J Med Chem 57: 2813-9 (2014) | University of Nottingham | 2D 3D TSV |
24592867 | 58 | Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. | J Med Chem 57: 2755-72 (2014) | CSIC | 2D 3D TSV |
24592859 | 59 | Cathepsin C inhibitors: property optimization and identification of a clinical candidate. | J Med Chem 57: 2357-67 (2014) | AstraZeneca | 2D 3D TSV |
24589511 | 60 | Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties. | Bioorg Med Chem Lett 24: 1776-9 (2014) | University of Cagliari | 2D 3D TSV |
24589487 | 7 | Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease. | Eur J Med Chem 76: 314-31 (2014) | Sichuan University | 2D 3D TSV |
24589486 | 4 | Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity. | Eur J Med Chem 76: 301-13 (2014) | Tohoku Pharmaceutical University | 2D 3D TSV |
24589484 | 92 | 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII. | Eur J Med Chem 76: 284-90 (2014) | Kurukshetra University | 2D 3D TSV |
24588963 | 21 | Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus. | Bioorg Med Chem 22: 2280-93 (2014) | Yuhan Research Institute | 2D 3D TSV |
24588961 | 36 | Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa). | Bioorg Med Chem 22: 2261-8 (2014) | AstraZeneca | 2D 3D TSV |
24588269 | 4 | Biologically active eremophilane-type sesquiterpenes from Camarops sp., an endophytic fungus isolated from Alibertia macrophylla. | J Nat Prod 77: 668-72 (2014) | Universidade Estadual Paulista | 2D 3D TSV |
24588105 | 56 | Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold. | J Med Chem 57: 2258-74 (2014) | Universit£ degli Studi di Siena | 2D 3D TSV |
24588073 | 24 | Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib. | J Med Chem 57: 2692-703 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24583379 | 2 | Discovery of novel urea derivatives as dual-target hypoglycemic agents that activate glucokinase and PPAR¿. | Eur J Med Chem 76: 182-92 (2014) | Chinese Academy of Medical Sciences & Peking Union Medical College | 2D 3D TSV |
24583357 | 4 | Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications. | Eur J Med Chem 76: 193-244 (2014) | Quaid-i-Azam University | 2D 3D TSV |
24583353 | 13 | The applications of binuclear metallohydrolases in medicine: recent advances in the design and development of novel drug leads for purple acid phosphatases, metallo-ß-lactamases and arginases. | Eur J Med Chem 76: 132-44 (2014) | The University of Queensland | 2D 3D TSV |
24583352 | 13 | Homoisoflavonoids as potential imaging agents for ?-amyloid plaques in Alzheimer's disease. | Eur J Med Chem 76: 125-31 (2014) | Hefei University of Technology | 2D 3D TSV |
24582987 | 30 | The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimization. | Bioorg Med Chem Lett 24: 1466-71 (2014) | Merck & Co. | 2D 3D TSV |
24582986 | 37 | Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein. | Bioorg Med Chem Lett 24: 1484-8 (2014) | Research & Development, AbbVie | 2D 3D TSV |
24582985 | 1 | 5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor. | Bioorg Med Chem Lett 24: 1489-92 (2014) | Virginia Commonwealth University | 2D 3D TSV |
24582477 | 33 | Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold. | Bioorg Med Chem Lett 24: 1557-61 (2014) | China Pharmaceutical University | 2D 3D TSV |
24582476 | 17 | cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists. | Bioorg Med Chem Lett 24: 1458-61 (2014) | Lundbeck Research USA, Inc. | 2D 3D TSV |
24581547 | 11 | Interaction kinetics of liposome-incorporated unsaturated fatty acids with fatty acid-binding protein 3 by surface plasmon resonance. | Bioorg Med Chem 22: 1804-8 (2014) | Osaka University | 2D 3D TSV |
24581546 | 4 | Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays. | Bioorg Med Chem 22: 1863-72 (2014) | Shandong University | 2D 3D TSV |
24580635 | 21 | Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors. | J Med Chem 57: 2413-28 (2014) | Universit£ di Salerno | 2D 3D TSV |
24580531 | 6 | Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors. | J Med Chem 57: 2524-35 (2014) | University of Geneva | 2D 3D TSV |
24576797 | 8 | Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents. | Eur J Med Chem 87: 868-80 (2014) | National Research Centre, Dokki | 2D 3D TSV |
24571273 | 32 | Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus. | J Nat Prod 77: 1021-30 (2014) | Peking University | 2D 3D TSV |
24571165 | 55 | Targeting carnitine biosynthesis: discovery of new inhibitors against¿-butyrobetaine hydroxylase. | J Med Chem 57: 2213-36 (2014) | Latvian Biomedical Research and Study centre | 2D 3D TSV |
24569110 | 11 | Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk. | Bioorg Med Chem Lett 24: 1523-7 (2014) | University of Zurich | 2D 3D TSV |
24568695 | 76 | Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists. | J Med Chem 57: 6301-15 (2014) | University of Bradford | 2D 3D TSV |
24568657 | 34 | Propargyl-linked antifolates are dual inhibitors of Candida albicans and Candida glabrata. | J Med Chem 57: 2643-56 (2014) | University of Connecticut | 2D 3D TSV |
24568631 | 15 | Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity. | J Med Chem 57: 2568-81 (2014) | University of Athens | 2D 3D TSV |
24568559 | 7 | Multitarget drug discovery for tuberculosis and other infectious diseases. | J Med Chem 57: 3126-39 (2014) | University of Illinois at Urbana-Champaign | 2D 3D TSV |
24568372 | 40 | Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents. | J Med Chem 57: 2549-67 (2014) | Universitat de Barcelona | 2D 3D TSV |
24568342 | 19 | X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases. | J Med Chem 57: 2393-412 (2014) | Purdue University | 2D 3D TSV |
24568313 | 4 | Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compound. | J Med Chem 57: 2058-73 (2014) | GlaxoSmithKline | 2D 3D TSV |
24568185 | 76 | wALADin benzimidazoles differentially modulate the function of porphobilinogen synthase orthologs. | J Med Chem 57: 2498-510 (2014) | University Hospital of Bonn | 2D 3D TSV |
24568174 | 3 | One-step semisynthesis of oleacein and the determination as a 5-lipoxygenase inhibitor. | J Nat Prod 77: 441-5 (2014) | University of Athens | 2D 3D TSV |
24565972 | 29 | Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads. | Bioorg Med Chem 22: 1938-47 (2014) | Birla Institute of Technology | 2D 3D TSV |
24565969 | 69 | Design, synthesis and biological evaluation of novel 6-alkenylamides substituted of 4-anilinothieno[2,3-d]pyrimidines as irreversible epidermal growth factor receptor inhibitors. | Bioorg Med Chem 22: 2366-78 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24565968 | 1 | Polyphenols bearing cinnamaldehyde scaffold showing cell growth inhibitory effects on the cisplatin-resistant A2780/Cis ovarian cancer cells. | Bioorg Med Chem 22: 1809-20 (2014) | Konkuk University | 2D 3D TSV |
24565573 | 35 | 4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors. | Eur J Med Chem 76: 53-60 (2014) | Universit£ degli Studi di Ferrara | 2D 3D TSV |
24564570 | 12 | Diamidine compounds for selective inhibition of protein arginine methyltransferase 1. | J Med Chem 57: 2611-22 (2014) | The University of Georgia | 2D 3D TSV |
24564525 | 7 | Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility. | J Med Chem 57: 3687-706 (2014) | Chinese Academy of Sciences | 2D 3D TSV |
24563723 | 10 | Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc. | ACS Med Chem Lett 5: 133-137 (2014) | The Scripps Research Institute | 2D 3D TSV |
24561716 | 18 | Identification of a new series of amides as non-covalent proteasome inhibitors. | Eur J Med Chem 76: 1-9 (2014) | Universit£ degli Studi di Messina | 2D 3D TSV |
24560739 | 124 | Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII. | Bioorg Med Chem 22: 1821-31 (2014) | Sapienza University of Rome | 2D 3D TSV |
24560738 | 64 | Alkynyl-coumarinyl ethers as MAO-B inhibitors. | Bioorg Med Chem 22: 1916-28 (2014) | University of Bonn | 2D 3D TSV |
24560737 | 88 | Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII. | Bioorg Med Chem 22: 1873-82 (2014) | Kurukshetra University | 2D 3D TSV |
24560540 | 119 | Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2-morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kß inhibitors. | Bioorg Med Chem Lett 24: 1506-10 (2014) | Sanofi | 2D 3D TSV |
24560539 | 6 | Discovery of 1,3,4-oxidiazole scaffold compounds as inhibitors of superoxide dismutase expression. | Bioorg Med Chem Lett 24: 1532-7 (2014) | Northwestern University | 2D 3D TSV |
24560538 | 5 | Preparation and evaluation of novel pyrazolo[1,5-a]pyrimidine acetamides, closely related to DPA-714, as potent ligands for imaging the TSPO 18kDa with PET. | Bioorg Med Chem Lett 24: 1550-6 (2014) | CEA | 2D 3D TSV |
24559867 | 6 | Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors. | Bioorg Med Chem 22: 1948-59 (2014) | The University of Tokyo | 2D 3D TSV |
24559768 | 4 | Development of tag-free photoprobes for studies aimed at identifying the target of novel Group A Streptococcus antivirulence agents. | Bioorg Med Chem Lett 24: 1538-44 (2014) | University of Michigan | 2D 3D TSV |
24559070 | 1 | A perspective on natural products research and ethnopharmacology in Mexico: the eagle and the serpent on the prickly pear cactus. | J Nat Prod 77: 678-89 (2014) | University of London | 2D 3D TSV |
24559051 | 141 | Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders. | J Med Chem 57: 2670-82 (2014) | Intra-Cellular Therapies Inc | 2D 3D TSV |
24556381 | 4 | Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase. | Bioorg Med Chem Lett 24: 1545-9 (2014) | Universidad de Buenos Aires | 2D 3D TSV |
24556380 | 47 | Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties. | Bioorg Med Chem Lett 24: 1615-20 (2014) | Merck Research Laboratories | 2D 3D TSV |
24556379 | 34 | Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors. | Bioorg Med Chem Lett 24: 1528-31 (2014) | CSIR-Indian Institute of Chemical Technology | 2D 3D TSV |
24556147 | 52 | Novel 8-(p-substituted-phenyl/benzyl)xanthines with selectivity for the A2A adenosine receptor possess bronchospasmolytic activity. | Eur J Med Chem 75: 327-35 (2014) | Panjab University | 2D 3D TSV |
24556146 | 26 | Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor. | Eur J Med Chem 75: 308-26 (2014) | University of Ljubljana | 2D 3D TSV |
24556143 | 5 | Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors. | Eur J Med Chem 75: 289-96 (2014) | Hainan University | 2D 3D TSV |
24555570 | 1 | Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection. | J Med Chem 57: 1708-29 (2014) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
24548297 | 50 | Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interaction. | J Med Chem 57: 2472-88 (2014) | Amgen Inc | 2D 3D TSV |
24548207 | 14 | Heat shock protein 70 inhibitors. 1. 2,5'-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70. | J Med Chem 57: 1188-207 (2014) | Memorial Sloan-Kettering Cancer Center | 2D 3D TSV |
24547899 | 4 | Isolation and synthesis of pulmonarins A and B, acetylcholinesterase inhibitors from the colonial ascidian Synoicum pulmonaria. | J Nat Prod 77: 364-9 (2014) | University of Troms£ | 2D 3D TSV |
24534538 | 27 | Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity. | Eur J Med Chem 75: 222-32 (2014) | Universit£ degli Studi di Milano | 2D 3D TSV |
24534487 | 3 | New C(4)- and C(1)-derivatives of furo[3,4-c]pyridine-3-ones and related compounds: evidence for site-specific inhibition of the constitutive proteasome and its immunoisoform. | Bioorg Med Chem Lett 24: 1571-80 (2014) | Yerevan State University | 2D 3D TSV |
24534486 | 56 | 2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors. | Bioorg Med Chem Lett 24: 1592-6 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24533839 | 24 | Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents. | J Med Chem 57: 2380-92 (2014) | Universidade de S£o Paulo | 2D 3D TSV |
24531230 | 34 | 2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes. | Eur J Med Chem 75: 169-83 (2014) | Universit£ degli Studi di Sassari | 2D 3D TSV |
24531229 | 62 | New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies. | Eur J Med Chem 75: 159-68 (2014) | Universit£ de Lyon | 2D 3D TSV |
24531224 | 30 | Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. | Eur J Med Chem 75: 111-22 (2014) | Shenyang Pharmaceutical University | 2D 3D TSV |
24531199 | 16 | Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles. | Eur J Med Chem 74: 606-18 (2014) | University of Bari "A. Moro" | 2D 3D TSV |
24530494 | 42 | Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease. | Eur J Med Chem 75: 82-95 (2014) | Laboratorio de Quimica Medica (IQOG, CSIC) | 2D 3D TSV |
24530227 | 30 | Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors. | Bioorg Med Chem 22: 1909-15 (2014) | Rajiv Gandhi Proudyogiki Vishwavidyalaya | 2D 3D TSV |
24530032 | 65 | Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action. | Bioorg Med Chem 22: 1548-57 (2014) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
24530031 | 43 | Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase. | Bioorg Med Chem 22: 1850-62 (2014) | Chinese Academy of Medical Sciences & Peking Union Medical College | 2D 3D TSV |
24529871 | 7 | Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist. | Bioorg Med Chem Lett 24: 1565-70 (2014) | Kyung Hee University | 2D 3D TSV |
24529308 | 34 | Synthesis of 2,6-disubstituted benzylamine derivatives as reversible selective inhibitors of copper amine oxidases. | Bioorg Med Chem 22: 1558-67 (2014) | Universit£ di Genova | 2D 3D TSV |
24527807 | 82 | 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators. | J Med Chem 57: 2462-71 (2014) | Pfizer Inc | 2D 3D TSV |
24527792 | 8 | Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors. | J Med Chem 57: 2807-12 (2014) | Universit£ degli Studi di Perugia | 2D 3D TSV |
24527772 | 262 | The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. | J Med Chem 57: 2601-10 (2014) | Merck Research Laboratories | 2D 3D TSV |
24525003 | 28 | Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors. | Bioorg Med Chem 22: 1529-38 (2014) | Shandong University | 2D 3D TSV |
24524217 | 65 | Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates. | J Med Chem 57: 2726-35 (2014) | Hokkaido University | 2D 3D TSV |
24523409 | 5 | Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif. | J Biol Chem 289: 8839-51 (2014) | Karlsruhe Institute of Technology | 2D 3D TSV |
24521299 | 2 | Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvir. | J Med Chem 57: 2013-32 (2014) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
24521209 | 24 | Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems. | J Nat Prod 77: 392-6 (2014) | Universidade Federal de S£o Carlos | 2D 3D TSV |
24521095 | 7 | Chemical composition of the bark of Tetrapterys mucronata and identification of acetylcholinesterase inhibitory constituents. | J Nat Prod 77: 650-6 (2014) | Universidade Estadual Paulista (UNESP) | 2D 3D TSV |
24521039 | 5 | Nitric oxide (NO) releasing poly ADP-ribose polymerase 1 (PARP-1) inhibitors targeted to glutathione S-transferase P1-overexpressing cancer cells. | J Med Chem 57: 2292-302 (2014) | National Cancer Institute-Frederick | 2D 3D TSV |
24520998 | 2 | 2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: an appealing scaffold for the design of Rac1-Tiam1 protein-protein interaction inhibitors. | J Med Chem 57: 2953-62 (2014) | Universit£ degli Studi di Milano | 2D 3D TSV |
24520947 | 87 | Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitors. | J Med Chem 57: 2683-91 (2014) | Hoffmann-La Roche Inc | 2D 3D TSV |
24520856 | 14 | Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase. | J Med Chem 57: 2582-8 (2014) | Eisai Inc. | 2D 3D TSV |
24518874 | 61 | 1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor. | Eur J Med Chem 74: 524-32 (2014) | Universit£ di Pisa | 2D 3D TSV |
24518296 | 119 | Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies. | Bioorg Med Chem 22: 1751-65 (2014) | National University of Singapore | 2D 3D TSV |
24518190 | 88 | 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII. | Bioorg Med Chem Lett 24: 1256-60 (2014) | Latvian Institute of Organic Synthesis | 2D 3D TSV |
24517312 | 98 | Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs). | J Med Chem 57: 4615-28 (2014) | University of Florida | 2D 3D TSV |
24517277 | 4 | Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibition. | J Med Chem 57: 5835-44 (2014) | The University of Arizona | 2D 3D TSV |
24517248 | 20 | Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776). | J Med Chem 57: 1495-512 (2014) | Purdue University | 2D 3D TSV |
24513188 | 22 | Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists. | Bioorg Med Chem 22: 1596-607 (2014) | East China University of Science and Technology | 2D 3D TSV |
24513186 | 52 | Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII. | Bioorg Med Chem 22: 1522-8 (2014) | Latvian Institute of Organic Synthesis | 2D 3D TSV |
24513184 | 84 | Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties. | Bioorg Med Chem 22: 1586-95 (2014) | Birla Institute of Technology | 2D 3D TSV |
24513048 | 88 | 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase. | Bioorg Med Chem Lett 24: 1280-4 (2014) | Janssen Pharmaceutical Companies of Johnson & Johnson L.L.C. | 2D 3D TSV |
24513046 | 28 | Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel. | Bioorg Med Chem Lett 24: 1269-73 (2014) | AstraZeneca | 2D 3D TSV |
24513044 | 19 | Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent. | Bioorg Med Chem Lett 24: 1294-8 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24513042 | 22 | Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): histamine H(3) receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity. | Bioorg Med Chem Lett 24: 1303-6 (2014) | Teva Pharmaceutical Global R & D | 2D 3D TSV |
24512267 | 41 | Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators. | J Med Chem 57: 2334-56 (2014) | Emory University | 2D 3D TSV |
24512214 | 7 | Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis. | J Med Chem 57: 2736-45 (2014) | China Pharmaceutical University | 2D 3D TSV |
24512187 | 69 | Discovery of isoquinolinone indole acetic acids as antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases. | J Med Chem 57: 1299-322 (2014) | Pfizer Inc | 2D 3D TSV |
24508831 | 7 | Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. | Eur J Med Chem 75: 21-30 (2014) | Khon Kaen University | 2D 3D TSV |
24508830 | 13 | Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors. | Eur J Med Chem 75: 11-20 (2014) | Zhejiang University | 2D 3D TSV |
24508142 | 26 | Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists. | Bioorg Med Chem 22: 1649-66 (2014) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24508141 | 30 | Lead modification: amino acid appended indoles as highly effective 5-LOX inhibitors. | Bioorg Med Chem 22: 1642-8 (2014) | Guru Nanak Dev University | 2D 3D TSV |
24508140 | 59 | Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT? receptor. | Bioorg Med Chem 22: 1736-50 (2014) | Universit£ degli Studi di Bari A. Moro | 2D 3D TSV |
24508134 | 53 | Syntheses and structure-activity relationships for some triazolyl p38? MAPK inhibitors. | Bioorg Med Chem Lett 24: 1352-7 (2014) | Syncom B.V. | 2D 3D TSV |
24508133 | 4 | Discovery of 2-(1H-indazol-1-yl)-thiazole derivatives as selective EP(1) receptor antagonists for treatment of overactive bladder by core structure replacement. | Bioorg Med Chem Lett 24: 1327-33 (2014) | Asahi Kasei Pharma Corporation | 2D 3D TSV |
24508129 | 45 | HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase. | Bioorg Med Chem Lett 24: 1315-21 (2014) | AstraZeneca | 2D 3D TSV |
24508127 | 19 | Switching cannabinoid response from CB(2) agonists to FAAH inhibitors. | Bioorg Med Chem Lett 24: 1322-6 (2014) | University of Lille | 2D 3D TSV |
24507922 | 20 | Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor. | Bioorg Med Chem Lett 24: 1611-4 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24507921 | 44 | Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis ofa-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum. | Bioorg Med Chem Lett 24: 1274-9 (2014) | University of Mississippi | 2D 3D TSV |
24507919 | 45 | 3-Amino-N-adamantyl-3-methylbutanamide derivatives as 11ß-hydroxysteroid dehydrogenase 1 inhibitor. | Bioorg Med Chem Lett 24: 1421-5 (2014) | Yonsei University | 2D 3D TSV |
24507918 | 68 | Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII. | Bioorg Med Chem Lett 24: 1310-4 (2014) | Shri G.S. Institute of Technology and Science | 2D 3D TSV |
24507827 | 5 | Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase. | Bioorg Med Chem 22: 1726-35 (2014) | Soochow University | 2D 3D TSV |
24506830 | 91 | Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects. | J Med Chem 57: 1583-98 (2014) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
24503274 | 7 | Synthesis, [¹8F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography. | Bioorg Med Chem 22: 1700-7 (2014) | Washington University Saint Louis | 2D 3D TSV |
24502897 | 9 | Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease. | Eur J Med Chem 74: 491-501 (2014) | Universidad Complutense de Madrid | 2D 3D TSV |
24502334 | 123 | Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-¿ (ROR¿ or RORc). | J Med Chem 57: 5871-92 (2014) | Genentech | 2D 3D TSV |
24499352 | 3 | Bioactive limonoids from the leaves of Azaridachta indica (Neem). | J Nat Prod 77: 596-602 (2014) | Universidad de Los Andes | 2D 3D TSV |
24497639 | 38 | Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1. | J Biol Chem 289: 9304-19 (2014) | Bayer HealthCare | 2D 3D TSV |
24495863 | 35 | Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT? antagonists. | Bioorg Med Chem 22: 1782-90 (2014) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
24495846 | 3 | Lipoxygenase inhibitors derived from marine macroalgae. | Bioorg Med Chem Lett 24: 1383-5 (2014) | Hokkaido University | 2D 3D TSV |
24495281 | 22 | A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies. | Chem Biol Drug Des 84: 92-8 (2014) | Mirpur University of Science and Technology (MUST) | 2D 3D TSV |
24495105 | 1 | Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells. | J Nat Prod 77: 618-24 (2014) | University of California | 2D 3D TSV |
24495018 | 77 | Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H4 receptor antagonists. | J Med Chem 57: 2429-39 (2014) | Janssen Research and Development LLC | 2D 3D TSV |
24494745 | 92 | Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues. | J Med Chem 57: 1000-13 (2014) | National Institute on Drug Abuse-Intramural Research Program | 2D 3D TSV |
24494061 | 35 | Potent and selective inhibitors of CDPK1 from | ACS Med Chem Lett 5: 40-44 (2014) | University of Washington | 2D 3D TSV |
24491635 | 4 | Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity. | Bioorg Med Chem 22: 1766-72 (2014) | National Defense Medical Center, Taiwan | 2D 3D TSV |
24491459 | 5 | Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists. | Bioorg Med Chem Lett 24: 1426-31 (2014) | Sichuan University | 2D 3D TSV |
24491171 | 44 | Discovery of a potent stapled helix peptide that binds to the 70N domain of replication protein A. | J Med Chem 57: 2455-61 (2014) | Vanderbilt University School of Medicine | 2D 3D TSV |
24491146 | 4 | Imaging evaluation of 5HT2C agonists, [(11)C]WAY-163909 and [(11)C]vabicaserin, formed by Pictet-Spengler cyclization. | J Med Chem 57: 1488-94 (2014) | Harvard Medical School | 2D 3D TSV |
24487236 | 2 | Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors. | Eur J Med Chem 73: 310-24 (2014) | University of Louisiana at Monroe | 2D 3D TSV |
24487191 | 6 | Synthesis and evaluation of new coumarin derivatives as potential atypical antipsychotics. | Eur J Med Chem 74: 427-39 (2014) | Huazhong University of Science and Technology | 2D 3D TSV |
24486414 | 48 | Synthesis and in vitro urease inhibitory activity of N,N'-disubstituted thioureas. | Eur J Med Chem 74: 314-23 (2014) | University Karachi | 2D 3D TSV |
24486134 | 4 | Substituted piperidines as HDM2 inhibitors. | Bioorg Med Chem Lett 24: 1026-30 (2014) | Merck Research Laboratories | 2D 3D TSV |
24486132 | 38 | IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles. | Bioorg Med Chem Lett 24: 1085-8 (2014) | Merck Research Laboratories | 2D 3D TSV |
24486131 | 16 | Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands. | Bioorg Med Chem Lett 24: 1021-5 (2014) | University of Trieste | 2D 3D TSV |
24485123 | 43 | Discovery of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 5-(aminomethylene)pyrimidine-2,4,6-trione moiety as c-Met kinase inhibitors. | Bioorg Med Chem 22: 1236-49 (2014) | Shenyang Pharmaceutical University | 2D 3D TSV |
24485122 | 9 | Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors. | Bioorg Med Chem 22: 1262-7 (2014) | Kyung Hee University | 2D 3D TSV |
24485121 | 12 | A perylene derivative regulates HIF-1a and Stat3 signaling pathways. | Bioorg Med Chem 22: 1496-505 (2014) | Baylor College of Medicine | 2D 3D TSV |
24484240 | 19 | Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree. | J Nat Prod 77: 285-97 (2014) | University of Shizuoka | 2D 3D TSV |
24482730 | 4 | Rational Design of Novel Pyridinol-Fused Ring Acetaminophen Analogues. | ACS Med Chem Lett 4: 710-714 (2013) | Vanderbilt University | 2D 3D TSV |
24480359 | 25 | Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents. | Eur J Med Chem 74: 278-301 (2014) | Universidad de Granada | 2D 3D TSV |
24479418 | 39 | Cytotoxic and protein kinase inhibiting nakijiquinones and nakijiquinols from the sponge Dactylospongia metachromia. | J Nat Prod 77: 218-26 (2014) | Heinrich Heine Universit£t | 2D 3D TSV |
24476493 | 2 | Study of the structural and dynamic effects in the FimH adhesin upona-d-heptyl mannose binding. | J Med Chem 57: 1416-27 (2014) | Vrije Universiteit Brussel | 2D 3D TSV |
24472039 | 39 | Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition. | J Med Chem 57: 1513-30 (2014) | Northwestern University | 2D 3D TSV |
24472025 | 32 | High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction. | J Med Chem 57: 1543-56 (2014) | University of Michigan | 2D 3D TSV |
24471976 | 3 | Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule. | J Med Chem 57: 1557-72 (2014) | Wayne State University | 2D 3D TSV |
24471873 | 4 | Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)-2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: synthesis, structure-activity relationships, and biological activities. | J Med Chem 57: 2275-91 (2014) | University of South Australia | 2D 3D TSV |
24471857 | 47 | Euodenine A: a small-molecule agonist of human TLR4. | J Med Chem 57: 1252-75 (2014) | Griffith University | 2D 3D TSV |
24471816 | 28 | Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants. | J Med Chem 57: 1573-82 (2014) | National Cancer Institute-Frederick | 2D 3D TSV |
24471650 | 30 | Novel inhibitors of human DOPA decarboxylase extracted from Euonymus glabra Roxb. | ACS Chem Biol 9: 897-903 (2014) | Shanghai Center for Systems Biomedicine, School of Pharmacy, and State Key Laboratory of Microbial Metabolism & School of Life Sciences and Biotechnology | 2D 3D TSV |
24471526 | 8 | Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors. | J Nat Prod 77: 673-7 (2014) | University of Bonn | 2D 3D TSV |
24471493 | 1 | Octulosonic acid derivatives from Roman chamomile (Chamaemelum nobile) with activities against inflammation and metabolic disorder. | J Nat Prod 77: 509-15 (2014) | University of Mississippi | 2D 3D TSV |
24471437 | 40 | Synthesis, structure-activity relationships and brain uptake of a novel series of benzopyran inhibitors of insulin-regulated aminopeptidase. | J Med Chem 57: 1368-77 (2014) | Monash Institute of Pharmaceutical Sciences | 2D 3D TSV |
24471412 | 12 | Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. | J Med Chem 57: 5509-24 (2014) | Penn State Hershey Cancer Institute | 2D 3D TSV |
24470841 | 9 | Discovery of potent and selective inhibitors of | ACS Med Chem Lett 4: 1148-1151 (2013) | Duquesne University | 2D 3D TSV |
24469112 | 20 | Nonclassical antifolates, part 5. Benzodiazepine analogs as a new class of DHFR inhibitors: synthesis, antitumor testing and molecular modeling study. | Eur J Med Chem 74: 234-45 (2014) | Future University | 2D 3D TSV |
24468632 | 25 | Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors. | Bioorg Med Chem 22: 1303-12 (2014) | Universit£ de Lyon | 2D 3D TSV |
24466406 | 79 | Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors. | Medchemcomm 4: 1085-1092 (2013) | University of Pittsburgh | 2D 3D TSV |
24466405 | 213 | The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface. | Medchemcomm 4: 1501-1507 (2013) | University of North Carolina | 2D 3D TSV |
24463645 | 1 | Synthesis, structure-activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and anti-mycobacterial agents. | Eur J Med Chem 74: 225-33 (2014) | P.C. Jabin Science College | 2D 3D TSV |
24462667 | 28 | New class of azaheptapyridine FPT inhibitors as potential cancer therapy agents. | Bioorg Med Chem Lett 24: 1228-31 (2014) | Merck Research Laboratories | 2D 3D TSV |
24462666 | 105 | Discovery of 6-aryl-azabenzimidaoles that inhibit the TBK1/IKK-e kinases. | Bioorg Med Chem Lett 24: 1138-43 (2014) | AstraZeneca | 2D 3D TSV |
24462665 | 30 | Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPAR¿ agonists. | Bioorg Med Chem Lett 24: 1098-103 (2014) | GlaxoSmithKline | 2D 3D TSV |
24462664 | 58 | Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteres. | Bioorg Med Chem Lett 24: 1062-6 (2014) | Vanderbilt University Medical Center | 2D 3D TSV |
24462176 | 3 | Identification of dihydrostilbenes in Pholidota chinensis as a new scaffold for GABAA receptor modulators. | Bioorg Med Chem 22: 1276-84 (2014) | University of Basel | 2D 3D TSV |
24461562 | 1 | Synthesis of a C-phosphonate mimic of maltose-1-phosphate and inhibition studies on Mycobacterium tuberculosis GlgE. | Bioorg Med Chem 22: 1404-11 (2014) | The University of Toledo | 2D 3D TSV |
24461561 | 24 | Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies. | Bioorg Med Chem 22: 1318-28 (2014) | Universiti Sains Malaysia | 2D 3D TSV |
24461494 | 28 | Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease. | Bioorg Med Chem 22: 1355-61 (2014) | Sun Yat-sen University | 2D 3D TSV |
24461353 | 49 | Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs. | Bioorg Med Chem Lett 24: 1071-4 (2014) | Hyogo University of Health Science | 2D 3D TSV |
24461352 | 51 | Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based lead. | Bioorg Med Chem Lett 24: 1067-70 (2014) | Vanderbilt University Medical Center | 2D 3D TSV |
24461299 | 82 | Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors. | Bioorg Med Chem Lett 24: 1116-21 (2014) | Fox Chase Chemical Diversity Center Inc | 2D 3D TSV |
24461298 | 38 | Anion inhibition studies of two new ?-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. | Bioorg Med Chem Lett 24: 1127-32 (2014) | Kochi Medical School | 2D 3D TSV |
24461297 | 14 | Rat intestinal sucrase inhibition of constituents from the roots of Rosa rugosa Thunb. | Bioorg Med Chem Lett 24: 1192-6 (2014) | Chungnam National University | 2D 3D TSV |
24461292 | 14 | Heterocyclic core analogs of a direct thrombin inhibitor. | Bioorg Med Chem Lett 24: 1111-5 (2014) | Merck Research Laboratories | 2D 3D TSV |
24461289 | 46 | Benzimidazole CB2 agonists: design, synthesis and SAR. | Bioorg Med Chem Lett 24: 1218-21 (2014) | Merck Research Laboratories | 2D 3D TSV |
24457265 | 4 | Novel lung adenocarcinoma and nuclear factor-kappa B (NF-¿B) inhibitors: synthesis and evaluation of lantadene congeners. | Eur J Med Chem 74: 135-44 (2014) | Jaypee University of Information Technology | 2D 3D TSV |
24457093 | 12 | Inhibition of I¿B kinase-ß and I¿B kinase-a by heterocyclic adamantyl arotinoids. | Bioorg Med Chem 22: 1285-302 (2014) | Universidade de Vigo | 2D 3D TSV |
24457091 | 2 | Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I). | Bioorg Med Chem 22: 1450-8 (2014) | The University of Texas M.D. Anderson Cancer Center | 2D 3D TSV |
24457090 | 2 | Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin. | Bioorg Med Chem 22: 1383-93 (2014) | China Pharmaceutical University | 2D 3D TSV |
24457088 | 34 | Design and synthesis of N?-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. | Bioorg Med Chem 22: 1459-67 (2014) | Universit£ di Messina | 2D 3D TSV |
24456902 | 14 | Synthesis and biological evaluation of novel pazopanib derivatives as antitumor agents. | Bioorg Med Chem Lett 24: 1108-10 (2014) | Tianjin University | 2D 3D TSV |
24456578 | 1 | Isochromans and ?-pyrones from Penicillium corylophilum. | J Nat Prod 77: 206-12 (2014) | Carleton University | 2D 3D TSV |
24456490 | 33 | Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists. | J Med Chem 57: 1344-54 (2014) | Seoul National University | 2D 3D TSV |
24456472 | 67 | Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development. | J Med Chem 57: 1454-72 (2014) | Amgen Inc | 2D 3D TSV |
24456369 | 1 | Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface. | J Med Chem 57: 632-41 (2014) | The Ohio State University | 2D 3D TSV |
24456288 | 2 | De-novo designed library of benzoylureas as inhibitors of BCL-XL: synthesis, structural and biochemical characterization. | J Med Chem 57: 1323-43 (2014) | The Walter and Eliza Hall Institute of Medical Research | 2D 3D TSV |
24456245 | 24 | Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes. | J Med Chem 57: 1236-51 (2014) | Fudan University | 2D 3D TSV |
24456116 | 105 | Design, synthesis, and characterization ofa-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase. | J Med Chem 57: 1079-89 (2014) | The Scripps Research Institute | 2D 3D TSV |
24454993 | 1 | Discovery of?2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor. | ACS Med Chem Lett 4: 1005-1010 (2013) | University of Dundee | 2D 3D TSV |
24450589 | 64 | Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA. | J Med Chem 57: 1276-88 (2014) | GlaxoSmithKline | 2D 3D TSV |
24447850 | 122 | Discovery of substituted lactams as novel dual orexin receptor antagonists. Synthesis, preliminary structure-activity relationship studies and efforts towards improved metabolic stability and pharmacokinetic properties. Part 1. | Bioorg Med Chem Lett 24: 1201-8 (2014) | Actelion Pharmaceuticals Ltd | 2D 3D TSV |
24447275 | 33 | Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma. | J Med Chem 57: 686-700 (2014) | Northwestern University | 2D 3D TSV |
24447248 | 18 | Structure-based optimization of tyrosine kinase inhibitor CLM3. Design, synthesis, functional evaluation, and molecular modeling studies. | J Med Chem 57: 1225-35 (2014) | Universit£ di Pisa | 2D 3D TSV |
24446728 | 30 | Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design. | J Med Chem 57: 849-60 (2014) | Eli Lilly and Company | 2D 3D TSV |
24446664 | 6 | 2,4-Diaminothienopyrimidines as orally active antimalarial agents. | J Med Chem 57: 1014-22 (2014) | University of Cape Town | 2D 3D TSV |
24445311 | 1 | Benzofuran derivatives as a novel class of inhibitors of mTOR signaling. | Eur J Med Chem 74: 41-9 (2014) | CNRS/Universit£ de Strasbourg | 2D 3D TSV |
24445310 | 25 | Design, synthesis, biological evaluation, and comparative docking study of 1,2,4-triazolones as CB1 receptor selective antagonists. | Eur J Med Chem 74: 73-84 (2014) | Zhejiang University | 2D 3D TSV |
24444054 | 70 | Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2,3-diones. | J Med Chem 57: 714-22 (2014) | Indiana University School of Medicine | 2D 3D TSV |
24443569 | 4 | The different inhibition mechanisms of OXA-1 and OXA-24 ß-lactamases are determined by the stability of active site carboxylated lysine. | J Biol Chem 289: 6152-64 (2014) | Case Western Reserve University | 2D 3D TSV |
24440480 | 26 | Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation. | Bioorg Med Chem 22: 1362-9 (2014) | The Scripps Research Institute-Florida | 2D 3D TSV |
24440479 | 4 | Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl)-sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III. | Bioorg Med Chem 22: 1487-95 (2014) | Shandong University | 2D 3D TSV |
24440478 | 22 | Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors. | Bioorg Med Chem 22: 1468-78 (2014) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24440379 | 179 | Substituted 4-phenyl-2-aminoimidazoles and 4-phenyl-4,5-dihydro-2-aminoimidazoles as voltage-gated sodium channel modulators. | Eur J Med Chem 74: 23-30 (2014) | University of Ljubljana | 2D 3D TSV |
24440378 | 42 | N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism. | Eur J Med Chem 74: 12-22 (2014) | University of Li£ge | 2D 3D TSV |
24440299 | 48 | Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists. | Bioorg Med Chem Lett 24: 1133-7 (2014) | Amgen Inc | 2D 3D TSV |
24440298 | 5 | Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase. | Bioorg Med Chem Lett 24: 1232-5 (2014) | Yale University | 2D 3D TSV |
24439847 | 24 | Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV. | Bioorg Med Chem Lett 24: 731-6 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24437735 | 16 | Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selectiveß3 adrenergic receptor agonists for the treatment of overactive bladder. | J Med Chem 57: 1437-53 (2014) | Merck and Co. | 2D 3D TSV |
24436777 | 8 | Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions? | ACS Med Chem Lett 5: 23-28 (2014) | University of Cambridge | 2D 3D TSV |
24433964 | 30 | Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase. | Bioorg Med Chem 22: 1163-75 (2014) | Ehime University | 2D 3D TSV |
24433863 | 76 | Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. | Bioorg Med Chem Lett 24: 737-41 (2014) | Janssen Research and Development LLC | 2D 3D TSV |
24433862 | 18 | Discovery of MK-7655, aß-lactamase inhibitor for combination with Primaxin®. | Bioorg Med Chem Lett 24: 780-5 (2014) | Merck Research Labs | 2D 3D TSV |
24433860 | 60 | Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors. | Bioorg Med Chem Lett 24: 790-3 (2014) | PKUCare Pharmaceutical R & D Center | 2D 3D TSV |
24433859 | 80 | Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). | Bioorg Med Chem Lett 24: 954-62 (2014) | Genentech | 2D 3D TSV |
24432909 | 13 | Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib. | J Med Chem 57: 1170-87 (2014) | Pfizer Inc | 2D 3D TSV |
24432870 | 42 | Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitors. | J Med Chem 57: 1033-45 (2014) | Genentech | 2D 3D TSV |
24432385 | 14 | Sulfur incorporation generally improves Ricin inhibition in pterin-appended glycine-phenylalanine dipeptide mimics. | Bioorg Med Chem Lett 23: 6799-804 (2014) | TBA | 2D 3D TSV |
24432384 | 7 | Tissue transglutaminase: an emerging target for therapy and imaging. | Bioorg Med Chem Lett 23: 6528-43 (2014) | TBA | 2D 3D TSV |
24428686 | 6 | Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues. | J Med Chem 57: 836-48 (2014) | Research Triangle Institute | 2D 3D TSV |
24428639 | 56 | Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines. | J Med Chem 57: 651-68 (2014) | Trius Therapeutics Inc | 2D 3D TSV |
24428186 | 10 | Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione¿-secretase modulators. | J Med Chem 57: 1046-62 (2014) | Pfizer Inc | 2D 3D TSV |
24424304 | 10 | Recent progress in the identification of BRAF inhibitors as anti-cancer agents. | Eur J Med Chem 72: 170-205 (2014) | Cairo University | 2D 3D TSV |
24424134 | 76 | Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors. | Bioorg Med Chem Lett 24: 860-4 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24422550 | 107 | Optimization of brain penetrant 11ß-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice. | J Med Chem 57: 970-86 (2014) | AstraZeneca | 2D 3D TSV |
24422530 | 32 | Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A. | J Med Chem 57: 759-69 (2014) | Christian-Albrechts University of Kiel | 2D 3D TSV |
24422519 | 31 | Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases. | J Med Chem 57: 5011-22 (2014) | Saarland University and Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) | 2D 3D TSV |
24418776 | 2 | Inhibition of reverse transcriptase and Taq DNA polymerase by compounds possessing the coumarin framework. | Bioorg Med Chem Lett 24: 760-4 (2014) | INTEQUI-CONICET | 2D 3D TSV |
24418775 | 72 | A biochemical screen for GroEL/GroES inhibitors. | Bioorg Med Chem Lett 24: 786-9 (2014) | Indiana University | 2D 3D TSV |
24418773 | 61 | Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophilia. | Bioorg Med Chem Lett 24: 821-7 (2014) | AstraZeneca | 2D 3D TSV |
24417609 | 4 | Direct interaction of garcinol and related polyisoprenylated benzophenones of Garcinia cambogia fruits with the transcription factor STAT-1 as a likely mechanism of their inhibitory effect on cytokine signaling pathways. | J Nat Prod 77: 543-9 (2014) | Universit£ degli Studi di Salerno | 2D 3D TSV |
24417566 | 43 | Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5). | J Med Chem 57: 578-99 (2014) | Icahn School of Medicine at Mount Sinai | 2D 3D TSV |
24417533 | 63 | Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases. | J Med Chem 57: 5023-38 (2014) | Pfizer Inc | 2D 3D TSV |
24417449 | 54 | Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search. | J Med Chem 57: 1121-6 (2014) | University of Minnesota | 2D 3D TSV |
24412498 | 15 | Synthesis and assay of retro-a4ß1 integrin-targeting motifs. | Eur J Med Chem 73: 225-32 (2014) | University of Bologna | 2D 3D TSV |
24412340 | 24 | Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors. | Bioorg Med Chem 22: 1016-28 (2014) | Institut f£r Pharmazeutische und Medizinische Chemie der Westf£lischen Wilhelms-Universit£t M£nster | 2D 3D TSV |
24412339 | 26 | Inhibition of tyrosinase activity by polyphenol compounds from Flemingia philippinensis roots. | Bioorg Med Chem 22: 1115-20 (2014) | Gyeongsang National University | 2D 3D TSV |
24412111 | 70 | Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration. | Bioorg Med Chem Lett 24: 750-5 (2014) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
24412109 | 18 | Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker. | Bioorg Med Chem Lett 24: 880-3 (2014) | The Catholic University of Korea | 2D 3D TSV |
24412072 | 28 | Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350). | Bioorg Med Chem Lett 24: 995-9 (2014) | Gilead Sciences Inc | 2D 3D TSV |
24412070 | 167 | Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymes. | Bioorg Med Chem Lett 24: 1000-4 (2014) | Sanford-Burnham Medical Research Institute | 2D 3D TSV |
24412069 | 87 | Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors. | Bioorg Med Chem Lett 24: 893-9 (2014) | Kyushu University | 2D 3D TSV |
24412068 | 13 | Structure-activity relationships of N-substituted 4-(trifluoromethoxy)benzamidines with affinity for GluN2B-containing NMDA receptors. | Bioorg Med Chem Lett 24: 828-30 (2014) | The University of Sydney | 2D 3D TSV |
24412066 | 5 | Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists. | Bioorg Med Chem Lett 24: 949-53 (2014) | Hoffmann-La Roche Inc | 2D 3D TSV |
24411477 | 84 | Carbamazepine derivatives with P2X4 receptor-blocking activity. | Bioorg Med Chem 22: 1077-88 (2014) | University of Bonn | 2D 3D TSV |
24411201 | 150 | Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-ß-hydroxysteroid dehydrogenase (AKR1C3). | Bioorg Med Chem 22: 967-77 (2014) | University of Auckland | 2D 3D TSV |
24411199 | 58 | Formosusin A, a novel specific inhibitor of mammalian DNA polymeraseß from the fungus Paecilomyces formosus. | Bioorg Med Chem 22: 1070-6 (2014) | Kobe Gakuin University | 2D 3D TSV |
24411198 | 22 | Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents. | Bioorg Med Chem 22: 1008-15 (2014) | Institute of Information Technology | 2D 3D TSV |
24411196 | 8 | Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors. | Bioorg Med Chem 22: 1040-8 (2014) | Universit£ di Messina | 2D 3D TSV |
24411125 | 36 | Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: core region. | Bioorg Med Chem Lett 24: 989-94 (2014) | Gilead Sciences Inc | 2D 3D TSV |
24411123 | 28 | Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 1: erlotinib analogs. | Bioorg Med Chem Lett 24: 884-7 (2014) | Jiangsu Aosaikang Pharmaceutical Co. Ltd | 2D 3D TSV |
24410637 | 86 | Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition. | J Med Chem 57: 733-58 (2014) | AstraZeneca | 2D 3D TSV |
24406103 | 77 | Effects of novel diarylpentanoid analogues of curcumin on secretory phospholipase A2 , cyclooxygenases, lipo-oxygenase, and microsomal prostaglandin E synthase-1. | Chem Biol Drug Des 83: 670-81 (2014) | Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia | 2D 3D TSV |
24405707 | 100 | Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists. | Bioorg Med Chem Lett 24: 845-9 (2014) | Vertex Pharmaceuticals Inc | 2D 3D TSV |
24405703 | 72 | 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs. | Bioorg Med Chem Lett 24: 1437-41 (2014) | Janssen Research and Development LLC | 2D 3D TSV |
24405701 | 30 | Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy. | Bioorg Med Chem Lett 24: 870-9 (2014) | AstraZeneca | 2D 3D TSV |
24405419 | 96 | Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). | J Med Chem 57: 770-92 (2014) | Genentech | 2D 3D TSV |
24405391 | 2 | Mutagenesis studies of the 14 Å internal cavity of histone deacetylase 1: insights toward the acetate-escape hypothesis and selective inhibitor design. | J Med Chem 57: 642-50 (2014) | Wayne State University | 2D 3D TSV |
24405333 | 69 | Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors. | J Med Chem 57: 955-69 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24405213 | 60 | Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles. | J Med Chem 57: 325-38 (2014) | Amgen Inc | 2D 3D TSV |
24405172 | 35 | Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept. | J Med Chem 57: 309-24 (2014) | Amgen Inc | 2D 3D TSV |
24403173 | 12 | Long residence times revealed by Aurora A kinase-targeting fluorescent probes derived from inhibitors MLN8237 and VX-689. | Chembiochem 15: 443-50 (2014) | University of Tartu, Ravila 14A, 50411 Tartu (Estonia) | 2D 3D TSV |
24400806 | 101 | Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases. | J Med Chem 57: 793-816 (2014) | Chiesi Farmaceutici S.p.A. | 2D 3D TSV |
24398385 | 18 | Synthesis of novel indenoquinoxaline derivatives as potenta-glucosidase inhibitors. | Bioorg Med Chem 22: 1195-200 (2014) | University of the Punjab | 2D 3D TSV |
24398383 | 24 | 7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors. | Bioorg Med Chem 22: 1089-103 (2014) | Universit£ di Milano | 2D 3D TSV |
24398382 | 3 | Linear propargylic alcohol functionality attached to the indazole-7-carboxamide as a JAK1-specific linear probe group. | Bioorg Med Chem 22: 1156-62 (2014) | Konkuk University | 2D 3D TSV |
24398380 | 29 | Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3). | Bioorg Med Chem 22: 1029-39 (2014) | University of Auckland | 2D 3D TSV |
24398298 | 3 | The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target. | Bioorg Med Chem Lett 24: 911-6 (2014) | University of Leeds | 2D 3D TSV |
24397738 | 41 | Discovery of 7-tetrahydropyran-2-yl chromans:ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloidß-protein (Aß) in the central nervous system. | J Med Chem 57: 878-902 (2014) | Array BioPharma | 2D 3D TSV |
24397558 | 45 | Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase. | J Med Chem 57: 1855-79 (2014) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
24396570 | 9 | Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells. | Medchemcomm 4: (2013) | The City University of New York | 2D 3D TSV |
24393810 | 6 | A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. | Eur J Med Chem 73: 177-86 (2014) | NeuroSearch Sweden AB | 2D 3D TSV |
24393583 | 2 | Danshen diversity defeating dementia. | Bioorg Med Chem Lett 24: 708-16 (2014) | RMIT University | 2D 3D TSV |
24393580 | 6 | Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR). | Bioorg Med Chem Lett 24: 835-8 (2014) | Sejong University | 2D 3D TSV |
24393039 | 97 | Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase. | J Med Chem 57: 495-506 (2014) | National Institutes of Health | 2D 3D TSV |
24392688 | 31 | Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator. | J Med Chem 57: 861-77 (2014) | Pfizer Inc | 2D 3D TSV |
24389511 | 25 | Structure-based design, synthesis and biological evaluation of diphenylmethylamine derivatives as novel Akt1 inhibitors. | Eur J Med Chem 73: 167-76 (2014) | Zhejiang University | 2D 3D TSV |
24389509 | 17 | 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies. | Eur J Med Chem 73: 141-52 (2014) | Universitat de Barcelona | 2D 3D TSV |
24388993 | 76 | Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent ROR¿t inhibitors. | Bioorg Med Chem 22: 692-702 (2014) | GlaxoSmithKline | 2D 3D TSV |
24388834 | 3 | Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. | Eur J Med Chem 73: 126-34 (2014) | Universit£ di Napoli"Federico II" | 2D 3D TSV |
24388807 | 12 | Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors. | Bioorg Med Chem Lett 24: 495-500 (2014) | Guru Nanak Dev University | 2D 3D TSV |
24388805 | 2 | New natural products as new leads for antibacterial drug discovery. | Bioorg Med Chem Lett 24: 413-8 (2014) | AstraZeneca | 2D 3D TSV |
24388690 | 48 | Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold. | Bioorg Med Chem Lett 24: 462-6 (2014) | R&D Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | 2D 3D TSV |
24388688 | 1 | Synthesis and evaluation of isoleucine derived angiotensin II AT(2) receptor ligands. | Bioorg Med Chem Lett 24: 476-9 (2014) | Uppsala University | 2D 3D TSV |
24387981 | 8 | Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities. | Bioorg Med Chem 22: 703-10 (2014) | Universiti Sains Malaysia | 2D 3D TSV |
24387325 | 2 | Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. | J Med Chem 57: 937-54 (2014) | Istituto Italiano di Tecnologia | 2D 3D TSV |
24387280 | 63 | Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain. | J Med Chem 57: 669-76 (2014) | The Scripps Research Institute | 2D 3D TSV |
24387243 | 4 | Discovery of a new binding site on human choline kinasea1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives. | J Med Chem 57: 507-15 (2014) | Universidad de Granada | 2D 3D TSV |
24387221 | 150 | Discovery and optimization of pyrimidone indoline amide PI3Kß inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers. | J Med Chem 57: 903-20 (2014) | Sanofi | 2D 3D TSV |
24387159 | 36 | Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells. | J Med Chem 57: 701-13 (2014) | Sapienza University of Rome | 2D 3D TSV |
24387105 | 27 | Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells. | J Med Chem 57: 449-61 (2014) | Indiana University School of Medicine | 2D 3D TSV |
24384549 | 24 | Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold. | Eur J Med Chem 73: 83-96 (2014) | University of Ljubljana | 2D 3D TSV |
24383475 | 22 | Structure-activity relationship analysis of imidazoquinolines with Toll-like receptors 7 and 8 selectivity and enhanced cytokine induction. | J Med Chem 57: 339-47 (2014) | University of Minnesota | 2D 3D TSV |
24379401 | 5 | A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer. | J Biol Chem 289: 5208-16 (2014) | Universität Duisburg-Essen | 2D 3D TSV |
24378711 | 50 | Specific features of HIV-1 integrase inhibition by bisphosphonate derivatives. | Eur J Med Chem 73: 73-82 (2014) | Lomonosov Moscow State University | 2D 3D TSV |
24378710 | 18 | Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease. | Eur J Med Chem 73: 56-72 (2014) | Instituto de Qu£mica M£dica (CSIC) | 2D 3D TSV |
24378707 | 45 | [DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting. | Eur J Med Chem 73: 30-7 (2014) | INRASTES | 2D 3D TSV |
24376907 | 17 | Discovery of Inhibitors of | ACS Med Chem Lett 4: (2013) | Northern Illinois University | 2D 3D TSV |
24374347 | 19 | Identification of small molecule sphingomyelin synthase inhibitors. | Eur J Med Chem 73: 1-7 (2014) | Fudan University | 2D 3D TSV |
24374277 | 41 | Design and synthesis of potential dual NK(1)/NK(3) receptor antagonists. | Bioorg Med Chem Lett 24: 510-4 (2014) | Universit£ de Montr£al | 2D 3D TSV |
24374272 | 48 | Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases. | Bioorg Med Chem Lett 24: 520-5 (2014) | Xenon Pharmaceuticals Inc | 2D 3D TSV |
24374271 | 56 | Bifunctional thiosialosides inhibit influenza virus. | Bioorg Med Chem Lett 24: 636-43 (2014) | Georgia State University | 2D 3D TSV |
24373842 | 1 | Structurally diverse low molecular weight activators of the mammalian pre-mRNA 3' cleavage reaction. | Bioorg Med Chem 22: 834-41 (2014) | The City University of New York | 2D 3D TSV |
24373735 | 48 | Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. | Bioorg Med Chem 22: 772-86 (2014) | Universit£ degli Studi di Roma "La Sapienza" | 2D 3D TSV |
24373724 | 47 | Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases. | Bioorg Med Chem Lett 24: 565-70 (2014) | Toray Industries Inc | 2D 3D TSV |
24370012 | 47 | Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects. | Bioorg Med Chem Lett 24: 526-31 (2014) | Xenon Pharmaceuticals Inc | 2D 3D TSV |
24369842 | 62 | Cholinesterase inhibitory activity versus aromatic core multiplicity: a facile green synthesis and molecular docking study of novel piperidone embedded thiazolopyrimidines. | Bioorg Med Chem 22: 906-16 (2014) | Universiti Sains Malaysia | 2D 3D TSV |
24369839 | 18 | Design and synthesis of 2-amino-6-(1H,3H-benzo[de]isochromen-6-yl)-1,3,5-triazines as novel Hsp90 inhibitors. | Bioorg Med Chem 22: 892-905 (2014) | Chugai Pharmaceutical Co., Ltd | 2D 3D TSV |
24368209 | 7 | A development of chimeric VEGFR2 TK inhibitor based on two ligand conformers from PDB: 1Y6A complex--medicinal chemistry consequences of a TKs analysis. | Eur J Med Chem 72: 146-59 (2014) | Comenius University | 2D 3D TSV |
24368208 | 13 | Inhibition of LOX by flavonoids: a structure-activity relationship study. | Eur J Med Chem 72: 137-45 (2014) | Universidade do Porto | 2D 3D TSV |
24368028 | 4 | Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors. | Bioorg Med Chem 22: 787-95 (2014) | Medical University of Lublin | 2D 3D TSV |
24367923 | 108 | Novel S1P(1) receptor agonists--part 3: from thiophenes to pyridines. | J Med Chem 57: 110-30 (2014) | Actelion Pharmaceuticals Ltd. | 2D 3D TSV |
24365162 | 126 | Ligands of the neuropeptide Y Y2 receptor. | Bioorg Med Chem Lett 24: 430-41 (2014) | The Scripps Research Institute | 2D 3D TSV |
24365161 | 45 | Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity ? opioid receptor (MOR) agonist/? opioid receptor (DOR) antagonist ligands. | Bioorg Med Chem Lett 24: 548-51 (2014) | University of Michigan | 2D 3D TSV |
24365159 | 35 | The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds. | Bioorg Med Chem Lett 24: 576-9 (2014) | University of Missouri | 2D 3D TSV |
24365158 | 9 | Synthesis and activity of substituted heteroaromatics as positive allosteric modulators fora4ß2a5 nicotinic acetylcholine receptors. | Bioorg Med Chem Lett 24: 674-8 (2014) | The Scripps Research Institute | 2D 3D TSV |
24364476 | 9 | The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L. | J Nat Prod 77: 92-9 (2014) | University of California | 2D 3D TSV |
24363888 | 32 | Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors. | Medchemcomm 4: (2013) | University of Hawai'i at Hilo | 2D 3D TSV |
24363833 | 4 | Bisubstrate Inhibitors of Biotin Protein Ligase in | ACS Med Chem Lett 4: (2013) | University of Minnesota | 2D 3D TSV |
24362350 | 8 | Amino and carboxy functionalized modified nucleosides: a potential class of inhibitors for angiogenin. | Bioorg Chem 52: 56-61 (2014) | SASTRA University, Thanjavur, Tamil Nadu 613401, India | 2D 3D TSV |
24361187 | 12 | Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors. | Bioorg Med Chem 22: 865-73 (2014) | Mazandaran University of Medical Sciences | 2D 3D TSV |
24360826 | 17 | Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain. | Bioorg Med Chem 22: 1208-17 (2014) | The Scripps Research Institute | 2D 3D TSV |
24360824 | 3 | 4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors. | Bioorg Med Chem 22: 917-26 (2014) | Northeastern University | 2D 3D TSV |
24360604 | 60 | Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1). | Bioorg Med Chem Lett 24: 654-60 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24360562 | 3 | The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs. | Bioorg Med Chem Lett 24: 649-53 (2014) | George Washington University | 2D 3D TSV |
24360557 | 6 | Synthesis and evaluation of curcumin derivatives toward an inhibitor of beta-site amyloid precursor protein cleaving enzyme 1. | Bioorg Med Chem Lett 24: 685-90 (2014) | Yamagata University | 2D 3D TSV |
24360556 | 66 | Structure-activity relationship studies and biological characterization of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors. | Bioorg Med Chem Lett 24: 630-5 (2014) | National Center for Advancing Translational Sciences | 2D 3D TSV |
24360554 | 3 | Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position. | Bioorg Med Chem Lett 24: 618-23 (2014) | Kobe Gakuin University | 2D 3D TSV |
24359708 | 6 | Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention. | Bioorg Med Chem 22: 178-85 (2013) | University of Alabama at Birmingham | 2D 3D TSV |
24359706 | 1 | Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents. | Bioorg Med Chem 22: 116-25 (2013) | St. John's University | 2D 3D TSV |
24359257 | 10 | Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin. | J Med Chem 57: 29-41 (2014) | Universit£ de Sherbrooke | 2D 3D TSV |
24359185 | 4 | Discovery of a rapidly metabolized, long-actingß(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing. | J Med Chem 57: 159-70 (2014) | GlaxoSmithKline | 2D 3D TSV |
24359159 | 60 | Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors. | J Med Chem 57: 144-58 (2014) | AstraZeneca | 2D 3D TSV |
24356970 | 37 | Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket. | J Biol Chem 289: 4432-43 (2014) | University of Texas Southwestern Medical Center | 2D 3D TSV |
24355348 | 1 | 4-Thiazolidinones: the advances continue?. | Eur J Med Chem 72: 52-77 (2014) | Institute of Technology | 2D 3D TSV |
24355130 | 4 | Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer. | Bioorg Med Chem Lett 24: 126-31 (2014) | Xavier University of Louisiana | 2D 3D TSV |
24355129 | 21 | The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin. | Bioorg Med Chem Lett 24: 177-80 (2013) | H. Lundbeck A/S | 2D 3D TSV |
24354364 | 3 | d-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors. | J Med Chem 57: 243-7 (2014) | Johns Hopkins University | 2D 3D TSV |
24354345 | 34 | Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. | J Med Chem 57: 921-36 (2014) | Genentech | 2D 3D TSV |
24354319 | 30 | Exploring the determinants of trace amine-associated receptor 1's functional selectivity for the stereoisomers of amphetamine and methamphetamine. | J Med Chem 57: 378-90 (2014) | Oregon Health & Science University | 2D 3D TSV |
24354316 | 1 | Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis. | J Med Chem 57: 828-35 (2014) | University of Washington | 2D 3D TSV |
24351031 | 41 | Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists. | J Med Chem 57: 364-77 (2014) | McGill University | 2D 3D TSV |
24350995 | 46 | Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor. | J Med Chem 57: 98-109 (2014) | Universit£ de Sherbrooke | 2D 3D TSV |
24345481 | 14 | Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors. | Bioorg Med Chem 22: 126-34 (2013) | Northern Kentucky University | 2D 3D TSV |
24345448 | 4 | Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF. | Bioorg Med Chem Lett 24: 113-6 (2013) | Utrecht University | 2D 3D TSV |
24345446 | 133 | Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors. | Bioorg Med Chem Lett 24: 61-4 (2014) | Universit£ degli Studi di Siena | 2D 3D TSV |
24345273 | 111 | Design, synthesis, and biological activity of pyridopyrimidine scaffolds as novel PI3K/mTOR dual inhibitors. | J Med Chem 57: 613-31 (2014) | Universit£ d'Orl£ans | 2D 3D TSV |
24345087 | 108 | Novel S1P(1) receptor agonists--part 2: from bicyclo[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes. | J Med Chem 57: 78-97 (2014) | Actelion Pharmaceuticals Ltd. | 2D 3D TSV |
24342240 | 20 | A tetradecapeptide somatostatin dicarba-analog: Synthesis, structural impact and biological activity. | Bioorg Med Chem Lett 24: 103-7 (2014) | Institute for Research in Biomedicine (IRB Barcelona) | 2D 3D TSV |
24341381 | 2 | Design of an amide N-glycoside derivative of ?-glucogallin: a stable, potent, and specific inhibitor of aldose reductase. | J Med Chem 57: 71-7 (2014) | University of Colorado Anschutz Medical Campus | 2D 3D TSV |
24340169 | 11 | The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors. | Medchemcomm (2012) | Imperial College London | 2D 3D TSV |
24332658 | 38 | Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moiet | Bioorg Med Chem 22: 141-7 (2014) | Salman bin Abdulaziz University | 2D 3D TSV |
24332657 | 35 | Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings. | Bioorg Med Chem 22: 167-77 (2014) | University of Illinois at Chicago | 2D 3D TSV |
24332652 | 1 | Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A? adenosine receptor. | Bioorg Med Chem 22: 148-66 (2014) | Universit£ di Ferrara | 2D 3D TSV |
24332628 | 12 | Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory. | Bioorg Med Chem Lett 24: 90-5 (2013) | Nanjing University | 2D 3D TSV |
24332627 | 26 | Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists. | Bioorg Med Chem Lett 24: 141-6 (2013) | Shanghai Hengrui Pharmaceutical Co., Ltd | 2D 3D TSV |
24332624 | 12 | Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists. | Bioorg Med Chem Lett 24: 152-5 (2014) | Soochow University | 2D 3D TSV |
24332496 | 8 | Chemical synthesis and tyrosinase inhibitory activity of rhododendrol glycosides. | Bioorg Med Chem Lett 24: 122-5 (2014) | Tokyo University of Agriculture and Technology | 2D 3D TSV |
24332494 | 16 | Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer. | Bioorg Med Chem Lett 24: 54-60 (2014) | LEO Pharma A/S | 2D 3D TSV |
24332493 | 33 | The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists. | Bioorg Med Chem Lett 24: 72-6 (2014) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24332492 | 16 | Rationally designed hybrid molecules with appreciable COX-2 inhibitory and anti-nociceptive activities. | Bioorg Med Chem Lett 24: 77-82 (2014) | Guru Nanak Dev University | 2D 3D TSV |
24332491 | 24 | Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists. | Bioorg Med Chem Lett 24: 156-60 (2013) | Amgen Inc | 2D 3D TSV |
24332488 | 11 | Correlation between chemotype-dependent binding conformations of HSP90a/ß and isoform selectivity-Implications for the structure-based design of HSP90a/ß selective inhibitors for treating neurodegenerative diseases. | Bioorg Med Chem Lett 24: 204-8 (2013) | Vertex Pharmaceuticals Inc | 2D 3D TSV |
24332487 | 46 | Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors. | Bioorg Med Chem Lett 24: 161-4 (2014) | The Scripps Research Institute | 2D 3D TSV |
24332486 | 35 | Structure activity relationships of fused bicyclic and urea derivatives of spirocyclic compounds as potent CCR1 antagonists. | Bioorg Med Chem Lett 24: 108-12 (2013) | AstraZeneca | 2D 3D TSV |
24332093 | 27 | (E)-Alkenes as replacements of amide bonds: development of novel and potent acyclic CGRP receptor antagonists. | Bioorg Med Chem Lett 24: 258-61 (2013) | Merck & Co. | 2D 3D TSV |
24332092 | 6 | Synthesis and biological properties of thiazole-analogues of pyochelin, a siderophore of Pseudomonas aeruginosa. | Bioorg Med Chem Lett 24: 132-5 (2013) | University of Strasburg | 2D 3D TSV |
24332090 | 6 | Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents. | Bioorg Med Chem Lett 24: 220-3 (2013) | Zhejiang Academy of Medical Sciences | 2D 3D TSV |
24332089 | 35 | Imidazole-derived agonists for the neurotensin 1 receptor. | Bioorg Med Chem Lett 24: 262-7 (2013) | Sanford-Burnham Medical Research Institute | 2D 3D TSV |
24332088 | 79 | Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor. | Bioorg Med Chem Lett 24: 199-203 (2013) | Merck Research Laboratories | 2D 3D TSV |
24331758 | 7 | Involvement of apoptosis and autophagy in the death of RPMI 8226 multiple myeloma cells by two enantiomeric sigma receptor ligands. | Bioorg Med Chem 22: 221-33 (2013) | University of Greifswald | 2D 3D TSV |
24331756 | 9 | Pyrrolizines: Promising scaffolds for anticancer drugs. | Bioorg Med Chem 22: 46-53 (2013) | Beni-Suef University | 2D 3D TSV |
24330598 | 27 | Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors. | Chem Biol Drug Des 83: 592-9 (2014) | Xi'an Jiaotong University, No. 76, Yanta West Road, Xi'an, 710061, China | 2D 3D TSV |
24328302 | 94 | Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum. | J Nat Prod 77: 49-56 (2014) | Heinrich-Heine-Universit£t D£sseldorf | 2D 3D TSV |
24328113 | 9 | Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1. | J Med Chem 57: 421-34 (2014) | Universit£ Pierre et Marie Curie-Paris 6 | 2D 3D TSV |
24328103 | 9 | Discovery of a non-estrogenic irreversible inhibitor of 17?-hydroxysteroid dehydrogenase type 1 from 3-substituted-16?-(m-carbamoylbenzyl)-estradiol derivatives. | J Med Chem 57: 204-22 (2014) | Laval University | 2D 3D TSV |
24327656 | 9 | The molecular chaperone Hsp70 activates protein phosphatase 5 (PP5) by binding the tetratricopeptide repeat (TPR) domain. | J Biol Chem 289: 2908-17 (2014) | University of Michigan | 2D 3D TSV |
24326277 | 11 | Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma. | Bioorg Med Chem 22: 478-87 (2013) | George Mason University | 2D 3D TSV |
24326276 | 63 | Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the ??-adrenergic receptor. | Bioorg Med Chem 22: 234-46 (2014) | Medical University of Lublin | 2D 3D TSV |
24325601 | 74 | Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities. | J Med Chem 57: 42-55 (2014) | Sapienza University of Rome | 2D 3D TSV |
24325578 | 84 | Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine D2/3 receptors in their high-affinity state. | J Med Chem 57: 391-410 (2014) | University of Amsterdam | 2D 3D TSV |
24324854 | 4 | Exploring novel strategies for AIDS protozoal pathogens: ?-helix mimetics targeting a key allosteric protein-protein interaction in | Medchemcomm 4: (2013) | Yale University | 2D 3D TSV |
24321833 | 95 | A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor. | Eur J Med Chem 71: 290-305 (2014) | Institute of Bio-Science and Technology | 2D 3D TSV |
24321832 | 38 | Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones. | Eur J Med Chem 71: 282-9 (2014) | Universidade Federal de Minas Gerais | 2D 3D TSV |
24321345 | 11 | Preparation and evaluation of deconstruction analogues of 7-deoxykalafungin as AKT kinase inhibitors. | Bioorg Med Chem Lett 24: 271-4 (2013) | Virginia Commonwealth University | 2D 3D TSV |
24321344 | 16 | Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands. | Bioorg Med Chem Lett 24: 382-5 (2013) | Seoul National University | 2D 3D TSV |
24320998 | 41 | Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582). | J Med Chem 56: 9897-919 (2013) | AstraZeneca | 2D 3D TSV |
24320749 | 3 | Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling. | Biochemistry 52: 9187-201 (2013) | Pfizer Inc | 2D 3D TSV |
24316669 | 21 | Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors. | Eur J Med Chem 71: 259-66 (2014) | Zhejiang University | 2D 3D TSV |
24316668 | 34 | Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping. | Eur J Med Chem 71: 250-8 (2014) | Asahi Kasei Pharma Corporation | 2D 3D TSV |
24316352 | 27 | Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors. | Bioorg Med Chem 22: 292-302 (2014) | Tianjin University of Science and Technology | 2D 3D TSV |
24316025 | 17 | Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands. | Eur J Med Chem 71: 237-49 (2014) | Universidad de Santiago de Compostela | 2D 3D TSV |
24315194 | 18 | Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model. | Bioorg Med Chem 22: 311-24 (2013) | Wayne State University | 2D 3D TSV |
24315192 | 26 | Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation. | Bioorg Med Chem 22: 277-84 (2014) | Xi'an Jiaotong University | 2D 3D TSV |
24315190 | 21 | Probing the human estrogen receptor-? binding requirements for phenolic mono- and di-hydroxyl compounds: a combined synthesis, binding and docking study. | Bioorg Med Chem 22: 303-10 (2014) | Marquette University | 2D 3D TSV |
24315189 | 10 | Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase. | Bioorg Med Chem 22: 406-18 (2013) | Purdue University | 2D 3D TSV |
24314880 | 60 | Purinergic receptor P2X?: a novel target for anti-inflammatory therapy. | Bioorg Med Chem 22: 54-88 (2014) | Punjabi University | 2D 3D TSV |
24314397 | 7 | Inhibition of serine and proline racemases by substrate-product analogues. | Bioorg Med Chem Lett 24: 390-3 (2013) | Dalhousie University | 2D 3D TSV |
24314394 | 40 | Sulfonamide inhibition studies of thed-carbonic anhydrase from the diatom Thalassiosira weissflogii. | Bioorg Med Chem Lett 24: 275-9 (2013) | Universit£ degli Studi di Firenze | 2D 3D TSV |
24313801 | 41 | Computer-guided approach to access the anti-influenza activity of licorice constituents. | J Nat Prod 77: 563-70 (2014) | University of Innsbruck | 2D 3D TSV |
24313754 | 43 | [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains. | J Med Chem 57: 462-76 (2014) | University of Oxford | 2D 3D TSV |
24312699 | 14 | Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents. | ACS Med Chem Lett 4: (2013) | University of California San Francisco | 2D 3D TSV |
24308675 | 2 | Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73. | J Nat Prod 76: 2298-306 (2013) | Ocean University of China | 2D 3D TSV |
24308627 | 19 | Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates. | J Med Chem 56: 9955-68 (2013) | China Pharmaceutical University | 2D 3D TSV |
24304424 | 5 | Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode. | J Med Chem 56: 9837-48 (2013) | £bo Akademi University | 2D 3D TSV |
24304387 | 48 | Structure-activity relationships of chromone derivatives toward the mechanism of interaction with and inhibition of breast cancer resistance protein ABCG2. | J Med Chem 56: 9849-60 (2013) | BMSSI UMR 5086 CNRS/Universit£ Lyon 1 | 2D 3D TSV |
24304348 | 30 | Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors. | J Med Chem 56: 9969-81 (2013) | Georgia Institute of Technology | 2D 3D TSV |
24304323 | 38 | Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain. | J Med Chem 56: 10183-7 (2013) | University of Cambridge | 2D 3D TSV |
24304238 | 22 | 8-Substituted O(6)-cyclohexylmethylguanine CDK2 inhibitors: using structure-based inhibitor design to optimize an alternative binding mode. | J Med Chem 57: 56-70 (2014) | University of Oxford | 2D 3D TSV |
24304219 | 7 | Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists. | J Med Chem 56: 10079-102 (2013) | University of Bath | 2D 3D TSV |
24304150 | 18 | Two analogues of fenarimol show curative activity in an experimental model of Chagas disease. | J Med Chem 56: 10158-70 (2013) | Epichem Pty Ltd. | 2D 3D TSV |
24300919 | 55 | Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. | Bioorg Med Chem 22: 334-40 (2014) | Universit£ degli Studi di Firenze | 2D 3D TSV |
24300918 | 9 | New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase. | Bioorg Med Chem 22: 398-405 (2013) | Universidad de Buenos Aires | 2D 3D TSV |
24300734 | 12 | Design, synthesis and evaluation of dual pharmacologyß2-adrenoceptor agonists and PDE4 inhibitors. | Bioorg Med Chem Lett 24: 249-53 (2013) | Sun Yat-sen University | 2D 3D TSV |
24299557 | 9 | The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates. | Biochemistry 52: 9347-57 (2013) | Texas A&M University | 2D 3D TSV |
24299503 | 17 | Development of 1,8-naphthalimides as clathrin inhibitors. | J Med Chem 57: 131-43 (2014) | The University of Newcastle | 2D 3D TSV |
24299463 | 26 | Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease. | J Med Chem 57: 298-308 (2014) | Instituto Militar de Engenharia | 2D 3D TSV |
24296013 | 3 | Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors. | Bioorg Med Chem 22: 358-65 (2014) | Nantong University | 2D 3D TSV |
24296012 | 19 | Synthesis and SAR study of a novel series of dopamine receptor agonists. | Bioorg Med Chem 22: 381-92 (2013) | University of Copenhagen | 2D 3D TSV |
24295787 | 5 | Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities. | Bioorg Med Chem Lett 24: 317-24 (2013) | Medical University of South Carolina | 2D 3D TSV |
24295325 | 17 | Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay. | Biochemistry 52: 9155-66 (2013) | Johns Hopkins Bloomberg School of Public Health | 2D 3D TSV |
24295046 | 1 | Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3ß inhibitors. | J Med Chem 56: 10066-78 (2013) | Universit£ di Napoli Federico II | 2D 3D TSV |
24294985 | 42 | Medicinal chemistry of inhibitors of 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1). | J Med Chem 57: 4466-86 (2014) | AstraZeneca | 2D 3D TSV |
24294969 | 2 | Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors. | J Med Chem 56: 10003-15 (2013) | Amgen Inc | 2D 3D TSV |
24294923 | 65 | Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase. | J Med Chem 56: 10132-41 (2013) | Amgen Inc | 2D 3D TSV |
24294411 | 3 | Small-Molecule Allosteric Activation of Human Glucokinase in the Absence of Glucose. | ACS Med Chem Lett 4: (2013) | Florida State University | 2D 3D TSV |
24292338 | 41 | 2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists. | Eur J Med Chem 71: 168-84 (2014) | Rhône-Poulenc Rorer | 2D 3D TSV |
24291567 | 154 | Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. | Eur J Med Chem 71: 135-47 (2014) | Medical University of Gdansk | 2D 3D TSV |
24291042 | 4 | Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs. | Bioorg Med Chem Lett 24: 302-7 (2014) | Mumbai University | 2D 3D TSV |
24291040 | 5 | Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor. | Bioorg Med Chem Lett 24: 283-7 (2014) | Sanofi R&D | 2D 3D TSV |
24290064 | 44 | Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptorß agonists. | Bioorg Med Chem 22: 488-98 (2013) | Sanwa Kagaku Kenkyusho Co., Ltd | 2D 3D TSV |
24290063 | 15 | From NMDA receptor antagonists to discovery of selectives2 receptor ligands. | Bioorg Med Chem 22: 393-7 (2013) | Universit£ di Messina | 2D 3D TSV |
24290062 | 142 | Small molecule inhibitors of anthrax lethal factor toxin. | Bioorg Med Chem 22: 419-34 (2013) | Microbiotix Inc | 2D 3D TSV |
24287560 | 61 | Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells. | Eur J Med Chem 71: 112-27 (2014) | University of Messina | 2D 3D TSV |
24287559 | 36 | Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors. | Eur J Med Chem 71: 105-11 (2014) | Universit£ di Messina | 2D 3D TSV |
24287382 | 16 | Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations. | Bioorg Med Chem Lett 24: 360-6 (2013) | AstraZeneca | 2D 3D TSV |
24286762 | 34 | Fragment based discovery of arginine isosteres through REPLACE: towards non-ATP competitive CDK inhibitors. | Bioorg Med Chem 22: 616-22 (2013) | University of South Carolina | 2D 3D TSV |
24286207 | 30 | Controlled-deactivation cannabinergic ligands. | J Med Chem 56: 10142-57 (2013) | Northeastern University | 2D 3D TSV |
24280068 | 4 | Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level. | Bioorg Med Chem 22: 623-32 (2013) | The University of Texas M.D. Anderson Cancer Center | 2D 3D TSV |
24279990 | 14 | Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. | Bioorg Med Chem Lett 24: 337-43 (2013) | Forma Therapeutics Inc | 2D 3D TSV |
24279689 | 56 | Prostanoid receptor EP2 as a therapeutic target. | J Med Chem 57: 4454-65 (2014) | Emory University | 2D 3D TSV |
24275349 | 3 | Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs. | Bioorg Med Chem 22: 633-42 (2014) | Shandong University | 2D 3D TSV |
24275248 | 6 | Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs). | Eur J Med Chem 71: 53-66 (2014) | CSIR-Indian Institute of Chemical Technology | 2D 3D TSV |
24274468 | 2 | 2-Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step toward new antiexcitotoxic agents. | J Med Chem 56: 9482-95 (2014) | Universit£ degli Studi di Parma | 2D 3D TSV |
24274400 | 28 | Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies. | J Med Chem 56: 10103-17 (2013) | Torrey Pines Institute for Molecular Studies | 2D 3D TSV |
24273637 | 17 | Homodimers of the Antiviral Abacavir as Modulators of P-glycoprotein Transport in Cell Culture: Probing Tether Length. | Medchemcomm 4: (2013) | Purdue University | 2D 3D TSV |
24269986 | 12 | Design, synthesis, molecular docking studies and in vitro screening of ethyl 4-(3-benzoylthioureido) benzoates as urease inhibitors. | Bioorg Chem 52: 1-7 (2014) | Quaid-I-Azam University, Islamabad, Pakistan. | 2D 3D TSV |
24269511 | 17 | Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors. | Eur J Med Chem 71: 1-14 (2014) | Federal University of Rio de Janeiro | 2D 3D TSV |
24269482 | 35 | Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists. | Bioorg Med Chem Lett 23: 6890-6 (2013) | GlaxoSmithKline | 2D 3D TSV |
24269480 | 22 | Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds. | Bioorg Med Chem Lett 23: 6825-8 (2013) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24269479 | 11 | (S)-4-Trimethylsilyl-3-butyn-2-ol as an auxiliary for stereocontrolled synthesis of salinosporamide analogs with modifications at positions C2 and C5. | Bioorg Med Chem Lett 23: 6905-10 (2013) | The Pennsylvania State University | 2D 3D TSV |
24269162 | 84 | NAD-based inhibitors with anticancer potential. | Bioorg Med Chem Lett 24: 332-6 (2014) | University of Minnesota | 2D 3D TSV |
24269123 | 1 | Evaluation of benzoic acid derivatives as sirtuin inhibitors. | Bioorg Med Chem Lett 24: 349-52 (2013) | San Francisco State University | 2D 3D TSV |
24268551 | 28 | Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition. | Bioorg Med Chem Lett 23: 6580-4 (2013) | Kinki University | 2D 3D TSV |
24266880 | 12 | Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B. | J Med Chem 57: 2121-35 (2014) | PTC Therapeutics, Inc. | 2D 3D TSV |
24266771 | 3 | Bisphenol A binds to Ras proteins and competes with guanine nucleotide exchange: implications for GTPase-selective antagonists. | J Med Chem 56: 9664-72 (2014) | Ruhr University of Bochum | 2D 3D TSV |
24266709 | 1 | Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes. | J Med Chem 56: 9737-55 (2014) | Actelion Pharmaceuticals Ltd | 2D 3D TSV |
24262888 | 105 | The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, ? opioid receptor agonists. | Bioorg Med Chem 21: 7628-47 (2013) | Kitasato University | 2D 3D TSV |
24262887 | 11 | Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1). | Bioorg Med Chem 21: 7595-603 (2013) | University of Auckland | 2D 3D TSV |
24262886 | 23 | Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase¿ inhibitor for the treatment of inflammatory diseases. | Bioorg Med Chem 21: 7578-83 (2013) | Taisho Pharmaceutical Co., Ltd | 2D 3D TSV |
24262884 | 22 | Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor. | Bioorg Med Chem 21: 7604-11 (2013) | Universidad de Chile | 2D 3D TSV |
24262883 | 46 | Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors. | Bioorg Med Chem 21: 7715-23 (2013) | Shandong University | 2D 3D TSV |
24262882 | 15 | Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT. | Bioorg Med Chem 21: 7562-9 (2013) | Medical University of Vienna | 2D 3D TSV |
24261937 | 6 | Protease inhibitors from Microcystis aeruginosa bloom material collected from the Dalton Reservoir, Israel. | J Nat Prod 76: 2307-15 (2013) | Tel-Aviv University | 2D 3D TSV |
24261862 | 23 | Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease. | J Med Chem 56: 9934-54 (2013) | BioFocus | 2D 3D TSV |
24257746 | 6 | A L-lysine transporter of high stereoselectivity of the amino acid-polyamine-organocation (APC) superfamily: production, functional characterization, and structure modeling. | J Biol Chem 289: 1377-87 (2014) | Max Planck Institute of Biophysics | 2D 3D TSV |
24256330 | 8 | Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC). | J Med Chem 57: 3651-65 (2014) | University of Texas Medical Branch | 2D 3D TSV |
24256217 | 177 | Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1). | J Med Chem 56: 10045-65 (2013) | The Institute of Cancer Research | 2D 3D TSV |
24252546 | 9 | SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists. | Bioorg Med Chem Lett 23: 6569-76 (2013) | Asahi Kasei Pharma Corporation | 2D 3D TSV |
24252545 | 12 | Discovery of an irreversible HCV NS5B polymerase inhibitor. | Bioorg Med Chem Lett 23: 6585-7 (2013) | Merck Research Laboratories | 2D 3D TSV |
24251446 | 21 | Lipoamide channel-binding sulfonamides selectively inhibit mycobacterial lipoamide dehydrogenase. | Biochemistry 52: 9375-84 (2013) | Weill Cornell Medical College | 2D 3D TSV |
24251366 | 78 | Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists. | J Med Chem 56: 9612-22 (2014) | Universit£ du Qu£bec | 2D 3D TSV |
24247003 | 25 | Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors. | Bioorg Med Chem 21: 7752-62 (2013) | Shandong University | 2D 3D TSV |
24246730 | 34 | Design and synthesis of potent and selective P2X3 receptor antagonists derived from PPADS as potential pain modulators. | Eur J Med Chem 70: 811-30 (2013) | Gwangju Institute of Science and Technology (GIST) | 2D 3D TSV |
24239625 | 10 | Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities. | Eur J Med Chem 70: 781-8 (2013) | Instituto de Qu£mica M£dica (CSIC) | 2D 3D TSV |
24239482 | 9 | Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia. | Bioorg Med Chem Lett 23: 6588-92 (2013) | Pfizer Inc | 2D 3D TSV |
24239481 | 3 | Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. | Bioorg Med Chem Lett 23: 6593-7 (2013) | Shandong University | 2D 3D TSV |
24239189 | 85 | Substituted phenyl as a steroid A-ring mimetic: providing agonist activity to a class of arylsulfonamide nonsteroidal glucocorticoid ligands. | Bioorg Med Chem Lett 23: 6645-9 (2013) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
24239188 | 63 | Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors. | Bioorg Med Chem Lett 23: 6610-5 (2013) | Hoffmann-La Roche Inc | 2D 3D TSV |
24239186 | 84 | Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc. | Bioorg Med Chem Lett 23: 6604-9 (2013) | Genentech | 2D 3D TSV |
24239017 | 15 | Design, synthesis and biological evaluation of ?-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors. | Bioorg Med Chem Lett 23: 6598-603 (2013) | Biota Holdings Ltd | 2D 3D TSV |
24238902 | 12 | Design and synthesis of novel benzimidazole derivatives as phosphodiesterase 10A inhibitors with reduced CYP1A2 inhibition. | Bioorg Med Chem 21: 7612-23 (2013) | Astellas Pharma Inc | 2D 3D TSV |
24238901 | 2 | The synthesis and biodistribution of [(11)C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo. | Bioorg Med Chem 21: 7584-90 (2013) | RIKEN Center for Life Science Technologies | 2D 3D TSV |
24237195 | 46 | High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors. | J Med Chem 56: 9496-508 (2014) | University of Utah | 2D 3D TSV |
24237160 | 52 | Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites. | J Med Chem 56: 9709-24 (2013) | National Institute on Drug Abuse-Intramural Research Program | 2D 3D TSV |
24237039 | 6 | 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant. | J Med Chem 56: 9265-74 (2013) | Universitat de Barcelona | 2D 3D TSV |
24231650 | 2 | Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection. | Bioorg Med Chem 21: 7763-78 (2013) | University of Groningen | 2D 3D TSV |
24231362 | 13 | Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors. | Bioorg Med Chem Lett 23: 6747-54 (2013) | Glenmark Pharmaceuticals Limited | 2D 3D TSV |
24231308 | 80 | Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors. | Eur J Med Chem 70: 723-39 (2013) | Universit£ degli Studi di Bari "Aldo Moro" | 2D 3D TSV |
24228714 | 64 | MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential. | J Med Chem 57: 3161-85 (2014) | The German University in Cairo | 2D 3D TSV |
24225950 | 7 | Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor. | J Biol Chem 289: 942-55 (2014) | Genentech Inc | 2D 3D TSV |
24224843 | 11 | Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity. | J Nat Prod 76: 2080-7 (2013) | Chosun University | 2D 3D TSV |
24224763 | 51 | Removal of human ether-à-go-go related gene (hERG) K+ channel affinity through rigidity: a case of clofilium analogues. | J Med Chem 56: 9427-40 (2013) | Leiden University | 2D 3D TSV |
24224729 | 4 | Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism. | J Med Chem 57: 1964-75 (2014) | GlaxoSmithKline Research & Development | 2D 3D TSV |
24224654 | 6 | Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds. | J Med Chem 56: 9789-801 (2014) | Pharma Research and Early | 2D 3D TSV |
24224573 | 31 | Optimization of O3-acyl kojic acid derivatives as potent and selective human neutrophil elastase inhibitors. | J Med Chem 56: 9802-6 (2014) | Universidade de Lisboa | 2D 3D TSV |
24220173 | 37 | Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors. | Bioorg Med Chem Lett 23: 6663-6 (2013) | Charles University in Prague | 2D 3D TSV |
24220172 | 25 | Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity. | Bioorg Med Chem Lett 23: 6737-42 (2013) | Sun Yat-sen University | 2D 3D TSV |
24220171 | 5 | Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration. | Bioorg Med Chem Lett 23: 6673-6 (2013) | Medical University of Lodz | 2D 3D TSV |
24220170 | 8 | In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers. | Bioorg Med Chem Lett 23: 6656-62 (2013) | Kyung Hee University | 2D 3D TSV |
24219778 | 139 | Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. | J Med Chem 56: 9693-700 (2014) | Eshelman School of Pharmacy�Department of Pharmacology�Lineberger Compreh | 2D 3D TSV |
24216094 | 89 | Isoquinoline derivatives as potent CRTH2 antagonists: design, synthesis and SAR. | Bioorg Med Chem 21: 7674-85 (2013) | Taisho Pharmaceutical Co., Ltd | 2D 3D TSV |
24216091 | 24 | Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors. | Bioorg Med Chem 21: 7686-98 (2013) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24215892 | 34 | Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs). | Bioorg Med Chem Lett 23: 6620-4 (2013) | Merck Research Laboratories | 2D 3D TSV |
24215891 | 107 | Function-regulating pharmacophores in a sulfonamide class of glucocorticoid receptor agonists. | Bioorg Med Chem Lett 23: 6640-4 (2013) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
24215890 | 1 | Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells. | Bioorg Med Chem Lett 23: 6721-7 (2013) | MNR Degree & PG College | 2D 3D TSV |
24215889 | 21 | Metabolism-guided discovery of a potent and orally bioavailable urea-based calcimimetic for the treatment of secondary hyperparathyroidism. | Bioorg Med Chem Lett 23: 6625-8 (2013) | Amgen Inc | 2D 3D TSV |
24215819 | 17 | Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors. | Eur J Med Chem 70: 685-91 (2013) | COMSATS Institute of Information Technology | 2D 3D TSV |
24215352 | 9 | Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins. | J Med Chem 56: 9635-45 (2014) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24211642 | 49 | Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins. | Eur J Med Chem 70: 661-8 (2013) | Universit£ Pierre et Marie Curie | 2D 3D TSV |
24211641 | 3 | An efficient approach to novel 17-5'-(1',2',4')-oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17a-hydroxylase/C17,20-lyase. | Eur J Med Chem 70: 649-60 (2013) | University of Szeged | 2D 3D TSV |
24211638 | 28 | Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. | Eur J Med Chem 70: 623-30 (2013) | Kerman University of Medical Sciences | 2D 3D TSV |
24211637 | 1 | Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors. | Eur J Med Chem 70: 613-22 (2013) | Sun Yat-sen University | 2D 3D TSV |
24211633 | 14 | Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-? based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation. | Eur J Med Chem 70: 579-88 (2013) | Jamia Hamdard (Hamdard University) | 2D 3D TSV |
24211162 | 55 | Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice. | Bioorg Med Chem 21: 7724-34 (2013) | Xenon Pharmaceuticals Inc | 2D 3D TSV |
24211020 | 35 | Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands. | Bioorg Med Chem Lett 23: 6920-6922 (2013) | University of Maryland | 2D 3D TSV |
24210504 | 106 | Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors. | Bioorg Med Chem Lett 23: 6711-6 (2013) | Korea Research Institute of Chemical Technology | 2D 3D TSV |
24210501 | 1 | Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain. | Bioorg Med Chem Lett 23: 6700-5 (2013) | Chonbuk National University | 2D 3D TSV |
24210500 | 3 | Anion inhibition studies of aß-carbonic anhydrase from Clostridium perfringens. | Bioorg Med Chem Lett 23: 6706-10 (2013) | Universit£ degli Studi di Firenze | 2D 3D TSV |
24205976 | 2 | Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112). | J Med Chem 56: 9019-30 (2013) | Janssen Pharmaceutical Companies of Johnson & Johnson L.L.C. | 2D 3D TSV |
24200932 | 2 | Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates. | Bioorg Med Chem 21: 7742-51 (2013) | China Pharmaceutical University | 2D 3D TSV |
24200808 | 6 | Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells. | Bioorg Med Chem Lett 23: 6923-7 (2013) | Universit£ di Pisa | 2D 3D TSV |
24200193 | 32 | Characterization of a novela-conotoxin TxID from Conus textile that potently blocks rata3ß4 nicotinic acetylcholine receptors. | J Med Chem 56: 9655-63 (2014) | Hainan University | 2D 3D TSV |
24200125 | 135 | A prodrug approach toward cancer-related carbonic anhydrase inhibition. | J Med Chem 56: 9623-34 (2013) | Griffith University | 2D 3D TSV |
24195776 | 67 | Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin. | J Med Chem 56: 9542-55 (2014) | University of Auckland | 2D 3D TSV |
24195762 | 135 | Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors. | J Med Chem 56: 9683-92 (2014) | University of North Carolina at Chapel Hill | 2D 3D TSV |
24195668 | 57 | Aurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells. | J Med Chem 56: 9122-35 (2013) | The Institute of Cancer Research | 2D 3D TSV |
24194520 | 5 | Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis. | J Biol Chem 289: 423-36 (2014) | Universidade Federal do Rio de Janeiro | 2D 3D TSV |
24194519 | 15 | Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates. | J Biol Chem 288: 36636-47 (2013) | University of Otago Christchurch | 2D 3D TSV |
24194515 | 1 | Insights into distinct modulation of a7 and a7ß2 nicotinic acetylcholine receptors by the volatile anesthetic isoflurane. | J Biol Chem 288: 35793-800 (2013) | University of Pittsburgh | 2D 3D TSV |
24189496 | 67 | 8-(2-Furyl)adenine derivatives as A?A adenosine receptor ligands. | Eur J Med Chem 70: 525-35 (2013) | University of Camerino | 2D 3D TSV |
24189186 | 3 | Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists. | Bioorg Med Chem 21: 7841-52 (2013) | Astellas Pharma Inc | 2D 3D TSV |
24189056 | 64 | Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors. | Bioorg Med Chem Lett 23: 6759-63 (2013) | Sapienza University of Rome | 2D 3D TSV |
24189054 | 2 | PDE2 inhibition: potential for the treatment of cognitive disorders. | Bioorg Med Chem Lett 23: 6522-7 (2013) | Dart Neuroscience LLC | 2D 3D TSV |
24188023 | 32 | Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3. | J Med Chem 56: 9556-68 (2014) | Ume£ University | 2D 3D TSV |
24188002 | 41 | Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity. | J Med Chem 56: 9569-85 (2014) | UPR 2301, CNRS | 2D 3D TSV |
24187998 | 96 | Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists. | J Med Chem 56: 9673-82 (2014) | University of Copenhagen | 2D 3D TSV |
24187139 | 9 | Defining the communication between agonist and coactivator binding in the retinoid X receptor a ligand binding domain. | J Biol Chem 289: 814-26 (2014) | University of Alabama at Birmingham | 2D 3D TSV |
24185379 | 28 | Solution-phase microwave assisted parallel synthesis of N,N'-disubstituted thioureas derived from benzoic acid: biological evaluation and molecular docking studies. | Eur J Med Chem 70: 487-96 (2013) | Quaid-i-Azam University | 2D 3D TSV |
24185377 | 6 | Design, synthesis and molecular modelling studies of novel 3-acetamido-4-methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B. | Eur J Med Chem 70: 469-76 (2013) | School of Pharmaceutical Sciences | 2D 3D TSV |
24185375 | 76 | Synthesis, structure-activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents. | Eur J Med Chem 70: 447-55 (2013) | University of Nottingham | 2D 3D TSV |
24184776 | 19 | Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors. | Eur J Med Chem 70: 427-33 (2013) | Nanjing University | 2D 3D TSV |
24184213 | 71 | Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2). | Bioorg Med Chem 21: 7858-73 (2013) | University of Bonn | 2D 3D TSV |
24184076 | 1 | Recycling antimalarial leads for cancer: Antiproliferative properties of N-cinnamoyl chloroquine analogues. | Bioorg Med Chem Lett 23: 6769-72 (2013) | Centro de Investiga££o em Qu£mica da Universidade do Porto | 2D 3D TSV |
24183742 | 40 | Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor. | Bioorg Med Chem 21: 7988-98 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
24183741 | 20 | Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests. | Bioorg Med Chem 21: 7981-7 (2013) | Universit£ de Lyon | 2D 3D TSV |
24183739 | 6 | Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1. | Bioorg Med Chem 21: 7874-83 (2013) | Goethe-University Frankfurt | 2D 3D TSV |
24183588 | 1 | Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chromen-4-one. | Bioorg Med Chem 21: 7816-29 (2013) | Universit£ de Montr£al | 2D 3D TSV |
24183538 | 19 | Novel Mps1 kinase inhibitors: from purine to pyrrolopyrimidine and quinazoline leads. | Bioorg Med Chem Lett 23: 6829-33 (2013) | Myrexis Inc | 2D 3D TSV |
24182233 | 57 | Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic properties. | J Med Chem 56: 9586-600 (2014) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24177367 | 6 | Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors. | Eur J Med Chem 70: 400-10 (2013) | National University of Singapore | 2D 3D TSV |
24177366 | 3 | Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening. | Eur J Med Chem 70: 393-9 (2013) | Blood Transfusion Centre of Slovenia | 2D 3D TSV |
24176400 | 78 | Synthesis of novel 7-substituted pyrido[2',3':4,5]furo[3,2-d]pyrimidin-4-amines and their N-aryl analogues and evaluation of their inhibitory activity against Ser/Thr kinases. | Bioorg Med Chem Lett 23: 6784-8 (2013) | COBRA | 2D 3D TSV |
24176396 | 41 | The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors. | Bioorg Med Chem Lett 23: 6777-83 (2013) | Jiangsu Simcere Pharmaceutical Co. Ltd | 2D 3D TSV |
24176395 | 30 | 2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3ß inhibitors. | Bioorg Med Chem Lett 23: 6933-7 (2013) | Mitsubishi Tanabe Pharma Corporation | 2D 3D TSV |
24175626 | 17 | Identification of CB1/CB2 ligands from Zanthoxylum bungeanum. | J Nat Prod 76: 2060-4 (2013) | National Institute on Aging | 2D 3D TSV |
24175584 | 35 | 5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor. | J Med Chem 56: 9441-56 (2014) | Sanofi-Aventis R&D | 2D 3D TSV |
24175572 | 1 | 6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compounds. | J Med Chem 56: 9874-96 (2013) | F. Hoffmann-La Roche Inc | 2D 3D TSV |
24171552 | 52 | Expanding the Scope of Human DNA Polymerase ¿ and ß Inhibitors. | ACS Chem Biol 9: 282-90 (2014) | University of Konstanz | 2D 3D TSV |
24171493 | 95 | Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo. | J Med Chem 56: 9031-44 (2013) | Goethe-University Frankfurt | 2D 3D TSV |
24171478 | 4 | Structure-activity relationship study of permethyl ningalin B analogues as P-glycoprotein chemosensitizers. | J Med Chem 56: 9057-70 (2013) | Ocean University of China | 2D 3D TSV |
24171469 | 78 | Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor. | J Med Chem 56: 9045-56 (2013) | National Institutes of Health | 2D 3D TSV |
24169316 | 46 | Chromenylchalcones with inhibitory effects on monoamine oxidase B. | Bioorg Med Chem 21: 7890-7 (2013) | Konkuk University | 2D 3D TSV |
24169315 | 9 | Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells. | Bioorg Med Chem 21: 7938-54 (2013) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24167659 | 15 | Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 Receptor. | ACS Med Chem Lett 4: (2013) | State University of New York | 2D 3D TSV |
24165164 | 9 | Beyond topoisomerase inhibition: antitumor 1,4-naphthoquinones as potential inhibitors of human monoamine oxidase. | Chem Biol Drug Des 83: 401-10 (2014) | Federal University of Rio de Janeiro | 2D 3D TSV |
24164966 | 16 | Identification of type II inhibitors targeting BRAF using privileged pharmacophores. | Chem Biol Drug Des 83: 27-36 (2014) | Shanghai Institute of Pharmaceutical Industry, 1111 Zhongshan North One Road, Hongkou District, Shanghai, 200437, China | 2D 3D TSV |
24164628 | 186 | Adenosine A2A receptor as a drug discovery target. | J Med Chem 57: 3623-50 (2014) | Merck Research Laboratories | 2D 3D TSV |
24164599 | 9 | Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375). | J Med Chem 56: 9351-5 (2013) | Vanderbilt University | 2D 3D TSV |
24164581 | 82 | Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist. | J Med Chem 56: 9275-95 (2013) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24164513 | 9 | Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors. | J Med Chem 56: 9310-27 (2013) | The City University of New York | 2D 3D TSV |
24164245 | 11 | Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp. | J Nat Prod 76: 2026-33 (2013) | University of Connecticut | 2D 3D TSV |
24164086 | 17 | Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship. | J Med Chem 56: 9071-88 (2013) | Topotarget A/S | 2D 3D TSV |
24161834 | 17 | The discovery of the benzazepine class of histamine H3 receptor antagonists. | Bioorg Med Chem Lett 23: 6897-901 (2013) | GlaxoSmithKline | 2D 3D TSV |
24161678 | 9 | Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging ofs2 receptors. | Eur J Med Chem 69: 920-30 (2013) | Universit£ degli Studi di Bari Aldo Moro | 2D 3D TSV |
24160350 | 4 | Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors. | J Med Chem 56: 9361-5 (2013) | Friedrich-Alexander University | 2D 3D TSV |
24160297 | 37 | Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen. | J Med Chem 56: 9089-99 (2013) | Sun Yat-sen University | 2D 3D TSV |
24160253 | 14 | Design and synthesis of P1-P3 macrocyclic tertiary-alcohol-comprising HIV-1 protease inhibitors. | J Med Chem 56: 8999-9007 (2013) | Uppsala University | 2D 3D TSV |
24158442 | 40 | Transition state analogues of Plasmodium falciparum and human orotate phosphoribosyltransferases. | J Biol Chem 288: 34746-54 (2013) | Albert Einstein College of Medicine | 2D 3D TSV |
24158015 | 15 | A stereoselective approach to peptidomimetic BACE1 inhibitors. | Eur J Med Chem 70: 233-47 (2013) | University of Siena | 2D 3D TSV |
24158012 | 3 | Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model. | Eur J Med Chem 70: 189-98 (2013) | Universidad de Granada | 2D 3D TSV |
24157370 | 22 | The sulfamide moiety affords higher inhibitory activity and oral bioavailability to a series of coumarin dual selective RAF/MEK inhibitors. | Bioorg Med Chem Lett 23: 6223-7 (2013) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
24157369 | 3 | Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699. | Bioorg Med Chem Lett 23: 6243-7 (2013) | Molecular NeuroImaging LLC | 2D 3D TSV |
24157367 | 7 | Cytidine derivatives as IspF inhibitors of Burkolderia pseudomallei. | Bioorg Med Chem Lett 23: 6860-3 (2013) | Northern Illinois University | 2D 3D TSV |
24157366 | 46 | Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors. | Bioorg Med Chem Lett 23: 6228-33 (2013) | Merck Research Laboratories | 2D 3D TSV |
24157365 | 23 | Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists. | Bioorg Med Chem Lett 23: 6239-42 (2013) | Pfizer Inc | 2D 3D TSV |
24156938 | 12 | The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents. | Bioorg Med Chem 21: 7283-308 (2013) | University of Bonn | 2D 3D TSV |
24156012 | 42 | Synthesis and | Medchemcomm 4: 1283-1289 (2013) | Washington University School of Medicine | 2D 3D TSV |
24153396 | 97 | Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes. | Bioorg Med Chem 21: 7418-29 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
24153205 | 21 | 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogs. | Bioorg Med Chem Lett 23: 6773-6 (2013) | Janssen Research and Development LLC | 2D 3D TSV |
24152295 | 12 | Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of a/ß-hydrolase domain containing 6 (ABHD6). | Cell Chem Biol 56: 8270-9 (2013) | The Scripps Research Institute | 2D 3D TSV |
24148993 | 4 | Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. | Eur J Med Chem 70: 165-88 (2013) | Punjabi University | 2D 3D TSV |
24148992 | 60 | Novel state-dependent voltage-gated sodium channel modulators, based on marine alkaloids from Agelas sponges. | Eur J Med Chem 70: 154-64 (2013) | University of Ljubljana | 2D 3D TSV |
24148991 | 5 | Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors. | Eur J Med Chem 70: 143-53 (2013) | Birla Institute of Technology | 2D 3D TSV |
24148835 | 41 | Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents. | Bioorg Med Chem 21: 7275-82 (2013) | Henan University | 2D 3D TSV |
24148325 | 8 | Discovery of novel PTP1B inhibitors via pharmacophore-oriented scaffold hopping from Ertiprotafib. | Bioorg Med Chem Lett 23: 6217-22 (2013) | Chinese Academy of Medical Sciences and Peking Union Medical College | 2D 3D TSV |
24147864 | 6 | Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1). | J Med Chem 56: 9146-55 (2013) | National Institute of Mental Health | 2D 3D TSV |
24147825 | 22 | 2'-Deoxyuridine 5'-monophosphate substrate displacement in thymidylate synthase through 6-hydroxy-2H-naphtho[1,8-bc]furan-2-one derivatives. | J Med Chem 56: 9356-60 (2013) | University of Modena and Reggio Emilia | 2D 3D TSV |
24147804 | 17 | Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach. | J Med Chem 56: 9242-50 (2013) | Vanderbilt University School of Medicine | 2D 3D TSV |
24145137 | 90 | The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs. | Bioorg Med Chem 21: 7309-29 (2013) | University of Bonn | 2D 3D TSV |
24144854 | 9 | Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors. | Bioorg Med Chem Lett 23: 6264-8 (2013) | Nanjing University | 2D 3D TSV |
24144853 | 3 | Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17ß-hydroxysteroid dehydrogenase type 3. | Bioorg Med Chem Lett 23: 6360-2 (2013) | Laval University | 2D 3D TSV |
24144851 | 24 | The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD. | Bioorg Med Chem Lett 23: 6248-53 (2013) | AstraZeneca | 2D 3D TSV |
24144848 | 1 | Anti-cancer evaluation of carboxamides of furano-sesquiterpene carboxylic acids from the soft coral Sinularia kavarattiensis. | Bioorg Med Chem Lett 23: 6234-8 (2013) | CSIR-IICT | 2D 3D TSV |
24144404 | 36 | 4?-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4?-methyl-5-(3-hydroxyphenyl)morphan pure antagonist. | J Med Chem 56: 8826-33 (2013) | Research Triangle Institute | 2D 3D TSV |
24144283 | 100 | Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains. | J Med Chem 56: 9251-64 (2013) | Icahn School of Medicine at Mount Sinai | 2D 3D TSV |
24144240 | 70 | Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity. | J Med Chem 56: 9156-69 (2013) | Virginia Commonwealth University | 2D 3D TSV |
24141201 | 8 | Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity. | Eur J Med Chem 70: 111-9 (2013) | Instituto de Qu£mica M£dica | 2D 3D TSV |
24140951 | 19 | Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases. | Eur J Med Chem 70: 88-101 (2013) | University of Padova | 2D 3D TSV |
24140950 | 6 | Design, synthesis and receptor affinity of novel conformationally restricteds ligands based on the [4.3.3]propellane scaffold. | Eur J Med Chem 70: 78-87 (2013) | Institut f£r Pharmazeutische und Medizinische Chemie der Westf£lischen Wilhelms-Universit£t M£nster | 2D 3D TSV |
24140447 | 18 | Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: high affinity and human/rat species-selective histamine H(3) receptor antagonists. | Bioorg Med Chem Lett 23: 6415-20 (2013) | Osaka University of Pharmaceutical Sciences | 2D 3D TSV |
24140446 | 62 | GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy. | Bioorg Med Chem Lett 23: 6463-6 (2013) | Centro de Investigaci�n Lilly | 2D 3D TSV |
24140444 | 30 | Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer's disease. | Bioorg Med Chem Lett 23: 6254-8 (2013) | Alma Mater Studiorum University of Bologna | 2D 3D TSV |
24139940 | 5 | Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker. | Bioorg Med Chem 21: 7381-91 (2013) | The University of Tokyo | 2D 3D TSV |
24139843 | 38 | Development of fluorinated CB(2) receptor agonists for PET studies. | Bioorg Med Chem 21: 7481-98 (2013) | Institut f£r Pharmazeutische und Medizinische Chemie der Universit£t M£nster | 2D 3D TSV |
24139584 | 17 | Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)phenyl] amide as histamine H(3) receptor antagonist for the treatment of depression. | Bioorg Med Chem Lett 23: 6269-73 (2013) | Sanofi US | 2D 3D TSV |
24139583 | 21 | Discovery of 2-methylpyridine-based biaryl amides as¿-secretase modulators for the treatment of Alzheimer's disease. | Bioorg Med Chem Lett 23: 6447-54 (2013) | Amgen Inc | 2D 3D TSV |
24139169 | 175 | Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases. | Bioorg Med Chem 21: 7364-80 (2013) | Nerviano Medical Sciences | 2D 3D TSV |
24139167 | 419 | 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. | Bioorg Med Chem 21: 7435-52 (2013) | University of Bonn | 2D 3D TSV |
24138940 | 34 | Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK). | Bioorg Med Chem Lett 23: 6331-5 (2013) | Evotec (UK) Ltd | 2D 3D TSV |
24138939 | 112 | Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors. | Bioorg Med Chem Lett 23: 6363-9 (2013) | Janssen Research and Development LLC | 2D 3D TSV |
24138311 | 25 | A structure-activity analysis of biased agonism at the dopamine D2 receptor. | J Med Chem 56: 9199-221 (2013) | Monash University (Parkville Campus) | 2D 3D TSV |
24135727 | 7 | Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors. | Bioorg Med Chem Lett 23: 6325-30 (2013) | Emory University | 2D 3D TSV |
24135724 | 73 | Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist. | Bioorg Med Chem Lett 23: 6346-9 (2013) | The Scripps Research Institute | 2D 3D TSV |
24134904 | 2 | Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs. | Bioorg Med Chem 21: 7398-405 (2013) | Shandong University | 2D 3D TSV |
24133210 | 8 | Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption. | J Biol Chem 288: 35346-57 (2013) | Western University | 2D 3D TSV |
24133207 | 44 | Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation. | J Biol Chem 288: 34777-90 (2013) | National Institutes of Health | 2D 3D TSV |
24131448 | 7 | Oxidative stress in Alzheimer's disease: are we connecting the dots? | J Med Chem 57: 2821-31 (2014) | University of Bologna | 2D 3D TSV |
24131420 | 33 | Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity. | J Med Chem 56: 8892-902 (2013) | Pontifical Catholic University of Rio Grande do Sul | 2D 3D TSV |
24131218 | 112 | Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole blood. | J Med Chem 56: 8561-78 (2013) | Eberhard-Karls-University T£bingen | 2D 3D TSV |
24131202 | 6 | Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold. | J Med Chem 56: 8736-45 (2013) | University of Copenhagen | 2D 3D TSV |
24131029 | 90 | Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration. | J Med Chem 56: 8543-60 (2013) | Zhengzhou University | 2D 3D TSV |
24129576 | 4 | High accuracy in silico sulfotransferase models. | J Biol Chem 288: 34494-501 (2013) | Albert Einstein College of Medicine | 2D 3D TSV |
24128816 | 10 | Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities. | Bioorg Med Chem 21: 7529-38 (2013) | University of Southampton | 2D 3D TSV |
24128815 | 4 | Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease. | Bioorg Med Chem 21: 7430-4 (2013) | Wayne State University | 2D 3D TSV |
24128814 | 38 | Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids. | Bioorg Med Chem 21: 7406-17 (2013) | Sun Yat-sen University | 2D 3D TSV |
24128813 | 8 | Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor. | Bioorg Med Chem 21: 7523-8 (2013) | Universit£ degli Studi di Modena e Reggio Emilia | 2D 3D TSV |
24128660 | 6 | Design, synthesis and binding affinity of acetylcholine carbamoyl analogues. | Bioorg Med Chem Lett 23: 6481-5 (2013) | Universit£ di Milano | 2D 3D TSV |
24128000 | 60 | Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates. | J Med Chem 56: 8512-20 (2013) | Ecole Nationale Sup£rieure de Chimie de Montpellier | 2D 3D TSV |
24127873 | 12 | Targeting botulinum A cellular toxicity: a prodrug approach. | J Med Chem 56: 7870-9 (2013) | The Scripps Research Institute | 2D 3D TSV |
24126916 | 31 | Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide. | J Biol Chem 288: 33894-911 (2013) | Rudjer Boskovic Institute | 2D 3D TSV |
24125888 | 2 | Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. | Bioorg Med Chem Lett 23: 6317-20 (2013) | Kansas State University | 2D 3D TSV |
24125886 | 40 | Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators. | Bioorg Med Chem Lett 23: 6370-6 (2013) | Merz Pharmaceuticals GmbH | 2D 3D TSV |
24125885 | 2 | Targeting the hydrophobic region of Hsp90's ATP binding pocket with novel 1,3,5-triazines. | Bioorg Med Chem Lett 23: 6427-31 (2013) | Kyungpook National University | 2D 3D TSV |
24125884 | 19 | Modulators of the Sphingosine 1-phosphate receptor 1. | Bioorg Med Chem Lett 23: 6377-89 (2013) | The Scripps Research Institute | 2D 3D TSV |
24125851 | 48 | Novel acetamidothiazole derivatives: synthesis and in vitro anticancer evaluation. | Eur J Med Chem 69: 908-19 (2013) | University of Mansoura | 2D 3D TSV |
24125850 | 89 | Mastering tricyclic ring systems for desirable functional cannabinoid activity. | Eur J Med Chem 69: 881-907 (2013) | The University of Montana | 2D 3D TSV |
24124919 | 101 | 6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach. | J Med Chem 56: 8588-98 (2013) | "Sapienza" Universit£ di Roma | 2D 3D TSV |
24124898 | 26 | Design, synthesis, and biological evaluation of 2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidinyl derivatives as new irreversible epidermal growth factor receptor inhibitors with improved pharmacokinetic properties. | J Med Chem 56: 8803-13 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
24121503 | 231 | Chemotype-selective modes of action of ¿-opioid receptor agonists. | J Biol Chem 288: 34470-83 (2013) | University of North Carolina | 2D 3D TSV |
24121234 | 26 | Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer. | Eur J Med Chem 69: 833-41 (2013) | Qilu Pharmaceutical Co. Ltd | 2D 3D TSV |
24120542 | 90 | The optimization of aminooxadiazoles as orally active inhibitors of Cdc7. | Bioorg Med Chem Lett 23: 6396-400 (2013) | Amgen Inc | 2D 3D TSV |
24120540 | 44 | Identification of 2-aminooxazole amides as acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) inhibitors through scaffold hopping strategy. | Bioorg Med Chem Lett 23: 6410-4 (2013) | Merck Research Laboratories | 2D 3D TSV |
24119869 | 9 | Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. | Eur J Med Chem 74: 717-25 (2014) | Anhui Medical University | 2D 3D TSV |
24119557 | 27 | 3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors. | Bioorg Med Chem Lett 23: 6442-6 (2013) | Amakem N.V. | 2D 3D TSV |
24119555 | 13 | Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors. | Bioorg Med Chem Lett 23: 6432-5 (2013) | Central South University | 2D 3D TSV |
24119554 | 52 | GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain models. | Bioorg Med Chem Lett 23: 6459-62 (2013) | Centro de Investigaci�n Lilly | 2D 3D TSV |
24119448 | 3 | Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs. | Bioorg Med Chem 21: 7091-100 (2013) | Shandong University | 2D 3D TSV |
24119291 | 26 | Design, synthesis and biological evaluation of pazopanib derivatives as antitumor agents. | Chem Biol Drug Des 83: 306-16 (2014) | Shandong Institute of Pharmaceutical Industry, Ji'nan, Shandong, 250101, China. | 2D 3D TSV |
24119242 | 17 | Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents. | Chem Biol Drug Des 83: 297-305 (2014) | Institute of Traditional Chinese Medicine, Chengde Medical University, Chengde, 067000, China | 2D 3D TSV |
24116873 | 16 | Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. | J Med Chem 56: 7880-9 (2013) | University of Oulu | 2D 3D TSV |
24114842 | 25 | The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity. | J Biol Chem 288: 34181-9 (2013) | Soochow University | 2D 3D TSV |
24113240 | 4 | Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists. | Bioorg Med Chem 21: 7134-45 (2013) | University of Oslo | 2D 3D TSV |
24113239 | 26 | 5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2. | Bioorg Med Chem 21: 6868-77 (2013) | University of Nottingham | 2D 3D TSV |
24113238 | 5 | Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors. | Bioorg Med Chem 21: 6893-909 (2013) | Shiraz University of Medical Sciences | 2D 3D TSV |
24113062 | 17 | Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase). | Bioorg Med Chem Lett 23: 6060-3 (2013) | McMaster University | 2D 3D TSV |
24112084 | 6 | The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities. | J Nat Prod 76: 1889-95 (2013) | Drexel University College of Medicine | 2D 3D TSV |
24112024 | 7 | Fragment-based identification of a locus in the Sec7 domain of Arno for the design of protein-protein interaction inhibitors. | J Med Chem 56: 8497-511 (2013) | University of Montpellier | 2D 3D TSV |
24111942 | 3 | Tumor-targeting with novel non-benzoyl 6-substituted straight chain pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor a and inhibition of de novo purine nucleotide biosynthesis. | J Med Chem 56: 8684-95 (2013) | Duquesne University | 2D 3D TSV |
24108128 | 2 | Structural basis for the recognition of mycolic acid precursors by KasA, a condensing enzyme and drug target from Mycobacterium tuberculosis. | J Biol Chem 288: 34190-204 (2013) | University of Wuerzburg | 2D 3D TSV |
24107104 | 37 | Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors. | J Med Chem 56: 8872-8 (2013) | Harvard Medical School | 2D 3D TSV |
24107081 | 17 | Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis. | J Med Chem 56: 8533-42 (2013) | AstraZeneca India Pvt. Ltd. | 2D 3D TSV |
24103580 | 36 | Novel 6?-acylaminomorphinans with analgesic activity. | Eur J Med Chem 69: 786-9 (2013) | Semmelweis University | 2D 3D TSV |
24103430 | 78 | Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties. | Bioorg Med Chem 21: 6929-36 (2013) | Universit£ degli Studi di Firenze | 2D 3D TSV |
24103428 | 271 | Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII. | Bioorg Med Chem 21: 6937-47 (2013) | Vilnius University | 2D 3D TSV |
24102612 | 105 | Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity. | J Med Chem 56: 8696-711 (2013) | University of Bari "Aldo Moro" | 2D 3D TSV |
24102193 | 17 | Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A). | J Med Chem 56: 8781-92 (2013) | Amgen Inc. | 2D 3D TSV |
24102161 | 4 | Clicking 3'-azidothymidine into novel potent inhibitors of human immunodeficiency virus. | J Med Chem 56: 8765-80 (2013) | University of Minnesota | 2D 3D TSV |
24102134 | 19 | Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP. | J Med Chem 56: 8931-42 (2013) | University of North Carolina at Chapel Hill | 2D 3D TSV |
24100158 | 148 | Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90). | Bioorg Med Chem 21: 7047-63 (2013) | Nerviano Medical Sciences srl | 2D 3D TSV |
24100078 | 59 | Click chemistry based synthesis of dopamine D4 selective receptor ligands for the selection of potential PET tracers. | Bioorg Med Chem Lett 23: 6079-82 (2013) | Friedrich-Alexander University | 2D 3D TSV |
24100077 | 5 | Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties. | Bioorg Med Chem Lett 23: 6083-6 (2013) | Universit£ degli Studi di Bari 'Aldo Moro' | 2D 3D TSV |
24099996 | 16 | Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton. | Eur J Med Chem 69: 768-78 (2013) | China Pharmaceutical University | 2D 3D TSV |
24099995 | 21 | Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives. | Eur J Med Chem 69: 762-7 (2013) | Birla Institute of Technology | 2D 3D TSV |
24099220 | 40 | Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice. | J Med Chem 56: 8321-31 (2013) | Fudan University | 2D 3D TSV |
24099149 | 7 | Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity. | J Med Chem 56: 8860-71 (2013) | University of Cape Town | 2D 3D TSV |
24099080 | 10 | On the histone lysine methyltransferase activity of fungal metabolite chaetocin. | J Med Chem 56: 8616-25 (2013) | Imperial College | 2D 3D TSV |
24099035 | 5 | Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else? | J Med Chem 57: 2197-212 (2014) | CHUV-UNIL | 2D 3D TSV |
24098982 | 39 | Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents. | Cell Chem Biol 56: 8712-35 (2013) | AstraZeneca R&D Boston | 2D 3D TSV |
24098954 | 14 | Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of a7 nicotinic acetylcholine receptors. | J Med Chem 56: 8352-65 (2013) | University of California Irvine | 2D 3D TSV |
24095934 | 60 | Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors. | Bioorg Chem 51: 24-30 (2013) | Ewha Womans University, Seoul 120-750, Republic of Korea. | 2D 3D TSV |
24095762 | 18 | Design and application of a rigid quinazolone scaffold based on two-face Bima-helix mimicking. | Eur J Med Chem 69: 711-8 (2013) | Dalian University of Technology | 2D 3D TSV |
24095761 | 72 | Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. | Eur J Med Chem 69: 701-10 (2013) | Medical University of Gdansk | 2D 3D TSV |
24095757 | 24 | Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents. | Eur J Med Chem 69: 647-58 (2013) | Virginia Commonwealth University | 2D 3D TSV |
24095756 | 48 | Multifunctional tacrine-flavonoid hybrids with cholinergic,ß-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease. | Eur J Med Chem 69: 632-46 (2013) | China Pharmaceutical University | 2D 3D TSV |
24095755 | 2 | Design, synthesis and biological activities of some 7-aminocephalosporanic acid derivatives. | Eur J Med Chem 69: 622-31 (2013) | Karadeniz Technical University | 2D 3D TSV |
24095744 | 8 | New combination of pharmacophoric elements of potents1 ligands: design, synthesis ands receptor affinity of aminoethyl substituted tetrahydrobenzothiophenes. | Eur J Med Chem 69: 490-7 (2013) | Universit£t M£nster | 2D 3D TSV |
24095096 | 3 | Synthesis and in vitro evaluation of a novel radioligand foravß3 integrin receptor imaging: [18F]FPPA-c(RGDfK). | Bioorg Med Chem Lett 23: 6068-72 (2013) | University Hospital of Geneva | 2D 3D TSV |
24095018 | 24 | The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase. | Bioorg Med Chem 21: 6981-95 (2013) | East China Normal University | 2D 3D TSV |
24095016 | 28 | Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors. | Bioorg Med Chem 21: 6973-80 (2013) | Xi'an Jiaotong University | 2D 3D TSV |
24095015 | 4 | Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors. | Bioorg Med Chem 21: 7216-21 (2013) | Universit£ d'Orl£ans | 2D 3D TSV |
24095014 | 52 | N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors. | Bioorg Med Chem 21: 7074-82 (2013) | UOS of Cagliari | 2D 3D TSV |
24095010 | 21 | Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells. | Bioorg Med Chem 21: 7107-17 (2013) | Institut de Recherche Exp£rimentale et Clinique (IREC) | 2D 3D TSV |
24094818 | 26 | 6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3? inhibitors. | Bioorg Med Chem Lett 23: 6928-32 (2013) | Mitsubishi Tanabe Pharma Corporation | 2D 3D TSV |
24094816 | 28 | Hit-to-lead optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as a novel class of EP1 receptor antagonists. | Bioorg Med Chem Lett 23: 6064-7 (2013) | Asahi Kasei Pharma Corporation | 2D 3D TSV |
24094436 | 23 | Synthesis and biological evaluation of 5-carbamoyl-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors. | Bioorg Med Chem 21: 7025-37 (2013) | Kyushu University | 2D 3D TSV |
24094432 | 8 | Discovery of 2-aryl-8-hydroxy (or methoxy)-isoquinolin-1(2H)-ones as novel EGFR inhibitor by scaffold hopping. | Bioorg Med Chem 21: 6956-64 (2013) | Xi'an Jiaotong University | 2D 3D TSV |
24093940 | 85 | Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain. | J Med Chem 56: 7788-803 (2013) | Hoffmann-La Roche Inc | 2D 3D TSV |
24092756 | 18 | Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gaiß¿: identification of key CB1 contacts with the C-terminal helix a5 of Gai. | J Biol Chem 288: 32449-65 (2013) | North Carolina Central University | 2D 3D TSV |
24091081 | 49 | Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: a template-based approach. | Bioorg Med Chem Lett 23: 6178-82 (2013) | Merck Research Laboratories | 2D 3D TSV |
24091080 | 22 | Synthesis, docking, and biological studies of phenanthrene ?-diketo acids as novel HIV-1 integrase inhibitors. | Bioorg Med Chem Lett 23: 6146-51 (2013) | University of Tennessee Health Science Center | 2D 3D TSV |
24090918 | 2 | Indenoindoles and cyclopentacarbazoles as bioactive compounds: synthesis and biological applications. | Eur J Med Chem 69: 465-79 (2013) | The University of Oslo | 2D 3D TSV |
24090913 | 42 | Synthesis and biological evaluation of novel delta (?) opioid receptor ligands with diazatricyclodecane skeletons. | Eur J Med Chem 69: 413-26 (2013) | C.N.R. Istituto di Farmacologia Traslazionale | 2D 3D TSV |
24090912 | 54 | Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy. | Eur J Med Chem 69: 399-412 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
24090602 | 21 | Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. | Bioorg Med Chem 21: 7210-5 (2013) | University of Florida | 2D 3D TSV |
24090443 | 1 | Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicotinic acetylcholine receptors. | J Med Chem 56: 8943-7 (2013) | Northeastern University | 2D 3D TSV |
24090423 | 13 | Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors. | J Enzyme Inhib Med Chem 29: 547-54 (2014) | Birla Institute of Technology | 2D 3D TSV |
24090419 | 36 | A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors. | J Enzyme Inhib Med Chem 29: 571-81 (2014) | Birla Institute of Technology | 2D 3D TSV |
24090364 | 96 | Replacement of Thr32 and Gln34 in the C-terminal neuropeptide Y fragment 25-36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y(4) receptor. | J Med Chem 56: 8422-31 (2013) | University of Regensburg | 2D 3D TSV |
24090311 | 12 | Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening. | J Med Chem 56: 8073-88 (2013) | The Institute of Cancer Research | 2D 3D TSV |
24090135 | 201 | Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replication. | J Med Chem 56: 8049-65 (2013) | Sanofi | 2D 3D TSV |
24088190 | 38 | Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B. | Cell Chem Biol 56: 8834-48 (2013) | AstraZeneca India Pvt. Ltd. | 2D 3D TSV |
24088171 | 19 | Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor. | J Med Chem 56: 8746-56 (2013) | Boehringer Ingelheim Pharma GmbH & Co. KG | 2D 3D TSV |
24088053 | 11 | Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching. | J Med Chem 56: 8377-88 (2013) | E£tv£s Lor£nd University | 2D 3D TSV |
24084296 | 9 | In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model. | Bioorg Med Chem 21: 7083-90 (2013) | University of Mississippi | 2D 3D TSV |
24084160 | 42 | Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors. | Bioorg Med Chem Lett 23: 6134-7 (2013) | Shandong University | 2D 3D TSV |
24083941 | 7 | Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study. | J Med Chem 56: 8308-20 (2013) | Université Laval | 2D 3D TSV |
24083878 | 61 | Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors. | J Med Chem 56: 8484-96 (2013) | University of Eastern Finland | 2D 3D TSV |
24083782 | 48 | Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain. | J Med Chem 56: 7772-87 (2013) | Hoffmann-La Roche Inc | 2D 3D TSV |
24083656 | 52 | Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase. | J Med Chem 56: 7636-50 (2013) | Yale University | 2D 3D TSV |
24083411 | 7 | Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells. | J Enzyme Inhib Med Chem 29: 538-46 (2014) | National Tsing Hua University | 2D 3D TSV |
24080463 | 1 | Restraining the flexibility of the central linker in terameprocol results in constrained analogs with improved growth inhibitory activity. | Bioorg Med Chem Lett 23: 6127-33 (2013) | National University of Singapore | 2D 3D TSV |
24080460 | 24 | Serendipity in drug-discovery: a new series of 2-(benzyloxy)benzamides as TRPM8 antagonists. | Bioorg Med Chem Lett 23: 6118-22 (2013) | Pfizer Inc | 2D 3D TSV |
24079912 | 6 | Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a. | Biochemistry 52: 8139-49 (2013) | North Dakota State University | 2D 3D TSV |
24079820 | 6 | Use of 2'-spirocyclic ethers in HCV nucleoside design. | J Med Chem 57: 1826-35 (2014) | Pharmasset, Inc. | 2D 3D TSV |
24079662 | 54 | Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents. | J Med Chem 56: 7651-68 (2013) | Scripps Florida | 2D 3D TSV |
24077529 | 1 | Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors. | Eur J Med Chem 69: 384-92 (2013) | University of Naples | 2D 3D TSV |
24077527 | 11 | Squaric acid/4-aminoquinoline conjugates: novel potent antiplasmodial agents. | Eur J Med Chem 69: 365-72 (2013) | University of Lisbon. Av. Prof. Gama Pinto | 2D 3D TSV |
24077526 | 8 | Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors. | Eur J Med Chem 69: 356-64 (2013) | Birla Institute of Technology | 2D 3D TSV |
24077183 | 32 | Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivatives. | Eur J Med Chem 69: 331-7 (2013) | Universit£ di Pisa | 2D 3D TSV |
24076173 | 64 | Reversible inhibition of human acetylcholinesterase by methoxypyridinium species. | Bioorg Med Chem Lett 23: 5786-9 (2013) | The University of Iowa | 2D 3D TSV |
24076172 | 30 | Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders. | Bioorg Med Chem Lett 23: 6141-5 (2013) | Sanofi US | 2D 3D TSV |
24075732 | 43 | Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one. | Bioorg Med Chem Lett 23: 5829-32 (2013) | Merck Research Laboratories | 2D 3D TSV |
24075729 | 4 | Structure-based identification of novel PPAR gamma ligands. | Bioorg Med Chem Lett 23: 5795-802 (2013) | Universidade Federal do ABC | 2D 3D TSV |
24075145 | 17 | Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate. | Bioorg Med Chem 21: 6264-73 (2013) | GlaxoSmithKline | 2D 3D TSV |
24074877 | 135 | Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors. | Bioorg Med Chem 21: 6303-22 (2013) | University of Regensburg | 2D 3D TSV |
24074876 | 17 | Synthesis of sterically encumbered 11ß-aminoprogesterone derivatives and evaluation as 11ß-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists. | Bioorg Med Chem 21: 6274-81 (2013) | University of Alberta | 2D 3D TSV |
24074844 | 6 | Identification of novel PARP-1 inhibitors by structure-based virtual screening. | Bioorg Med Chem Lett 23: 5790-4 (2013) | St. John's University | 2D 3D TSV |
24074843 | 2 | Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety. | Bioorg Med Chem Lett 23: 5779-85 (2013) | Vanderbilt University Medical Center | 2D 3D TSV |
24074257 | 6 | Synthesis and bioconversions of formestane. | J Nat Prod 76: 1966-9 (2013) | The University of Tampa | 2D 3D TSV |
24074052 | 24 | Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor. | J Med Chem 56: 8196-200 (2013) | Monash University | 2D 3D TSV |
24074025 | 3 | Investigating the selectivity of metalloenzyme inhibitors. | J Med Chem 56: 7997-8007 (2013) | University of California San Diego | 2D 3D TSV |
24073986 | 94 | Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives. | J Med Chem 56: 7911-24 (2013) | State Key Laboratory of Bioreactor Engineering | 2D 3D TSV |
24073326 | 34 | Development of new | Medchemcomm 4: 932-941 (2013) | Moffitt Cancer Center | 2D 3D TSV |
24072711 | 28 | The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9. | J Biol Chem 288: 32787-96 (2013) | Georg-August-University of Goettingen | 2D 3D TSV |
24072709 | 11 | Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site. | J Biol Chem 288: 33124-35 (2013) | University of Copenhagen | 2D 3D TSV |
24072703 | 64 | Structural determinants of Tau aggregation inhibitor potency. | J Biol Chem 288: 32599-611 (2013) | The Ohio State University | 2D 3D TSV |
24071448 | 24 | Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors. | Bioorg Med Chem 21: 6456-65 (2013) | Universit£ degli Studi 'Aldo Moro' di Bari | 2D 3D TSV |
24071447 | 39 | Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10. | Bioorg Med Chem 21: 6378-84 (2013) | Gifu Pharmaceutical University | 2D 3D TSV |
24071446 | 39 | Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors. | Bioorg Med Chem 21: 6466-76 (2013) | China Pharmaceutical University | 2D 3D TSV |
24071445 | 30 | Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors. | Bioorg Med Chem 21: 6282-91 (2013) | National Taiwan University | 2D 3D TSV |
24070783 | 9 | Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain. | Bioorg Med Chem Lett 23: 6188-91 (2013) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24070067 | 20 | Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor. | ACS Chem Biol 8: 2715-23 (2013) | Duke University Medical Center | 2D 3D TSV |
24070012 | 24 | Small molecule probe suitable for in situ profiling and inhibition of protein disulfide isomerase. | ACS Chem Biol 8: 2577-85 (2013) | National University of Singapore | 2D 3D TSV |
24069953 | 6 | Discovery of a novel series of potent non-nucleoside inhibitors of hepatitis C virus NS5B. | J Med Chem 56: 8163-82 (2013) | Hoffmann-La Roche Inc | 2D 3D TSV |
24063907 | 14 | Further SAR studies on bicyclic basic merbarone analogues as potent antiproliferative agents. | Bioorg Med Chem 21: 6328-36 (2013) | Universit£ degli Studi di Genova | 2D 3D TSV |
24063433 | 72 | Structure-activity relationships and discovery of a G protein biased ? opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain. | J Med Chem 56: 8019-31 (2013) | Trevena, Inc. | 2D 3D TSV |
24063417 | 14 | Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging. | J Med Chem 56: 7890-901 (2013) | Kyoto University | 2D 3D TSV |
24063369 | 20 | Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI). | J Med Chem 56: 7516-26 (2013) | University of Bologna | 2D 3D TSV |
24062308 | 21 | Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine. | J Biol Chem 288: 32160-71 (2013) | Hebrew University of Jerusalem | 2D 3D TSV |
24060489 | 1 | Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists ofß-catenin/TCF transcription. | Bioorg Med Chem Lett 23: 5814-20 (2013) | University of Michigan | 2D 3D TSV |
24060488 | 6 | Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors. | Bioorg Med Chem Lett 23: 5874-7 (2013) | Virginia Commonwealth University | 2D 3D TSV |
24060487 | 14 | Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib. | Bioorg Med Chem Lett 23: 5860-4 (2013) | Vanderbilt University | 2D 3D TSV |
24059701 | 21 | Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors. | J Enzyme Inhib Med Chem 29: 582-9 (2014) | Qingdao University | 2D 3D TSV |
24058293 | 12 | Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors. | PLoS Biol 11: (2013) | Durham University | 2D 3D TSV |
24055079 | 34 | Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors. | Bioorg Med Chem 21: 6349-58 (2013) | GlaxoSmithKline | 2D 3D TSV |
24055078 | 14 | Synthesis of amino-hydroxy-benzocycloheptenones as potent, selective, non-peptidic dinuclear zinc metalloaminopeptidase inhibitors. | Bioorg Med Chem 21: 6447-55 (2013) | Universit£ de Haute Alsace | 2D 3D TSV |
24055077 | 8 | Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies. | Bioorg Med Chem 21: 6477-83 (2013) | Fudan University | 2D 3D TSV |
24055076 | 8 | Binding mode characterization of 6?- and 6?-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists. | Bioorg Med Chem 21: 6405-13 (2013) | Virginia Commonwealth University | 2D 3D TSV |
24055075 | 42 | Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists. | Bioorg Med Chem 21: 6542-53 (2013) | Glenmark Pharmaceuticals Ltd | 2D 3D TSV |
24055046 | 11 | Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles as inhibitors of transforming growth factor-ß type I receptor (ALK5). | Bioorg Med Chem Lett 23: 5850-4 (2013) | Capital Normal University | 2D 3D TSV |
24055006 | 38 | A small molecule screen identifies selective inhibitors of urea transporter UT-A. | Chem Biol 20: 1235-44 (2013) | University of California San Francisco | 2D 3D TSV |
24054487 | 19 | Bacterial neuraminidase inhibitory effects of prenylated isoflavones from roots of Flemingia philippinensis. | Bioorg Med Chem 21: 6398-404 (2013) | Graduate School of Gyeongsang National University | 2D 3D TSV |
24054122 | 26 | Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors. | Bioorg Med Chem Lett 23: 5887-92 (2013) | 'Al. I. Cuza' University of Iasi | 2D 3D TSV |
24054120 | 5 | The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations. | Bioorg Med Chem Lett 23: 5992-6000 (2013) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24053674 | 80 | Discovery of pteridin-7(8H)-one-based irreversible inhibitors targeting the epidermal growth factor receptor (EGFR) kinase T790M/L858R mutant. | J Med Chem 56: 7821-37 (2013) | East China University of Science & Technology | 2D 3D TSV |
24053646 | 43 | 3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice. | J Med Chem 56: 7925-38 (2013) | China Pharmaceutical University | 2D 3D TSV |
24053596 | 10 | Telomere maintenance as a target for drug discovery. | J Med Chem 57: 521-38 (2014) | University of North Carolina at Chapel Hill | 2D 3D TSV |
24051074 | 26 | Conformational restriction approach to ?-secretase (BACE1) inhibitors III: effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations. | Bioorg Med Chem 21: 6506-22 (2013) | Hokkaido University | 2D 3D TSV |
24050887 | 49 | Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists. | Bioorg Med Chem Lett 23: 6001-3 (2013) | Merck Research Laboratories | 2D 3D TSV |
24050790 | 1 | Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand. | J Med Chem 56: 8191-5 (2013) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
24050755 | 10 | Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254). | J Med Chem 56: 7976-96 (2013) | Vanderbilt University | 2D 3D TSV |
24050653 | 59 | Derivatives of dibenzothiophene for positron emission tomography imaging ofa7-nicotinic acetylcholine receptors. | J Med Chem 56: 7574-89 (2013) | The Johns Hopkins University School of Medicine | 2D 3D TSV |
24050112 | 1 | New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo. | J Med Chem 56: 7851-61 (2013) | Universidad Complutense de Madrid | 2D 3D TSV |
24047900 | 19 | Complexes of Trypanosoma cruzi sterol 14a-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity. | J Biol Chem 288: 31602-15 (2013) | Vanderbilt University | 2D 3D TSV |
24047800 | 19 | Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors. | Bioorg Med Chem Lett 23: 5836-9 (2013) | Toho University | 2D 3D TSV |
24047231 | 52 | Design, synthesis and discovery of picomolar selective α4β2 nicotinic acetylcholine receptor ligands. | J Med Chem 56: 8404-21 (2013) | Georgetown University | 2D 3D TSV |
24047141 | 64 | Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. | J Med Chem 56: 8298-307 (2013) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
24044938 | 6 | Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring. | Eur J Med Chem 69: 262-77 (2013) | Research Foundation Itsuu Laboratory | 2D 3D TSV |
24044937 | 59 | Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group. | Eur J Med Chem 69: 244-61 (2013) | University of Lille | 2D 3D TSV |
24044867 | 86 | Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. | J Med Chem 56: 8032-48 (2013) | Califia Bio Inc. | 2D 3D TSV |
24044500 | 2 | Synthesis and structure-activity relationship studies of novel dihydropyridones as androgen receptor modulators. | J Med Chem 56: 8280-97 (2013) | National Cancer Institute-Frederick | 2D 3D TSV |
24044434 | 71 | Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models. | J Med Chem 56: 8089-103 (2013) | Università di Pisa | 2D 3D TSV |
24044354 | 11 | A general method for making peptide therapeutics resistant to serine protease degradation: application to dipeptidyl peptidase IV substrates. | J Med Chem 56: 8339-51 (2013) | Tufts University | 2D 3D TSV |
24042009 | 89 | Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitors. | Bioorg Med Chem Lett 23: 5923-30 (2013) | Genentech Inc | 2D 3D TSV |
24042008 | 6 | [(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues. | Bioorg Med Chem Lett 23: 5953-7 (2013) | Sungkyunkwan University | 2D 3D TSV |
24042006 | 78 | Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase. | Bioorg Med Chem Lett 23: 5896-9 (2013) | Array BioPharma Inc. | 2D 3D TSV |
24042005 | 2 | Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1). | Bioorg Med Chem Lett 23: 5971-4 (2013) | Northeastern University | 2D 3D TSV |
24041123 | 20 | Peripherally selective diphenyl purine antagonist of the CB1 receptor. | J Med Chem 56: 8066-72 (2013) | Research Triangle Institute | 2D 3D TSV |
24040942 | 632 | Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3. | J Med Chem 56: 7358-71 (2013) | University of North Carolina at Chapel Hill | 2D 3D TSV |
24040835 | 14 | The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity. | Biochemistry 52: 7486-99 (2013) | Mayo Clinic | 2D 3D TSV |
24040486 | 30 | Identification of Potent and Selective Diphenylpropanamide ROR? Inhibitors. | ACS Med Chem Lett 4: 79-84 (2013) | New York University School of Medicine | 2D 3D TSV |
24036119 | 2 | Role of the two structural domains from the periplasmic Escherichia coli histidine-binding protein HisJ. | J Biol Chem 288: 31409-22 (2013) | University of Calgary | 2D 3D TSV |
24036043 | 22 | Novel N-methylsulfonamide and retro-N-methylsulfonamide derivatives as 17ß-hydroxysteroid dehydrogenase type 2 (17ß-HSD2) inhibitors with good ADME-related physicochemical parameters. | Eur J Med Chem 69: 201-15 (2013) | Saarland University | 2D 3D TSV |
24036042 | 2 | Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: synthesis and biological evaluation. Part II. | Eur J Med Chem 69: 191-200 (2013) | Shandong University | 2D 3D TSV |
24035514 | 59 | TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides. | Bioorg Med Chem 21: 6657-64 (2013) | Seoul National University | 2D 3D TSV |
24035485 | 48 | Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity. | Bioorg Med Chem Lett 23: 6004-9 (2013) | Merck Research Laboratories | 2D 3D TSV |
24035340 | 3 | Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects. | Bioorg Med Chem Lett 23: 5949-52 (2013) | Vidasym | 2D 3D TSV |
24035339 | 4 | Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs. | Bioorg Med Chem Lett 23: 6025-8 (2013) | Colorado State University | 2D 3D TSV |
24035338 | 82 | Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension. | Bioorg Med Chem Lett 23: 5975-9 (2013) | Toray Industries Inc | 2D 3D TSV |
24035337 | 10 | 2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character. | Bioorg Med Chem Lett 23: 5945-8 (2013) | Virginia Commonwealth University | 2D 3D TSV |
24035092 | 2 | Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform B. | Bioorg Med Chem Lett 23: 5912-4 (2013) | Saint John's University | 2D 3D TSV |
24032981 | 25 | IspC as target for antiinfective drug discovery: synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters. | J Med Chem 56: 8151-62 (2013) | Lehrstuhl für Biochemie | 2D 3D TSV |
24028535 | 28 | Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists. | J Med Chem 56: 7706-14 (2013) | Leiden University | 2D 3D TSV |
24028490 | 46 | O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier. | J Med Chem 56: 8139-50 (2013) | University of Notre Dame | 2D 3D TSV |
24026016 | 56 | Synthesis and biological evaluation of N-(2-fluorophenyl)-2ß-deoxyfuconojirimycin acetamide as a potent inhibitor fora-l-fucosidases. | Bioorg Med Chem 21: 6565-73 (2013) | University of Toyama | 2D 3D TSV |
24025069 | 36 | Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors. | J Med Chem 56: 7536-51 (2013) | University of Padova | 2D 3D TSV |
24025027 | 5 | Inhibiting the HIV integration process: past, present, and the future. | J Med Chem 57: 539-66 (2014) | "Sapienza" Universit£ di Roma | 2D 3D TSV |
24022489 | 18 | Structural basis of mycobacterial inhibition by cyclomarin A | J Biol Chem 288: 30883-91 (2013) | Novartis Institute for Tropical Diseases | 2D 3D TSV |
24021582 | 52 | Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases. | Bioorg Med Chem 21: 6582-91 (2013) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
24021581 | 72 | Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position. | Bioorg Med Chem 21: 6788-95 (2013) | Queen's University | 2D 3D TSV |
24021463 | 37 | Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). | Bioorg Med Chem Lett 23: 5488-97 (2013) | Forma Therapeutics Inc | 2D 3D TSV |
24018188 | 4 | Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides. | Bioorg Med Chem Lett 23: 5484-7 (2013) | University of New Mexico | 2D 3D TSV |
24015967 | 71 | Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains. | J Med Chem 56: 7501-15 (2013) | GlaxoSmithKline | 2D 3D TSV |
24015910 | 18 | Identification of a new class of glucokinase activators through structure-based design. | J Med Chem 56: 7669-78 (2013) | Array BioPharma | 2D 3D TSV |
24015767 | 3 | Drug discovery for neglected diseases: molecular target-based and phenotypic approaches. | J Med Chem 56: 7719-26 (2013) | University of Dundee | 2D 3D TSV |
24015327 | 42 | Development of a chimeric c-Src kinase and HDAC inhibitor. | ACS Med Chem Lett 4: 779-783 (2013) | University of Michigan | 2D 3D TSV |
24013413 | 9 | 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase II? catalytic inhibitor with low DNA damage. | Eur J Med Chem 69: 139-45 (2013) | Ewha Womans University | 2D 3D TSV |
24012712 | 10 | Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents. | Eur J Med Chem 69: 77-89 (2013) | Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University) | 2D 3D TSV |
24012377 | 22 | Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition. | Bioorg Med Chem 21: 6674-80 (2013) | Universit£ degli Studi di Firenze | 2D 3D TSV |
24012376 | 5 | Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B). | Bioorg Med Chem 21: 6634-41 (2013) | Karolinska Institutet | 2D 3D TSV |
24012370 | 44 | Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance. | Chem Biol 20: 1116-24 (2013) | University of Massachusetts Medical School, Worcester, MA 01605, USA | 2D 3D TSV |
24012184 | 1 | Efforts toward broadening the spectrum of arylomycin antibiotic activity. | Bioorg Med Chem Lett 23: 5654-9 (2013) | The Scripps Research Institute | 2D 3D TSV |
24012183 | 91 | Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase. | Bioorg Med Chem Lett 23: 5533-9 (2013) | Genentech | 2D 3D TSV |
24012182 | 28 | Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives. | Bioorg Med Chem Lett 23: 5498-502 (2013) | North-West University | 2D 3D TSV |
24012181 | 46 | Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors. | Bioorg Med Chem Lett 23: 5515-8 (2013) | Sogang University | 2D 3D TSV |
24012179 | 30 | Calix[4]arene methylenebisphosphonic acids as inhibitors of protein tyrosine phosphatase 1B. | Bioorg Med Chem Lett 23: 5619-23 (2013) | National Academy of Sciences of Ukraine | 2D 3D TSV |
24012123 | 5 | New chemotypes for wALADin1-like inhibitors of delta-aminolevulinic acid dehydratase from Wolbachia endobacteria. | Bioorg Med Chem Lett 23: 5558-62 (2013) | University Hospital of Bonn | 2D 3D TSV |
24012121 | 49 | Synthesis and SAR studies of 5-(pyridin-4-yl)-1,3,4-thiadiazol-2-amine derivatives as potent inhibitors of Bloom helicase. | Bioorg Med Chem Lett 23: 5660-6 (2013) | National Center for Advancing Translational Sciences | 2D 3D TSV |
24012118 | 6 | Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands. | Bioorg Med Chem Lett 23: 5586-91 (2013) | Universidad de Santiago de Compostela | 2D 3D TSV |
24011644 | 81 | Heterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3-phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core. | Bioorg Med Chem Lett 23: 5571-4 (2013) | Bristol-Myers Squibb Co. | 2D 3D TSV |
24007918 | 6 | A Casein kinase 1/Checkpoint kinase 1 pyrazolo-pyridine protein kinase inhibitor as novel activator of the p53 pathway. | Bioorg Med Chem Lett 23: 5578-85 (2013) | University of Edinburgh Cancer Research Centre in the Institute of Genetics and Molecular Medicine | 2D 3D TSV |
24007860 | 46 | Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold. | Eur J Med Chem 69: 55-68 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
24007859 | 33 | Nonpeptidic angiotensin II AT? receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles. | Eur J Med Chem 69: 44-54 (2013) | Beijing Institute of Technology | 2D 3D TSV |
24007511 | 10 | Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity. | J Med Chem 56: 7334-42 (2013) | University of Freiburg | 2D 3D TSV |
24004176 | 16 | Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors. | ACS Chem Biol 8: 2550-60 (2013) | Georgia Institute of Technology | 2D 3D TSV |
24004110 | 7 | Discovery of inhibitors of Bacillus anthracis primase DnaG. | Biochemistry 52: 6905-10 (2013) | University of Michigan | 2D 3D TSV |
24003232 | 14 | Structural, functional, and inhibition studies of a Gcn5-related N-acetyltransferase (GNAT) superfamily protein PA4794: a new C-terminal lysine protein acetyltransferase from pseudomonas aeruginosa. | J Biol Chem 288: 30223-35 (2013) | University of Virginia | 2D 3D TSV |
24003220 | 1 | Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approaches. | J Biol Chem 288: 30125-38 (2013) | Sanofi Oncology | 2D 3D TSV |